
<html lang="en"     class="pb-page"  data-request-id="57e126da-c299-4c6e-94bc-6b6ca8d87005"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2018.61.issue-17;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.7b01847;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Novel Scaffolds for Dual Specificity Tyrosine-Phosphorylation-Regulated Kinase (DYRK1A) Inhibitors" /></meta><meta name="dc.Creator" content="Anna  Czarna" /></meta><meta name="dc.Creator" content="Jinhua  Wang" /></meta><meta name="dc.Creator" content="Diana  Zelencova" /></meta><meta name="dc.Creator" content="Yao  Liu" /></meta><meta name="dc.Creator" content="Xianming  Deng" /></meta><meta name="dc.Creator" content="Hwan Geun  Choi" /></meta><meta name="dc.Creator" content="Tinghu  Zhang" /></meta><meta name="dc.Creator" content="Wenjun  Zhou" /></meta><meta name="dc.Creator" content="Jae Won  Chang" /></meta><meta name="dc.Creator" content="Hanne  Kildalsen" /></meta><meta name="dc.Creator" content="Ole Morten  Seternes" /></meta><meta name="dc.Creator" content="Nathanael S.  Gray" /></meta><meta name="dc.Creator" content="Richard A.  Engh" /></meta><meta name="dc.Creator" content="Ulli  Rothweiler" /></meta><meta name="dc.Description" content="DYRK1A is one of five members of the dual-specificity tyrosine (Y) phosphorylation-regulated kinase (DYRK) family. The DYRK1A gene is located in the Down syndrome critical region and regulates cell..." /></meta><meta name="Description" content="DYRK1A is one of five members of the dual-specificity tyrosine (Y) phosphorylation-regulated kinase (DYRK) family. The DYRK1A gene is located in the Down syndrome critical region and regulates cell..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 10, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01847" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01847" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01847" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01847" /></link>
        
    
    

<title>Novel Scaffolds for Dual Specificity Tyrosine-Phosphorylation-Regulated Kinase (DYRK1A) Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01847" /></meta><meta property="og:title" content="Novel Scaffolds for Dual Specificity Tyrosine-Phosphorylation-Regulated Kinase (DYRK1A) Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0011.jpeg" /></meta><meta property="og:description" content="DYRK1A is one of five members of the dual-specificity tyrosine (Y) phosphorylation-regulated kinase (DYRK) family. The DYRK1A gene is located in the Down syndrome critical region and regulates cellular processes related to proliferation and differentiation of neuronal progenitor cells during early development. This has focused research on its role in neuronal degenerative diseases, including Alzheimer’s and Down syndrome. Recent studies have also shown a possible role of DYRK1A in diabetes. Here we report a variety of scaffolds not generally known for DYRK1A inhibition, demonstrating their effects in in vitro assays and also in cell cultures. These inhibitors effectively block the tau phosphorylation that is a hallmark of Alzheimer’s disease. The crystal structures of these inhibitors support the design of optimized and novel therapeutics." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01847"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01847">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01847&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01847&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01847&amp;href=/doi/10.1021/acs.jmedchem.7b01847" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 7560-7572</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00674" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00040" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Novel Scaffolds for Dual Specificity Tyrosine-Phosphorylation-Regulated Kinase (DYRK1A) Inhibitors</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Anna Czarna</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anna Czarna</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacy, Faculty of Health Sciences, UiT The Arctic University of Norway, N-9037 Tromsø, Norway</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anna++Czarna">Anna Czarna</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jinhua Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jinhua Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Cancer Biology, Dana-Farber Cancer Institute, and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jinhua++Wang">Jinhua Wang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Diana Zelencova</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Diana Zelencova</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">The Norwegian Structural Biology Centre, Department of Chemistry, UiT The Arctic University of Norway, N-9037 Tromsø, Norway</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Diana++Zelencova">Diana Zelencova</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yao Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yao Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Cancer Biology, Dana-Farber Cancer Institute, and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yao++Liu">Yao Liu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xianming Deng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xianming Deng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Cancer Biology, Dana-Farber Cancer Institute, and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xianming++Deng">Xianming Deng</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9354-5864" title="Orcid link">http://orcid.org/0000-0002-9354-5864</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hwan Geun Choi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hwan Geun Choi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Cancer Biology, Dana-Farber Cancer Institute, and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hwan+Geun++Choi">Hwan Geun Choi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tinghu Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tinghu Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Cancer Biology, Dana-Farber Cancer Institute, and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tinghu++Zhang">Tinghu Zhang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Wenjun Zhou</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wenjun Zhou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Cancer Biology, Dana-Farber Cancer Institute, and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wenjun++Zhou">Wenjun Zhou</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jae Won Chang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jae Won Chang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Cancer Biology, Dana-Farber Cancer Institute, and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jae+Won++Chang">Jae Won Chang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hanne Kildalsen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hanne Kildalsen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacy, Faculty of Health Sciences, UiT The Arctic University of Norway, N-9037 Tromsø, Norway</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hanne++Kildalsen">Hanne Kildalsen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ole Morten Seternes</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ole Morten Seternes</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacy, Faculty of Health Sciences, UiT The Arctic University of Norway, N-9037 Tromsø, Norway</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ole+Morten++Seternes">Ole Morten Seternes</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nathanael S. Gray</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nathanael S. Gray</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Cancer Biology, Dana-Farber Cancer Institute, and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nathanael+S.++Gray">Nathanael S. Gray</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5354-7403" title="Orcid link">http://orcid.org/0000-0001-5354-7403</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Richard A. Engh</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Richard A. Engh</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">The Norwegian Structural Biology Centre, Department of Chemistry, UiT The Arctic University of Norway, N-9037 Tromsø, Norway</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Richard+A.++Engh">Richard A. Engh</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6207-0560" title="Orcid link">http://orcid.org/0000-0002-6207-0560</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Ulli Rothweiler</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ulli Rothweiler</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">The Norwegian Structural Biology Centre, Department of Chemistry, UiT The Arctic University of Norway, N-9037 Tromsø, Norway</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#67120b0b0e491508130f10020e0b021527120e13490908"><span class="__cf_email__" data-cfemail="47322b2b2e693528332f30222e2b223507322e33692928">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ulli++Rothweiler">Ulli Rothweiler</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2802-7558" title="Orcid link">http://orcid.org/0000-0003-2802-7558</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01847&amp;href=/doi/10.1021%2Facs.jmedchem.7b01847" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 7560–7572</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 10, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 December 2017</li><li><span class="item_label"><b>Published</b> online</span>10 August 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 September 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01847" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01847</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7560%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAnna%2BCzarna%252C%2BJinhua%2BWang%252C%2BDiana%2BZelencova%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D17%26contentID%3Dacs.jmedchem.7b01847%26title%3DNovel%2BScaffolds%2Bfor%2BDual%2BSpecificity%2BTyrosine-Phosphorylation-Regulated%2BKinase%2B%2528DYRK1A%2529%2BInhibitors%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7572%26publicationDate%3DSeptember%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01847"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2988</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">9</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01847" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Novel Scaffolds for Dual Specificity Tyrosine-Phosphorylation-Regulated Kinase (DYRK1A) Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Anna&quot;,&quot;last_name&quot;:&quot;Czarna&quot;},{&quot;first_name&quot;:&quot;Jinhua&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Diana&quot;,&quot;last_name&quot;:&quot;Zelencova&quot;},{&quot;first_name&quot;:&quot;Yao&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Xianming&quot;,&quot;last_name&quot;:&quot;Deng&quot;},{&quot;first_name&quot;:&quot;Hwan&quot;,&quot;last_name&quot;:&quot;Geun Choi&quot;},{&quot;first_name&quot;:&quot;Tinghu&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Wenjun&quot;,&quot;last_name&quot;:&quot;Zhou&quot;},{&quot;first_name&quot;:&quot;Jae&quot;,&quot;last_name&quot;:&quot;Won Chang&quot;},{&quot;first_name&quot;:&quot;Hanne&quot;,&quot;last_name&quot;:&quot;Kildalsen&quot;},{&quot;first_name&quot;:&quot;Ole&quot;,&quot;last_name&quot;:&quot;Morten Seternes&quot;},{&quot;first_name&quot;:&quot;Nathanael&quot;,&quot;last_name&quot;:&quot;S. Gray&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;A. Engh&quot;},{&quot;first_name&quot;:&quot;Ulli&quot;,&quot;last_name&quot;:&quot;Rothweiler&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;10&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;7560-7572&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01847&quot;},&quot;abstract&quot;:&quot;DYRK1A is one of five members of the dual-specificity tyrosine (Y) phosphorylation-regulated kinase (DYRK) family. The DYRK1A gene is located in the Down syndrome critical region and regulates cellular processes related to proliferation and differentiation of neuronal progenitor cells during early development. This has focused research on its role in neuronal degenerative diseases, including Alzheimer’s and Down syndrome. Recent studies have also shown a possible role of DYRK1A in diabetes. Here we report a variety of scaffolds not generally known for DYRK1A inhibition, demonstrating their effects in in vitro assays and also in cell cultures. These inhibitors effectively block the tau phosphorylation that is a hallmark of Alzheimer’s disease. The crystal structures of these inhibitors support the design of optimized and novel therapeutics.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01847&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01847" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01847&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01847" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01847&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01847" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01847&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01847&amp;href=/doi/10.1021/acs.jmedchem.7b01847" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01847" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01847" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (11 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01847%26sid%3Dliteratum%253Aachs%26pmid%3D30095246%26genre%3Darticle%26aulast%3DCzarna%26date%3D2018%26atitle%3DNovel%2BScaffolds%2Bfor%2BDual%2BSpecificity%2BTyrosine-Phosphorylation-Regulated%2BKinase%2B%2528DYRK1A%2529%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D17%26spage%3D7560%26epage%3D7572%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292201" title="Scaffolds">Scaffolds</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/jmcmar.2018.61.issue-17/20180913/jmcmar.2018.61.issue-17.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/medium/jm-2017-01847p_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01847&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">DYRK1A is one of five members of the dual-specificity tyrosine (Y) phosphorylation-regulated kinase (DYRK) family. The DYRK1A gene is located in the Down syndrome critical region and regulates cellular processes related to proliferation and differentiation of neuronal progenitor cells during early development. This has focused research on its role in neuronal degenerative diseases, including Alzheimer’s and Down syndrome. Recent studies have also shown a possible role of DYRK1A in diabetes. Here we report a variety of scaffolds not generally known for DYRK1A inhibition, demonstrating their effects in in vitro assays and also in cell cultures. These inhibitors effectively block the tau phosphorylation that is a hallmark of Alzheimer’s disease. The crystal structures of these inhibitors support the design of optimized and novel therapeutics.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53412" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53412" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is the primary cause of dementia in the elderly.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> AD affects less than 5% of individuals 65 years of age and younger, but the incidence of AD reaches nearly 40% in patients 85 years of age and older.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> This neurodegenerative disorder is characterized by neuronal death and loss of gray matter in the frontal cortex and hippocampus. Memory loss is a typical symptom of AD and has been linked to the accumulation of amyloid plaques and neurofibrillary tangles (NFTs).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The latter process is mediated by hyperphosphorylation of tau proteins that are inactive and form multiple aggregates. According to the β-amyloid cascade hypothesis, the deposition of insoluble β-amyloid is responsible for neuronal death. Plaques are constituted by β-amyloid peptides (Aβ) that are generated via the cleavage of the amyloid precursor protein (APP) by β- and γ-secretases. Aβ-fragments, 37–42 amino acids in length, may produce soluble oligomers, although they aggregate into insoluble β-amyloid plaques in AD.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> Alternatively, the insoluble hyperphosphorylated tau proteins and the buildup of NFTs may be the etiology of neuronal death.<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4−6)</a> Both mechanisms of neuronal pathology depend on the kinase DYRK1A, which regulates the cell cycle, neuronal differentiation, and synaptic transmission.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><div class="NLM_p">Increased levels of DYRK1A are present in the brain of patients with AD and in other neurodegenerative diseases, including Parkinson, Huntington, and Pick syndromes.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The human <i>DYRK1A</i> gene is located in the Down syndrome critical region (DSCR) encoded by chromosome 21, and the overexpression of DYRK1A likely contributes to the neurological abnormalities of this disorder.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><div class="NLM_p last">DYRK1A increases the secretase-mediated cleavage of APP into Aβ peptides. DYRK1A phosphorylates APP directly,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and the Aβ peptides stimulate DYRK1A expression in a positive feedback loop.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Additionally DYRK1A phosphorylates presenilin 1 (PSEN1),<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> one of the four core proteins in the γ-secretase complex, which enhances secretase activity. DYRK1A phosphorylates human microtubule associated protein tau at 11 different sites,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> whereby most of the tau protein becomes hyperphosphorylated. The initial phosphorylation of tau by DYRK1A triggers tau phosphorylation by GSK3β, which potentiates self-aggregation and fibril formation in vitro.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> Because of the central role of DYRK1A in the development and progression of AD, DYRK1A has emerged as a high priority target for inhibition, offering a novel approach for the treatment of AD. In recent years, evidence has built up that points to a role of DYRK1A in diabetes and β-cell proliferation,<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13−15)</a> expanding the pharmaceutical application of a DYRK1A inhibitor. Therefore, we screened a diverse set of scaffolds for their ability to inhibit DYRK1A kinase activity and to prevent tau phosphorylation. The diversity of the novel scaffolds and the binding modes determined by crystal structure and in vitro assays may lead to the development of novel strategies for the clinical treatment of AD.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41451" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41451" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Identification of Novel DYRK1A Inhibitors</h3><div class="NLM_p">Novel DYRK1A inhibitors were identified by employing KinomeScan screening data of an in-house library of approximately 1000 compounds including previously synthesized kinase inhibitors. Twenty-three compounds were chosen as candidates for activity assay and their ability to inhibit the phosphorylation of DYRKtide (RRRFRPASPLRGPPK) by DYRK1A at a fixed concentration of 20 μM with an ATP regenerative assay (Cook et al.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a>). The results for the most promising compounds are shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, and all 23 compounds are shown in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b01847/suppl_file/jm7b01847_si_001.pdf" class="ext-link">Supporting Information Table S1</a>. The inhibitors had a broad range of activity: eight compounds showed strong inhibition (remaining activity of <5%), eight compounds showed moderate inhibition (11–46% remaining activity), and six compounds showed little or no inhibition (70–100% remaining activity). Fifteen inhibitors that showed at least 50% inhibition were titrated in decreasing concentrations (200 μM to 20 nM) to determine the IC<sub>50</sub> and <i>K</i><sub>i</sub> values.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibitory Activity of the Selected Most Active Compounds<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">code</th><th class="colsep0 rowsep0" align="center">name</th><th class="colsep0 rowsep0" align="center">remaining activity at 20 μM (%)</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center">kinome scan, 10 μM</th><th class="colsep0 rowsep0" align="center">kinome scan, 1 μM</th><th class="colsep0 rowsep0" align="center">cell line tau phosphorylation</th><th class="colsep0 rowsep0" align="center">cell line luciferase assay (μM)<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">PDB code</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>AC22</b></td><td class="colsep0 rowsep0" align="left">XMD8-49</td><td class="colsep0 rowsep0" align="left">24</td><td class="colsep0 rowsep0" align="left">>6000</td><td class="colsep0 rowsep0" align="left">>2800</td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">active</td><td class="colsep0 rowsep0" align="left">5–10</td><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIL">6EIL</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>AC23</b></td><td class="colsep0 rowsep0" align="left">XMD8-62e</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">4200</td><td class="colsep0 rowsep0" align="left">2015</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">active</td><td class="colsep0 rowsep0" align="left">0.5–1</td><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIP">6EIP</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>AC20</b></td><td class="colsep0 rowsep0" align="left">HG-8-60-1</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">3500</td><td class="colsep0 rowsep0" align="left">1680</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">active</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIJ">6EIJ</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>AC25</b></td><td class="colsep0 rowsep0" align="left">XMD15-27</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">1200</td><td class="colsep0 rowsep0" align="left">575</td><td class="colsep0 rowsep0" align="left">0.15</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">active</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIR">6EIR</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>AC24</b></td><td class="colsep0 rowsep0" align="left">XMD14-124</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">800</td><td class="colsep0 rowsep0" align="left">383</td><td class="colsep0 rowsep0" align="left">0.05</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">active</td><td class="colsep0 rowsep0" align="left">10–20</td><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIQ">6EIQ</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>AC27</b></td><td class="colsep0 rowsep0" align="left">JWC-055</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">532</td><td class="colsep0 rowsep0" align="left">252</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">active</td><td class="colsep0 rowsep0" align="left">0.05–0.1</td><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIS">6EIS</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>AC15</b></td><td class="colsep0 rowsep0" align="left">XMD7-112</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">329</td><td class="colsep0 rowsep0" align="left">158</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">active</td><td class="colsep0 rowsep0" align="left">5–10</td><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EJ4">6EJ4</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>AC12</b></td><td class="colsep0 rowsep0" align="left">XMD7-117</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">216</td><td class="colsep0 rowsep0" align="left">104</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">active</td><td class="colsep0 rowsep0" align="left">1–5</td><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIF">6EIF</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>AC28</b></td><td class="colsep0 rowsep0" align="left">JWD-065<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIV">6EIV</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values determined in the Cook assay at 25 °C and 128 μM ATP, <i>K</i><sub>i</sub> calculated with a <i>K</i><sub>M</sub> value for DYRK1A of 118 μM.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Due to solubility problems of the compound in stock solution and resulting uncertainty of the concentration, binding kinetics were not measured; however a cocrystal structure with inhibitor could be obtained.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Values available for DYRK1B only (0.5 and 0.2, respectively).</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">Concentration where inhibitory activity was above 1.5-fold the basal level.</p></div><div class="footnote" id="t1fn5"><sup><sup>e</sup></sup><p class="last">Compound failed to inhibit DYRK1A in this assay and negatively interferes with the cells.</p></div></div></div><div class="NLM_p last">Compounds <b>AC12</b>, <b>AC13</b>, <b>AC14</b>, <b>AC15</b>, and <b>AC27</b> were found to possess the highest ability to inhibit the phosphorylation of DYRKtide, with <i>K</i><sub>i</sub> values around 100–250 nM. <b>AC7</b>, <b>AC24</b>, and <b>AC25</b> inhibitors showed <i>K</i><sub>i</sub> values of around 326–570 nM. Inhibitors with identical core scaffolds revealed similar <i>K</i><sub>i</sub> values, as seen for the two pairs <b>AC12</b> and <b>AC15</b> (∼104 nM and ∼158 nM), and <b>AC24</b> and <b>AC25</b> (383 nM and 575 nM, respectively). The remaining compounds (<b>AC2</b>, <b>AC8</b>, <b>AC16</b>, <b>AC18</b>, <b>AC20</b>, <b>AC22</b>, and <b>AC23</b>) were weaker compared to the eight inhibitors discussed above and exhibited <i>K</i><sub>i</sub> values ranging from 1.7 μM to >8 μM (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01847/suppl_file/jm7b01847_si_001.pdf" class="ext-link">Supporting Information Table S1</a>).</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Tau Phosphorylation Inhibitory Activity Assay in Cells</h3><div class="NLM_p">Eight compounds that displayed inhibitory activity in vitro (see <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) were further tested in a cell line to establish whether they possessed the capacity to inhibit tau phosphorylation by DYRK1A. Expression vectors encoding FLAG-tagged TAU and EGFP-tagged DYRK1A were co-transfected into NCI-H1299 cells, and the amount of phospho-tau protein (p-tau) was analyzed by Western blot<named-content content-type="anchor" rid="fig1" type="simple"></named-content> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.7b01847/suppl_file/jm7b01847_si_001.pdf" class="ext-link">Supporting Information Figure S2</a>). Cells transfected with empty vectors were utilized as controls.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/medium/jm-2017-01847p_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of the nine novel DYRK1A inhibitors, representing six different core scaffolds. <b>AC12</b> and <b>AC15</b> share one core structure, and <b>AC24</b>, <b>AC25</b>, and <b>AC28</b> share a second type of core structure.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01847&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/medium/jm-2017-01847p_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Inhibition of DYRK1A dependent tau T212 phosphorylation by different compounds. NCI-H1299 cells were transfected with expression vector encoding FLAG-tagged tau in combination with either empty expression vector or EGFP-tagged DYRK1A. Twenty hours after transfection the cells were incubated for 2 h with vehicle (−) or the indicated inhibitor concentration before the cells were harvested. Phosphorylated T212 tau was detected by Western blotting using the polyclonal anti-phospho T212 tau antibody (44-740G, Invitrogen). Total FLAG-tau was detected by using a monoclonal M2 anti-FLAG antibody (F1804, Sigma-Aldrich) and EGFP-DYRK1A by a polyclonal anti-GFP antibody (Sc-8334, Santa-Cruz).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01847&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last"><b>AC12</b>, <b>AC15</b>, <b>AC24</b>, and <b>AC25</b> showed a significant dose-dependent inhibition of pT212-tau phosphorylation, in contrast to <b>AC20</b>, <b>AC22</b>, <b>AC23</b>, and <b>AC27</b>. However, all these compounds inhibited pT212-tau phosphorylation. The degree of kinase inhibition observed at the protein level reflected the one seen in the in vitro activity assay. In general, compounds with <i>K</i><sub>i</sub> of 600 nM or tighter showed clear dose–response effects, while compounds with <i>K</i><sub>i</sub> values ranging from 1.7 to 3 μM showed inhibition but with significantly greater noise with respect to dose–response correlation. An exception to this general observation is <b>AC27</b>. This compound inhibits DYRK1A in the pT212-tau phosphorylation assay but not as potently as it would have been expected from the in vitro activity assay.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Crystal Structures</h3><div class="NLM_p">The inhibitors were set up in cocrystallization trials with DYRK1A. Nine of the novel scaffolds (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) formed cocrystals. The crystal packing and asymmetric unit are similar to the previously published DYRK1A complexes with PKC412<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> or the benzothiazole fragments,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> with tetramers constituting the asymmetric unit. In general, the best electron density fit is found for protomer A and the greatest disorder is seen in protomer C. Several chains in the asymmetric unit show disulfide bridge formation between the HCD motif and the activation loop cysteine. However, in many chains the cysteine residues are reduced and/or in a mixed state, with additional evidence of radiation damage due to low amplitude electron density for cysteine C312.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17,18)</a> The compounds are bound to all four protomers in the tetramer of the asymmetric unit in DYRK1A (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). One exception is compound <b>AC22</b>, which lacks electron density for the entire inhibitor in chain C of the tetramer and the ATP-pocket is empty. However, the electron density is clear for the other three chains. The omit difference density maps after simulated annealing for all the nine inhibitors are shown in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b01847/suppl_file/jm7b01847_si_001.pdf" class="ext-link">Supporting Information Figure S3</a>. The crystallographic data and refinement statistics are summarized in <a href="/doi/suppl/10.1021/acs.jmedchem.7b01847/suppl_file/jm7b01847_si_001.pdf" class="ext-link">Supporting Information Table S2</a>.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/medium/jm-2017-01847p_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Binding pocket of DYRK1A bound to nine different inhibitors. The electron density for the inhibitor (2<i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> map) is shown at 1σ. The inhibitors form hydrogen bonds to E239 and L241, and <b>AC20</b>, <b>AC22</b>, and <b>AC27</b> form an H-bond to K188. Inhibitors <b>AC12</b> and <b>AC15</b> have a hydrogen bond acceptor group oriented toward K188. Most of the inhibitors are shown as they bind to chain A of the four protein molecules in the asymmetric unit of DYRK1A. The two exceptions are <b>AC23</b> where the inhibitor is shown bound in chain B, and <b>AC27</b> with the inhibitor shown in chain D. In the <b>AC23</b> crystal structure, only chain B has a water clearly visible in the electron density that could form bridging H-bonds between the inhibitor and K188 or D307. In the <b>AC27</b> crystal structure chain D has a water molecule, which connects the inhibitor to the hinge. There is no clear electron density for a water in the other chains; however, some diffuse electron density might suggest water molecules at these positions in the other chains too. PDB codes for DYRK1A complexes are the following: <b>AC12</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIF">6EIF</a>; <b>AC15</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EJ4">6EJ4</a>; <b>AC20</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIJ">6EIJ</a>; <b>AC22</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIL">6EIL</a>; <b>AC23</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIP">6EIP</a>; <b>AC24</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIQ">6EIQ</a>; <b>AC25</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIR">6EIR</a>; <b>AC27</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIS">6EIS</a>; <b>AC28</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIV">6EIV</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01847&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The inhibitors that could be cocrystallized with DYRK1A represent six different chemical scaffolds. Inhibitors <b>AC12</b> and <b>AC15</b> share a 3-(3-pyridin-3-yl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl)phenyl core scaffold, while inhibitors <b>AC24</b>, <b>AC25</b>, and <b>AC28</b> share a 4-[4-amino-2-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-1,3-thiazole-5-carbonyl]phenyl core scaffold. <b>AC12</b> and <b>AC15</b> differ by the substitutions of sulfonamide (para) or amine (meta) on the terminal arene, respectively. Compound <b>AC24</b> represents the core scaffold, whereby compounds <b>AC25</b> and <b>AC28</b> have terminal acrylamide functions added to the terminal arene at para and meta positions, respectively. <b>AC28</b> differs additionally by the lack of a methoxy substitution on the central phenyl ring. The other core scaffolds are represented by compounds <b>AC20</b> with 7-azathiazole, <b>AC22</b> as a pyrazine, <b>AC23</b> with an alkaloid, and <b>AC27</b> as a substituted 1,6-phenanthroline.</div><div class="NLM_p">With one exception, the inhibitors are typical hinge binders (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.7b01847/suppl_file/jm7b01847_si_001.pdf" class="ext-link">Supporting Information Figures S3, S4, and S5</a>). <b>AC12</b> and <b>AC15</b> each make two hydrogen bonds to E239 (gatekeeper + 1) and L241 (gatekeeper + 3). The pyridine nitrogen faces the catalytic lysine K188, but the 4 Å distance to the amine nitrogen is too long for a hydrogen bond. <b>AC22</b> is anchored to the hinge via two hydrogen bonds, which orients the pyridine nitrogen H-bond acceptor toward the catalytic lysine K188. Compared to <b>AC12</b> and <b>AC15</b>, the distances to K188 are shorter, including one contact at 3.2 Å, within the range of typical hydrogen bond distances. The crystal structure also shows that K188 shares a salt bridge with E203. Similarly, the aminopyrimidine functionality of <b>AC23</b> is anchored to the hinge, which points the benzamide substituent toward K188 but without a direct hydrogen bond interaction. However, in chain B there is a water molecule that bridges the gap between the amide and K188. The benzamide moiety has a parallel displaced π–π stacking interaction with the gatekeeper phenylalanine F238.</div><div class="NLM_p"><b>AC24</b>, <b>AC25</b>, and <b>AC28</b> make three hydrogen bonds to the hinge via the thiazole and two adjoining amines. In addition, the piperazine rings of these compounds have salt bridge interactions with D247 (the gatekeeper + 8 residue). They do not interact with K188. Compared to <b>AC24</b>, the addition of an acrylamide group on <b>AC25</b> weakens binding, and the crystal structure shows no favorable interactions and especially no covalent binding. A superposition of <b>AC24</b>, <b>AC25</b>, and <b>AC28</b> from all asymmetric unit domains shows that the acrylamide groups are pushed out of the binding pocket (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). However, the electron density for the acrylamide groups is relatively weak, and some divergence in their positions is evident in the refined structures. A rotation of the terminal benzene ring of approximately 90° may be seen in two binding poses for <b>AC25</b>. The other benzene ring of the scaffold (adjacent to the piperazine ring) is oriented differently and heterogeneously for <b>AC28</b>. The methoxy substituent of this ring, found in <b>AC24</b> and <b>AC25</b>, apparently stabilizes this benzene ring compared to <b>AC28</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). On the other hand, the ring of inhibitor <b>AC28</b> is stabilized by intramolecular π–π interactions of the acrylamide double bond with the π system of the benzene ring.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/medium/jm-2017-01847p_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Superposition of the binding pockets and inhibitors of the four chains in the asymmetric unit of DYRK1A of each inhibitor: <b>AC24</b> (green, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIQ">6EIQ</a>) with <b>AC25</b> (cyan, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIR">6EIR</a>) and <b>AC28</b> (violet, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIV">6EIV</a>). Although the general pose of each inhibitor remains similar, some differences are evident between the individual pockets. <b>AC24</b> has the greatest conservation of geometry, while especially the acrylamide groups of <b>AC25</b> and <b>AC28</b> show more variation, reflected also by lower electron density for these parts.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01847&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p"><b>AC20</b> has only a single hinge binding hydrogen bond, with L241 (gatekeeper + 3) rather than a pair (including the gatekeeper + 1 residue E239) that is typical for the other inhibitors. <b>AC20</b> shares a hydrogen bond with the catalytic lysine K188 with its urea oxygen and also shares a salt bridge with the DFG aspartate D307 via the morpholine nitrogen. It forms in addition a perpendicular π stacking interaction with the gatekeeper phenylalanine. Like all the other inhibitors, <b>AC20</b> binds in a typical type I binding mode.</div><div class="NLM_p last">The strongest of the inhibitors in this study, <b>AC27</b>, uniquely has no hydrogen bond to the hinge. It has anchoring hydrogen bonds with K188 and E203 via its diazole group, with N244 via its carbonyl group, and also with the N292 side chain as a C–H···O hydrogen bond with a hydrogen of the fluorinated arene. Additionally, a bridging water between the hinge and the inhibitor was found in chain D of the tetramer. This water has a hydrogen bonding distance of 2.7 Å from the 1,6-phenanthroline nitrogen and is in contact with the main chain amide nitrogen of L241 with a distance of 2.8 Å and to the carbonyl of E239 of 2.6 Å. The trifluoromethyl, fluorobenzyl ring is in perpendicular face–edge intramolecular contact with both the 1,6-phenanthroline and diazole rings. The trifluoromethyl group is embedded in a shallow hydrophobic pocket created by the first glycine (G166) of the glycine rich loop, the preceding I165 side chain, and the V173 side chain opposite of G166 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). A superposition of all the inhibitors is shown in <a href="/doi/suppl/10.1021/acs.jmedchem.7b01847/suppl_file/jm7b01847_si_001.pdf" class="ext-link">Supporting Information Figure S4</a>.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Kinase Profiling of DYRK1A Inhibitors</h3><div class="NLM_p">We evaluated kinase selectivity profiles as determined by KinomeScan binding assays against a panel of 353/402/442 distinct kinases and their mutants (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). The kinase profiling data for the inhibitors show that <b>AC12</b> and <b>AC15</b> are pan kinase inhibitors (with a broad spectrum of inhibition). As a consequence, these two inhibitors did not show a clear pattern of selectivity and were generally less effective against tyrosine kinases. The kinase profiling data for the remaining seven of the compounds with cocrystal structures showed the typical cross reactivities of the inhibitors between DYRK and CLK families. In addition, <b>AC22</b> and <b>AC27</b> show significant cross reactivities against GSK3β, which is consistent with the kinase selectivity pattern of leucettine L41.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/medium/jm-2017-01847p_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Kinome binding plots for the nine compounds. The levels of binding were measured at concentrations of 10 μM (except for <b>AC27</b>, measured at 1 μM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01847&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p"><b>AC20</b> exhibited good overall kinome selectivity, with a <i>S</i>(10) selectivity score of 0.06 at 10 μM. (The <i>S</i>(10) selectivity index is defined as the percentage of the kinome inhibited below 10% of the control; <i>S</i>[10] = [number of kinases with % Ctrl < 10]/[number of kinases tested]). <b>AC20</b> binds CLK2 more tightly than DYRK1A. This compound bound also the tyrosine kinases ABL and PDGFR, which is unsurprising, considering that the series of compounds with this core structure were initially designed for targeting BCR-ABL.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><div class="NLM_p"><b>AC22</b> is the only tested inhibitor that shows a stronger inhibition of GSK3β compared to DYRK1A. Other kinases of the CMGC group significantly inhibited by <b>AC22</b> include CLK2, HIPK1/2, and CDK7. <b>AC22</b> also interferes with other kinases across several families, albeit with weaker binding affinity.</div><div class="NLM_p"><b>AC23</b> exhibited rather weak and unspecific DYRK binding. The main targets of this compound belonged to the CMGC and CAMK families, with DRAK1/2 and ERK5 as the top hits.</div><div class="NLM_p">The three thiazole compounds, <b>AC24</b>, <b>AC25</b>, and <b>AC28</b>, have slightly varying affinities. While <b>AC24</b> had greater affinity for DYRKs compared to CLKs, the addition of the acrylamide in <b>AC25</b> and <b>AC28</b> shifted the profile toward CLK2 and also decreases the overall selectivity.</div><div class="NLM_p last"><b>AC27</b>, an analog of mTOR inhibitor Torin2,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> selectively binds to mTOR but also CMGC family kinases and lipid kinases PIK3CG, PIK4CB, with <i>S</i>(10) scores of 0.03 at 1 μM. It possesses similar inhibition strengths against DYRK1A/B, CLK1/3, and GSK3A/B among CMGC family members.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> NFAT Luc Reporter Assays</h3><div class="NLM_p">The newly identified compounds were studied in the HEK293 cell line by introducing the NFAT luciferase activity assay (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). The compounds were titrated in increasing amounts from 0.25 μM to 20 μM. <b>AC27</b>, as the most active compound, was titrated from 0.05 μM to 10 μM. With the exception of <b>AC25</b>, all compounds showed activity in the tested cell line. <b>AC12</b> was found to be active at concentrations up to 5 μM; higher concentrations of this compound led to a drop in the activity, suggesting that <b>AC12</b> might be toxic at concentrations of >5 μM. <b>AC15</b>, despite sharing the same core structure of <b>AC12</b>, showed dose-dependent inhibition up to 20 μM; this compound required a minimum of 5 μM to show considerable activity above the background level. This was also the case for <b>AC20</b>, <b>AC22</b>, and <b>AC24</b>. On the basis of the NFAT luciferase activity assay, the most active compounds were <b>AC23</b> and <b>AC27</b>. Specifically, <b>AC27</b> showed clear activity at 50 nM and thus is approximately 10-fold more active than <b>AC23</b> and approximately 100-fold more active than to the other six inhibitors in this assay. The drop in the activity of <b>AC27</b> at 10 μM and <b>AC23</b> at 20 μM may suggest that these concentrations might be toxic. As mentioned above, <b>AC25</b> was the only inactive compound with respect to this assay, showing an apparent dose-dependent drop in the basal activity, possibly coupled with toxicity for HEK293 cells.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/medium/jm-2017-01847p_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. NFAT Luc reporter assay. The plot is normalized to the basal activity of the luciferase. Numbers indicate the fold of increase in luciferase activity upon inhibition of DYRK1A (A). The most active compound <b>AC27</b> shows a 1.5-fold increase in luciferase activity at 50 nM. For comparison harmine is included in the same assay (<b>B</b>). Even though harmine reached a higher activity and does not display the drop in activity as <b>AC27</b> at higher concentrations toward DYRK1A, <b>AC27</b> is active at much lower concentrations. 100 nM <b>AC27</b> leads to the same activity as 5 μM harmine, making <b>AC27</b> nearly 50 times more active than harmine in this particular cellular assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01847&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31785" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31785" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The list of potential DYRK1A inhibitors has been growing over the past few years. Diverse chemical fragments that bind to DYRK1A with high affinity have been reported.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> However, none of these have advanced into clinical trials. This study presents a set of novel scaffolds with good potential for DYRK1A inhibition, evaluated using a series of structural and cellular assay experiments. <b>AC12</b>, <b>AC15</b>, and <b>AC22</b> are compounds with relatively low molecular weights and can be considered as fragments and classical hinge binders. In contrast to harmine, INDY,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> or recently published hydroxy- and methoxybenzothiazole<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> fragments, the distances of inhibitor atoms to the catalytic lysine or the aspartate from the DFG motive remain relatively long. On the other hand, structural variations in the physiological environment might include significant dynamic hydrogen bonding to the catalytic lysine K188, especially correlated with dynamic properties of helix C. Although <b>AC12</b>, <b>AC15</b>, and <b>AC22</b> have similar molecular weights and similar binding poses with the hinge region, their binding strengths differ greatly. <b>AC12</b> and <b>AC15</b> were the strongest binders, while <b>AC22</b> was one of the weakest that still enabled cocrystal structure determination. (The relatively weak binding of <b>AC22</b> is also reflected in the fact that one of the ATP pockets of the four DYRK1A chains in the asymmetric unit of the crystal structure was empty.) Detailed comparison of the structures <b>AC12</b>, <b>AC15</b>, and <b>AC22</b> shows that the pyridine rings occupy the same volume, and the overlap of the nitrogen atoms anchored to the hinge is apparent (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A). However, the methoxy group of <b>AC22</b> on the aniline ring most likely weakens the binding. The structure shows that the methoxy group pushes the compound away from the hinge, hence increasing intramolecular strain.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/medium/jm-2017-01847p_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Orientation and interaction of the inhibitors in the binding pocket. (A) Superimposition of <b>AC12</b> (cyan, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIF">6EIF</a>), <b>AC15</b> (pink, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EJ4">6EJ4</a>), and <b>AC22</b> (green, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIL">6EIL</a>). The methoxy group of <b>AC22</b> displaces the inhibitor away from the hinge, weakening binding. (B) Superposition of <b>AC20</b> (green, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIJ">6EIJ</a>) with 5-hydroxybenzothiazole (blue, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5A3X">5A3X</a>), and 6-cyanobenzothiazole (magenta, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5A4T">5A4T</a>). <b>AC20</b> binds with its 5-substiuted pyridothiazole in the same orientation as the 6-cyanobenzothiazole and, unlike 5-hydroxy-benzothiazole or INDY, does not make sulfur aromatic ring interactions with the gatekeeper phenylalanine. The three compounds also have differing selectivity profiles. While <b>AC12</b> and <b>AC15</b> are more nearly pan kinome inhibitors (targeting many different kinases), <b>AC22</b> is much more discriminating, with however a greatly reduced inhibitory strength.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01847&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The remaining inhibitors for which a cocrystal structure could be obtained are selective toward the CMGC kinase group and DYRKs. However, all show additional cross reactivity against targets outside the CMGC group.</div><div class="NLM_p">Inhibitor <b>AC20</b> inhibits DYRK1A; however the strongest inhibition of CMGC group kinases is of CLK2, and similar or stronger inhibition is seen of TK group members ABL and PDGFRB (with considerable variation across ABL mutants). <b>AC20</b> is clearly hydrogen-bonded to K188, wrapping its extended tail across and partially around the DFG motif. The pyridothiazole core structure of <b>AC20</b> is similar to the benzothiazoles found in other published DYRK1A inhibitors (including INDY,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> BINDY,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> or the recently published 5- or 6-substituted benzothiazole fragments<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a>) but differs by an additional nitrogen in the six membered ring. <b>AC20</b> is a 6-substituted pyridothiazole; analogous to the benzothiazole interactions, the pyridothiazole binds alongside the hinge instead of making sulfur aromatic ring interactions with the gatekeeper as seen for INDY<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> or the 5-substituted fragments of benzothiazoles<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B).</div><div class="NLM_p">The three thiazole compounds <b>AC24</b>, <b>AC25</b>, and <b>AC28</b> show intermediate binding strengths and selectivity. Compound <b>AC24</b> represents the core scaffold in this group, whereby compounds <b>AC25</b> and <b>AC28</b> have terminal acrylamide functions added to the terminal arene at para and meta positions, respectively. The addition of the acrylamide in <b>AC25</b> and <b>AC28</b> shifted the binding affinity away from DYRK toward CLK2 and also decreases the overall selectivity. Acrylamides as functional groups are typically used to introduce covalent binding of inhibitors via addition to cysteines. (These compounds were previously synthesized as inhibitors of kinases other than DYRK1A.) Because of the absence of cysteine at the ATP pocket in DYRK1A, the acrylamides in <b>AC25</b> and <b>AC28</b> are not expected to introduce covalent binding, but nonbonded interactions still affect binding strengths. The functional acrylamide group might stabilize binding to related off-targets. <b>AC25</b> was the only compound that did not inhibit DYRK1A in the NFATluc assay, instead showing toxicity.</div><div class="NLM_p">As described above, the crystal structure of <b>AC25</b> showed that the additional acrylamide was associated with a shift of its parent phenyl ring away from its position in <b>AC24</b>, presumably to avoid a steric clash with D307 (of DFG) but possibly colliding with V173. Two characteristics distinguish <b>AC28</b> from <b>AC24</b> and <b>AC25</b>: the acrylamide functional group at the meta position and the lack of a 2-methoxy substituent in aniline. These properties changed the inhibition selectivity pattern significantly, eliminating their inhibitory activity against many CAMK family kinases, JNK kinases and adding the binding to the pseudokinase domains of JAK1 and TYK2. Moreover, the cross reactivity toward MAST1 in the AGC group of <b>AC24</b> and <b>AC25</b> was lost in <b>AC28</b>. These clear and specific dependencies warrant further more detailed structural studies.</div><div class="NLM_p"><b>AC23</b> and <b>AC27</b> have a potential bridging water molecule in the binding pocket that could be an important affinity determinant. In fact, for <b>AC27</b> the water in the binding pocket is the only apparent interaction that anchors <b>AC27</b> to the hinge. The waters are unambiguous only in chain B (<b>AC23</b>) or chain D (<b>AC27</b>) in the electron density of the DYRK1A tetramer. Despite the missing electron density, a water bridging interaction may be important because multiple bridged geometries may exist. Optimization of these compounds can take this into account (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>).</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/medium/jm-2017-01847p_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Water mediated binding of <b>AC23</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIP">6EIP</a>) and <b>AC27</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIS">6EIS</a>) to DYRK1A. The structure of the inhibitor in the ATP pocket of DYRK1A includes a water molecule that enables bridging interactions between the inhibitor and the K188, E203, and D307 for <b>AC23</b> and between the inhibitor and the hinge carbonyl of E239 and amide nitrogen of L241 for <b>AC27</b>. There is no clear electron density for a water in the other chains; however, some diffuse electron density suggests it to be present there also.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01847&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p"><b>AC23</b> and especially <b>AC27</b> were the most active compounds in the cell line assay (NFATluc, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). These compounds were active at lower concentrations compared to harmine. <b>AC23</b> reached a 2-fold activity increase at 1 μM, and <b>AC27</b> reached 2-fold activation already at 0.1 μM. In contrast, harmine reaches this level only at ∼5 μM; i.e., <b>AC23</b> and <b>AC27</b> may be seen as 5× and 50× as active, respectively. On the other hand, both <b>AC23</b> and <b>AC27</b> show reduced activity at concentrations above 10 μM. This could be an indication that these higher concentrations introduce toxicity to the cells, while harmine continues to exhibit dose dependent inhibition at these concentrations.</div><div class="NLM_p">As mentioned above, several DYRK1A inhibitors were identified in the recent past, but none of these compounds have met the selectivity standards needed for use as probe molecules. Harmine, one of the most commonly used inhibitors in DYRK1A related research, has strong cross inhibition of monoamine oxidase that would create severe side effects. The low selectivity also makes harmine unsuitable as a probe to test DYRK1A inhibition in cell lines. Efforts to eliminate the MAO inhibition while keeping the DYRK1A inhibition lead to the harmine derivative AnnH75.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Another DYRK1A inhibitor, green tea flavonol epigallocatechin gallate (EGCG), was shown to correct cognitive deficits in Down syndrome mouse models and in humans.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> However, it also potentially has multiple targets (and correspondingly is under consideration for use a broad range of disorders) and cannot be considered a DYRK specific inhibitor. The compounds EHT1610 and EHT5372 are among the most selective DYRK inhibitors identified so far.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a> Crystal structures of these compounds in complex with a kinase are available for DYRK2 (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LXD">5LXD</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LXC">5LXC</a>). A comparison of this scaffold to AC27, one of the more selective compound in our series, shows some remarkable similarities. First, a structural comparison of the EHT1610 and EHT5372 compound bound to DYRK2 suggests that the canonical hinge binding may be less essential for high affinity binding in DYRK<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> as it is for AC27, because its hinge interaction is only indirect, via a bridging water molecule. Second, all three compounds interact with the P-loop, and the trifluoromethyl in AC27 or the 2-fluoro- and 2-chlorobenzyl groups of EHT1610 and EHT5372 occupy the same space. One major difference is in the overall orientation of the inhibitors. Considering them “U” or horseshoe shaped, the opening of the “U” for AC27 points toward the P-loop aryl F160, while the orientation is reversed for the EHT inhibitors. The benzyl rings of AC27 and the EHT inhibitors are roughly perpendicular to each other (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>).</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/medium/jm-2017-01847p_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Comparison of the binding of AC27 (light green, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIS">6EIS</a>) with EHT1610 (red, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LXD">5LXD</a>) and EHT5372 (magenta, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LXC">5LXC</a>) (DYRK1A, salmon; DYRK2, gray).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01847&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Additional inhibitors of DYRK1A discussed in the literature include a derivative of a marine sponge alkaloid leucettine L41, which has shown some efficacy in mice to prevent memory impairment.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Benzothiazole fragments<a onclick="showRef(event, 'ref18 ref30'); return false;" href="javascript:void(0);" class="ref ref18 ref30">(18,30)</a> and the independently developed benzothiazoles INDY<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and BINDY<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> are also effective inhibitors of DYRK1A. FINDY is a selective inhibitor of the kinase DYRK1A that targets its folding process.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> A detailed review article of the most recent DYRK1A inhibitors summarizes these results.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The lead compounds we present here, along with their binding poses as seen in the crystal structures, represent valuable additional resources for DYRK1A inhibitor development and optimization of druglikeness and selectivity profiles.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58821" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58821" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Twenty-two new compounds were tested for their ability to inhibit and bind to DYRK1A. These compounds belong to diverse chemical scaffolds of kinase inhibitors, and their inhibitory strengths (<i>K</i><sub>i</sub>) vary between 200 nM and >10 μM. Kinase profiling showed that some of the compounds (e.g., <b>AC12</b> and <b>AC15</b>) have a broad spectrum of kinase inhibition, while others are much more specific against DYRK and CLK2. These new scaffolds offer novel opportunities to design DYRK1A inhibitors. Their inhibitory properties vary across the characterization methods, and the results of in vitro vs cellular assays, especially the pT212-tau phosphorylation vs the NFAT Luc reporter assays, were less strongly correlated for the compounds. However, this only underlines the importance to study inhibitors in multiple approaches to find the most effective inhibitor. Newly revealed binding features, such as the CH–O interaction with Asn292 or the bound waters that serve as anchors to the catalytic lysine or the hinge, may provide valuable information for optimization of these inhibitors against DYRK1A and related kinases, targeting Alzheimer’s disease and diabetes.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56250" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56250" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13">1.  Synthesis of the Inhibitors</h3><div class="NLM_p">All the used test compounds in this manuscript had purities greater than 95% as determined by analytical high performance liquid chromatography (HPLC). <b>AC15</b>,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a><b>AC20</b>,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a><b>AC23</b>,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a><b>AC27</b>,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and <b>AC28</b><a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> were previously reported as TRK, Bcr-Abl, ERK5, mTOR, and HIPK2 inhibitors, respectively. <b>AC12</b><a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> and <b>AC22</b><a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> were synthesized following procedure described in references. <b>AC24</b> and <b>AC25</b> were generated from a common intermediate 1-(4-isothiocyanato-3-methoxyphenyl)-4-methylpiperazine <b>2</b>, which was obtained from reaction of 2-methoxy-4-(4-methylpiperazin-1-yl)aniline with triphosgene under basic condition (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). This isothiocyanate intermediate was allowed to react with cyanamide in the presence of <i>t</i>-BuOK, followed by addition of phenacyl bromide to give the desired 2,4-diaminothiazoles <b>AC24</b> in one-pot synthesis with 96% yield. Intermediate <b>3</b> was synthesized by similar procedure with 4-nitrophenacyl bromide and subjected to primary amine protection to generate <b>4</b>. Reduction of nitro group by platinum dioxide gave rise to corresponding aniline analog, which was subjected to acrylation and Boc deprotection to afford <b>AC25</b>.</div><figure id="sch1" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/medium/jm-2017-01847p_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>AC24</b> and <b>AC25</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01847&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reaction conditions: (a) 1.0 equiv of thiophosgene, 5.0 equiv of TEA, CHCl<sub>3</sub>, rt, 3 h, 94%; (b) (1) 2.4 equiv of NH<sub>2</sub>CN, 1.5 equiv of <i>t</i>-BuOK, acetonitrile, 0 °C to rt, 1 h; (2) 1.0 equiv of 2-bromo-1-phenylethan-1-one, rt, 4 h, 96%; (c) 1) 2.4 equiv of NH<sub>2</sub>CN, 1.5 equiv of <i>t</i>-BuOK, acetonitrile, 0 °C to rt, 1 h; (2) 1.0 equiv of 2-bromo-1-(4-nitrophenyl)ethan-1-one, rt, 4 h, 47%; (d) 1.0 equiv of (Boc)<sub>2</sub>O, 0.3 equiv of DMAP, 2.0 equiv of DIEA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 days, 89%; (e) (1) 1.05 equiv of PtO<sub>2</sub>, H<sub>2</sub>, MeOH, rt, 1 h; (2) 1.27 equiv of acryloyl chloride, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 0.5 h; (3) TFA, 0 °C to rt, 1 h, 46%.</p></p></figure></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15">2.  Chemistry</h3><div class="NLM_p last">Unless otherwise noted, reagents and solvents were obtained from commercial suppliers and were used without further purification. <sup>1</sup>H NMR and <sup>13</sup>C NMR were recorded on Bruker Ascend 500. <sup>1</sup>H NMR spectra were 500 MHz, and chemical shifts are reported in parts per million (ppm, δ) downfield from tetramethylsilane (TMS). Coupling constants (<i>J</i>) are reported in Hz. Spin multiplicities are described as s (singlet), d (doublet), t (triplet), m (multiplet), and br (broad). IR spectra were recorded on a Bruker ALPHA II platinum single reflection diamond ATR module. High-resolution mass spectra (HRMS) were recorded on a Bruker Impact HD q-TOF mass spectrometer. Preparative HPLC was performed on a Waters Symmetry C18 column (19 mm × 50 mm, 5 μm) using a gradient of 5–95% acetonitrile in water containing 0.05% trifluoroacetic acid (TFA) over 8 min (10 min run time) at a flow rate of 30 mL/min. Analytic HPLC was performed on a SunFire C18 column (4.6 mm × 150 mm, 3.5 μm) using a gradient of 5–95% acetonitrile in water containing 0.05% trifluoroacetic acid (TFA) over 15 min (17 min run time) at a flow rate of 1.0 mL/min. Purities of all new synthesized test compounds (<b>AC12</b>, <b>AC22</b>, <b>AC24</b>, and <b>AC25</b>) were greater than 95% as determined by analytical HPLC (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01847/suppl_file/jm7b01847_si_001.pdf" class="ext-link">Supporting Information</a>).</div></div><div id="sec5_2_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> <b>AC12</b>. 4-[3-(Pyridin-3-yl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl]benzene-1-sulfonamide (XMD7-117, <b>AC12</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.47 (s, 1H), 9.36 (br, 1H), 9.08–8.48 (m, 4H), 8.29 (d, <i>J</i> = 2.0 Hz, 1H), 8.05 (d, <i>J</i> = 8.3 Hz, 2H), 7.99–7.77 (m, 3H), 7.43 (s, 2H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 149.5, 143.2, 143.2, 142.2, 142.5, 142.4, 138.6, 128.5, 128.1, 127.8, 126.7, 126.6, 117.4, 110.3. IR ν<sub>max</sub> (neat): 3299, 3007, 2862, 1586, 1527, 1476, 1329, 1156, 1095, 909, 670, 589, 544 cm<sup>–1</sup>. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>18</sub>H<sub>14</sub>N<sub>4</sub>O<sub>2</sub>S [M + H]<sup>+</sup>, 351.0910; found 351.0909.</div></div><div id="sec5_2_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> <b>AC22</b>. 5-(5-Amino-2-methoxyphenyl)-3-(pyridine-3-carbonyl)pyrazin-2-amine (XMD8-49, <b>AC22</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 9.27 (d, <i>J</i> = 1.2 Hz, 1H), 8.84 (s, 1H), 8.70 (d, <i>J</i> = 4.9 Hz, 1H), 8.47 (d, <i>J</i> = 7.9 Hz, 1H), 7.61 (dd, <i>J</i> = 7.9, 5.0 Hz, 1H), 7.10 (d, <i>J</i> = 2.8 Hz, 1H), 6.94 (d, <i>J</i> = 8.7 Hz, 1H), 6.79 (dd, <i>J</i> = 8.6, 2.8 Hz, 1H), 3.83 (s, 3H). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 192.9, 154.7, 150.8, 150.7, 150.3, 149.6, 141.0, 139.9, 138.7, 134.5, 127.6, 125.9, 123.3, 117.1, 116.9, 113.00, 55.3. IR ν<sub>max</sub> (neat): 3424, 3252, 3124, 2836, 1632, 1585, 1503, 1222, 1207, 1032, 798, 679, 442 cm<sup>–1</sup>. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>17</sub>H<sub>15</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 322.1299; found 322.1299.</div></div><div id="sec5_2_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Synthesis Intermediate <b>2</b>. 1-(4-Isothiocyanato-3-methoxyphenyl)-4-methylpiperazine (<b>2</b>)</h3><div class="NLM_p last">To a solution of 2-methoxy-4-(4-methylpiperazin-1-yl)aniline (<b>1</b>) (663 mg, 3.0 mmol) and triethylamine (2.10 mL, 15.0 mmol) in 10 mL of CHCl<sub>3</sub> at 0 °C, thiophosgene (0.23 mL, 3.0 mmol) was added. After 15 min, the reaction mixture was stirred at room temperature. Once the reaction completed (about 3 h), the reaction mixture was diluted with ethyl acetate, washed with ice–water and brine. After the organic layer was dried with MgSO<sub>4</sub>, the solvent was removed. The crude product of title compound (747 mg, 94%) was used directly for the next step without purification (84.9% purity). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 6.93 (d, <i>J</i> = 8.6 Hz, 1H), 6.38–6.26 (m, 2H), 3.81 (s, 3H), 3.20 (t, <i>J</i> = 5.1 Hz, 4H), 2.56 (t, <i>J</i> = 5.0 Hz, 4H), 2.33 (s, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 156.7, 151.3, 137.8, 128.8, 126.1, 107.4, 99.6, 55.9, 54.7, 48.4, 45.9. IR ν<sub>max</sub> (neat): 2936, 2794, 2703, 2099, 1595, 1565, 1510, 1417, 1263, 1252, 1211, 1203, 1134, 1025, 1008, 969, 815, 556 cm<sup>–1</sup>. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>13</sub>H<sub>17</sub>N<sub>3</sub>OS [M + H]<sup>+</sup>, 264.1165; found 264.1165. HPLC: 84.9% at 254 nm.</div></div><div id="sec5_2_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> <b>AC24</b>. (4-Amino-2-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)thiazol-5-yl)(phenyl)methanone (XMD14-124, <b>AC24</b>)</h3><div class="NLM_p last">To a solution of 1-(4-isothiocyanato-3-methoxyphenyl)-4-methylpiperazine (<b>2</b>) (30 mg, 0.12 mmol) in 1.0 mL of acetonitrile at 0 °C cyanamide (10 mg, 0.24 mmol) was added, followed by potassium <i>tert-</i>butoxide (0.15 mL 1 M solution in THF, 0.15 mmol). After 10 min, the reaction mixture was stirred at room temperature. Once the reaction completed (about 1 h), 2-bromo-1-phenylethan-1-one (20 mg, 0.1 mmol) was added at room temperature. The reaction was completed in about 4 h. The reaction mixture was diluted with ethyl acetate, washed with ice–water and brine. After the organic layer was dried with MgSO<sub>4</sub>, the solvent was removed and the residue was purified by column purification (CH<sub>2</sub>Cl<sub>2</sub>/3.5 N ammonia in MeOH) to afford desired compound (40.7 mg, 96%). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.56–7.51 (m, 2H), 7.47 (d, <i>J</i> = 8.7 Hz, 1H), 7.40–7.24 (m, 3H), 6.56 (d, <i>J</i> = 2.5 Hz, 1H), 6.44 (dd, <i>J</i> = 8.8, 2.5 Hz, 1H), 3.75 (s, 3H), 3.18 (t, <i>J</i> = 5.0 Hz, 4H), 2.74 (t, <i>J</i> = 5.0 Hz, 4H), 2.42 (s, 3H). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 183.8, 172.5, 167.00, 152.8, 150.1, 141.9, 130.1, 128.0, 126.6, 124.4, 120.5, 107.6, 100.4, 94.4, 54.9, 54.2, 48.1, 44.0. IR ν<sub>max</sub> (neat): 2806, 1602, 1537, 1213, 1350, 1262, 1241, 737, 699, 509 cm<sup>–1</sup>. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>22</sub>H<sub>25</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup>, 424.1802; found 424.1802.</div></div><div id="sec5_2_5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Synthesis Intermediate <b>3</b>. (4-Amino-2-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)thiazol-5-yl)(4-nitrophenyl)methanone (<b>3</b>)</h3><div class="NLM_p last">To a solution of 1-(4-isothiocyanatophenyl)-4-methylpiperazine (<b>2</b>) (157.8 mg, 0.6 mmol) in 5.0 mL of acetonitrile at 0 °C cyanamide (50 mg, 1.19 mmol) was added, followed by potassium <i>tert-</i>butoxide (0.75 mL 1 M solution in THF). After 10 min, the reaction mixture was stirred at room temperature. Once the reaction completed (about 1 h), 2-bromo-1-(4-nitrophenyl)ethan-1-one (122 mg, 0.5 mmol) was added at room temperature. The reaction was completed in about 4 h. The reaction mixture was diluted with ethyl acetate, washed with ice–water and brine. After the organic layer was dried with MgSO<sub>4</sub>, the solvent was removed and the residue was purified by column purification (CH<sub>2</sub>Cl<sub>2</sub>/3.5 N ammonia in MeOH) to afford desired compound (219 mg, 47%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.17 (d, <i>J</i> = 8.3 Hz, 2H), 7.93 (s, 1H), 7.78 (d, <i>J</i> = 8.3 Hz, 2H), 7.39 (d, <i>J</i> = 8.6 Hz, 1H), 6.49–6.36 (m, 2H), 3.78 (s, 3H), 3.13 (t, <i>J</i> = 5.0 Hz, 4H), 2.50 (t, <i>J</i> = 5.0 Hz, 4H), 2.28 (s, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 181.5, 170.8, 165.9, 151.2, 150.2, 148.7, 147.3, 128.2, 123.7, 122.1, 119.5, 107.7, 100.0, 55.8, 55.0, 49.1, 46.1. IR ν<sub>max</sub> (neat): 2808, 1597, 1533, 1417, 1339, 1262, 1242, 972, 735, 705, 473 cm<sup>–1</sup>. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>22</sub>H<sub>24</sub>N<sub>6</sub>O<sub>4</sub>S [M + H]<sup>+</sup>, 469.1653; found 469.1652.</div></div><div id="sec5_2_6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Synthesis Intermediate <b>4</b>. <i>tert</i>-Butyl (2-((2-Methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)-5-(4-nitrobenzoyl)thiazol-4-yl)carbamate (<b>4</b>)</h3><div class="NLM_p last">To a stirred suspension of (4-amino-2-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)thiazol-5-yl)(4-nitrophenyl)methanone (<b>3</b>) (72 mg, 0.15 mmol) in 4.0 mL of dichloromethane at room temperature, 4-dimethylaminopyridine (6.0 mg, 0.05 mmol), <i>N</i>,<i>N</i>-diisopropylethylamine (0.06 mL, 0.3 mmol), and di-<i>tert</i>-butyl dicarbonate (34 mg, 0.15 mmol) were added. After 10 min, the reaction mixture turned clear. When the reaction completed (about 2 days), the reaction mixture was concentrated and the residue was purified by column purification (CH<sub>2</sub>Cl<sub>2</sub>/3.5 N ammonia in MeOH) to afford the title compound (93.1% purity, 77 mg, 89%). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 8.39 (d, <i>J</i> = 8.4 Hz, 2H), 7.99 (d, <i>J</i> = 8.4 Hz, 2H), 7.14 (d, <i>J</i> = 8.5 Hz, 1H), 6.77 (d, <i>J</i> = 2.5 Hz, 1H), 6.68 (dd, <i>J</i> = 8.7, 2.5 Hz, 1H), 4.07–3.92 (m, 2H), 3.84 (s, 3H), 3.72–3.60 (m, 2H), 3.32–3.05 (m, 4H), 3.02 (s, 3H), 1.40 (s, 9H). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 184.0, 167.9, 163.9, 155.4, 152.7, 151.5, 149.1, 146.8, 129.7, 128.2, 123.4, 120.5, 107.8, 100.7, 83.9, 54.9, 53.3, 46.5, 42.2, 26.6. IR ν<sub>max</sub> (neat): 1717, 1676, 1610, 1520, 1345, 1293, 1127, 1091, 847, 433 cm<sup>–1</sup>. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>27</sub>H<sub>32</sub>N<sub>6</sub>O<sub>6</sub>S [M + H]<sup>+</sup>, 569.2177; found 569.2182.</div></div><div id="sec5_2_7_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> <b>AC25</b>. <i>N</i>-(4-(4-Amino-2-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)thiazole-5-carbonyl)phenyl)acrylamide (XMD15-27, <b>AC25</b>)</h3><div class="NLM_p last">A suspension of <i>tert</i>-butyl (2-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)-5-(4-nitrobenzoyl)thiazol-4-yl)carbamate (<b>4</b>) (50 mg, 0.088 mmol) and platinum dioxide (21 mg, 0.093 mmol) in 6.0 mL of methanol was stirred at room temperature under hydrogen atmosphere. After 1 h, the reaction mixture was filtered. The solvent of the filtrate was removed, and the residue was dried under vacuum. The crude product was used directly without purification. To its solution in 3.0 mL of dichloromethane at 0 °C acryloyl chloride (9 μL, 0.11 mmol) was added. Once the reaction was completed (in about 30 min), 1.0 mL of trifluoroacetic acid was added at 0 °C. The temperature of reaction mixture gradually increased to room temperature. When the reaction was completed, reaction mixture was concentrated and the resulting residue was purified by reverse-phase prep-HPLC using a water (0.05%TFA)/methanol (0.05% TFA) gradient to afford the desired compound (20.5 mg, 46%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.32 (s, 1H), 9.86 (s, 1H), 7.71 (t, <i>J</i> = 9.8, 8.3 Hz, 2H), 7.59 (d, <i>J</i> = 8.3 Hz, 2H), 7.41 (s, 1H), 6.62 (d, <i>J</i> = 2.5 Hz, 1H), 6.51–6.41 (m, 2H), 6.28 (dd, <i>J</i> = 17.0, 2.0 Hz, 1H), 5.79 (dd, <i>J</i> = 10.0, 1.9 Hz, 1H), 3.79 (s, 3H), 3.17 (t, <i>J</i> = 4.9 Hz, 4H), 2.45 (t, <i>J</i> = 5.0 Hz, 4H), 2.23 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 181.8, 166.7, 163.8, 141.1, 137.5, 132.2, 128.1, 127.8, 119.1, 107.25, 100.3, 92.9, 56.0, 55.1, 48.5, 46.2. IR ν<sub>max</sub> (neat): 2920, 2849, 1672, 1594, 1517, 1409, 968, 762, 727 cm<sup>–1</sup>. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>25</sub>H<sub>28</sub>N<sub>6</sub>O<sub>3</sub>S [M + H]<sup>+</sup>, 493.2016; found 493.2016.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23">3.  Expression and Purification</h3><div class="NLM_p last">A DYRK1A construct comprising the kinase domain (126–490) was cloned into pEXP17 with N-terminal 6x(HIS) affinity tags and TEV protease cleavage sites.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17,18)</a> Expression was done in shaker flask cultures overnight at 17.8 °C in TB media. For the purification of DYRK1A the cells were resuspended in a lysis buffer containing 50 mM sodium phosphate buffer, pH 8.0, with 500 mM NaCl and 0.5% Tween20. Purification was done via NiNTA columns and an imidazole gradient (10–500 mM), followed by a TEV cleavage overnight and a second NiNTA to separate the kinase from uncut protein and the protease. Final purification for DYRK1A was done via size exclusion chromatography (SEC buffer: 50 mM MOPS, pH 6.8, 50 mM KCl, 2 mM β-Me).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24">4.  Crystallization</h3><div class="NLM_p last">DYRK1A was concentrated to 7–10 mg/mL in SEC buffer and mixed with inhibitor solutions in DMSO to achieve approximately a 5- to 10-fold excess of inhibitor. The final concentration of DMSO was ∼5%. The protein/inhibitor mixture was then mixed 1:1 with the crystallization solution (100 mM KSCN, 50–100 mM LiCl (or NaCl, or KCl), 10–20% PEG3350) for a final drop size of 4 μL. Crystallization was done in 24-well hanging drop plates. Octahedron shaped crystals appeared within 1–7 days at room temperature. Crystals were cryoprotected with 30% ethylene glycol and flash-frozen in liquid nitrogen.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25">5.  Structure Solving and Refinement</h3><div class="NLM_p last">Crystals were measured at the ESRF Grenoble, France. The images were integrated using the software XDSapp.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> The structure was solved by molecular replacement using the DYRK1A structure 5A4T as a search model. Refinement was done by Phenix<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> and the CCP4<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> program Refmac5.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> The waters were placed by the program Coot 0.7.2.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The crystallographic data and model statistics are summarized in <a href="/doi/suppl/10.1021/acs.jmedchem.7b01847/suppl_file/jm7b01847_si_001.pdf" class="ext-link">Table S2</a>.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26">6.  Activity Assay</h3><div class="NLM_p last">The determination of the IC<sub>50</sub> constants for DYRK1A was done by an ATP regenerative NADH consuming assay.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The enzyme velocity was measured at 340 nm over a time period of 300 s at room temperature. ATP and the peptide RRRFRPASPLRGPPK (DYRKtide) were used as substrates. The reaction mixture was composed of 75 μL of 100 mM MOPS buffer, pH 6.8, 10 mM KCl, 10 mM MgCl, 1 mM phosphoenolpyruvate, 1 mM DYRKtide, 1 mM β-ME, 15 units/mL lactate dehydrogenase, 10 units/ml pyruvate kinase, and 10.7 mM NADH. 10 μL of ∼5–20 μM DYRK1A, 2 μL of inhibitor in DMSO in concentrations ranging from 4 nM and 20 μM, and 10 μL of ATP 128 μM were added to a total volume of 97 μL. All measurements were done in triplicate at room temperature. All other in vitro kinase assays were conducted using the SelectScreen kinase profiling service at Thermo Fisher Scientific (Madison, WI). The protocols are available from Thermo Fisher Scientific Web site.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27">7.  Cell Culture, Transfections, and Treatments. DNA Constructs</h3><div class="NLM_p">The plasmid encoding EGFP-tagged DYRK1A has been described earlier<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> and was a kind gift from Dr. D’Arcangelo (Rutgers, U.S.). The expression vector encoding the FLAG-tagged tau<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> was a kind gift from Dr. Paudel (McGill University, Canada).</div><div class="NLM_p last">NCI-H1299 cells (ATCC-CRL-5803) were maintained in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal bovine serum (Invitrogen), 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine, penicillin (100 U/mL), and streptomycin (100 μg/mL). Lipofectamine LTX (Life Technologies) reagent was used to transfect the cells according to the manufacturer’s instructions. The cells were treated for 2 h with the indicated concentration of compound the day after transfection before they were harvested in MKK lysis buffer (50 mM Tris/HCl, pH 7.5, 1 mM EGTA, 1 mM EDTA, 1% (w/v) Triton-X 100, 1 mM sodium orthovanadate, 50 mM sodium fluoride, 5 mM sodium pyrophosphate, and 0.27 M sucrose) and processed for immunoblotting.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28">8.  Immunoblotting</h3><div class="NLM_p last">For detection of ectopically expressed FLAG-TAU or EGFP-DYRK1A, the samples were analyzed by SDS–PAGE (4–12% NUPAGE, Life Technologies), transferred to a nitrocellulose membrane (Li-Cor), and probed with a rabbit anti-phospho-tau-T212 (1:1000) antibody or a mouse monoclonal anti-FLAG antibody. Detection and quantification were performed either directly using anti-GFP Dylight 800-conjugated antibody or IRDye 800CW-conjugated goat anti-rabbit IgG (H&L) (1:10 000) or IRDye 680LT-conjugated donkey anti-mouse IgG (H&L) (1:10 000) and the Odyssey infrared imaging system (Li-Cor Biosciences). Protein molecular mass was estimated using the MagicMark Western protein standard (Life Technologies).</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29">9.  Antibodies</h3><div class="NLM_p last">The polyclonal antibody against tau phosphorylated at threonine 212 (44-740G) was purchased from Life Technologies. The monoclonal antibody against FLAG (F1804) was purchased from Sigma-Aldrich. The anti-GFP Dylight 800-conjugated antibody (600-145-215) was purchased from Rockland. The IRDye 800CW-conjugated goat anti-rabbit IgG (H&L) and IRDye 680LT-conjugated donkey anti-mouse IgG (H&L) were purchased from Li-Cor Bioscience.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30">10.  Generation of DYRK1A-NFAT-luc Reporter Cell Line</h3><div class="NLM_p">The pDEST-LTR-EGFP, a mammalian transfection vector for stable and doxycycline controlled inducible expression of N-terminal-EGFP tagged fusion constructs under the control of a truncated CMV promoter, was a kind gift from Dr. Trond Lamark UiT, Tromsø, Norway.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> The cDNA encoding human DYRK1A was amplified from the IMAGE clone IMAGE:100061742 with the following primers: 5-CACCATGCATACAGGAGGAGAGACTTCAGC-3′ and 5-TCACGAGCTAGCTACAGGACTCTG-3, cloned into the pENTR using the pENTR topo cloning kit (Thermo Fischer Scientific). The final pENTR-DYRK1a construct was verified by DNA sequencing. The DYRK1A was transferred from the pENTR-DYRK1A to the vector pDEST-LTR-EGFP to generate the retroviral expression vector pEXP-LRT-EGFP-DYRK1A using the Gateway LR reaction (Thermo Fischer Scientific).</div><div class="NLM_p last">Phoenix HEK cells were transfected with the pEXP-LRT-EGFP-DYRK1A plasmid using TransIT-LT1 transfection agent (Mirus Bio LLC) following the manufacturer’s protocol. Forty-eight and seventy-two hours later the supernatant was collected and filtered through a 0.45 μm filter. The supernatant was supplemented with 5 μg/mL proteome sulfate and used to transduce the NFAT/LUCPorter stable reporter HEK cell line (Novus Biologicals), which contains a stable renilla reporter gene under control of a NFAT response element. Two days after the transduction the cells were reseeded in medium containing 5 μg/mL blasticidine, and blasticidine resistant pools of cells were propagated and tested for expression of EGFP-DYRK1 fusion protein in the absence and presence of 1 μg/mL doxycycline (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01847/suppl_file/jm7b01847_si_001.pdf" class="ext-link">Supporting Information</a>).</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31">11.  Kinome Profiling</h3><div class="NLM_p last">Kinome profiling was performed using KinomeScan ScanMAX at compound concentration of 10 μM or 1 μM. Data were reported in <a href="/doi/suppl/10.1021/acs.jmedchem.7b01847/suppl_file/jm7b01847_si_001.pdf" class="ext-link">Supporting Information</a>. Protocols are available from DiscoverX.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01847" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00143" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00143" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01847" class="ext-link">10.1021/acs.jmedchem.7b01847</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Complete table with all 23 inhibitors, molecular formula strings of the inhibitors, scaffolds of all 23 inhibitors; crystallographic table of the nine crystal structures, omit maps, surface plots and a superimposition of all the nine inhibitors bound to the ATP pocket of DYRK1A, table of the kinome scan, additional tau phosphorylation assays, overview of the cell based NFAT mediated luciferase reporter gene activity assay including the positive controls, and NMR spectra and HPLC of the new compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01847/suppl_file/jm7b01847_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Detailed kinome scan results (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01847/suppl_file/jm7b01847_si_002.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01847/suppl_file/jm7b01847_si_003.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01847/suppl_file/jm7b01847_si_001.pdf">jm7b01847_si_001.pdf (2.48 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01847/suppl_file/jm7b01847_si_002.csv">jm7b01847_si_002.csv (17.14 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01847/suppl_file/jm7b01847_si_003.csv">jm7b01847_si_003.csv (1.81 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB codes for DYRK1A complexes are the following: compound <b>AC12</b>, 6EIF; compound <b>AC15</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EJ4">6EJ4</a>; compound <b>AC20</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIJ">6EIJ</a>; compound <b>AC22</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIL">6EIL</a>; compound <b>AC23</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIP">6EIP</a>; compound <b>AC24</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIQ">6EIQ</a>; compound <b>AC25</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIR">6EIR</a>; compound <b>AC27</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIS">6EIS</a>; compound <b>AC28</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIV">6EIV</a>. Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.7b01847" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21226" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21226" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ulli Rothweiler</span> - <span class="hlFld-Affiliation affiliation">The
Norwegian Structural Biology Centre, Department of Chemistry, UiT The Arctic University of Norway, N-9037 Tromsø, Norway</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2802-7558" title="Orcid link">http://orcid.org/0000-0003-2802-7558</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d8adb4b4b1f6aab7acb0afbdb1b4bdaa98adb1acf6b6b7"><span class="__cf_email__" data-cfemail="e89d848481c69a879c809f8d81848d9aa89d819cc68687">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anna Czarna</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy, Faculty of Health Sciences, UiT The Arctic University of Norway, N-9037 Tromsø, Norway</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jinhua Wang</span> - <span class="hlFld-Affiliation affiliation">Department
of
Cancer Biology, Dana-Farber Cancer Institute, and Department of Biological
Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Diana Zelencova</span> - <span class="hlFld-Affiliation affiliation">The
Norwegian Structural Biology Centre, Department of Chemistry, UiT The Arctic University of Norway, N-9037 Tromsø, Norway</span>; 
    <span>Present Address:
                        D.Z.: Department of Physical Organic Chemistry, Latvian Institute of Organic Synthesis, Aizkraukles 21, LV-1006, Riga, Latvia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yao Liu</span> - <span class="hlFld-Affiliation affiliation">Department
of
Cancer Biology, Dana-Farber Cancer Institute, and Department of Biological
Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xianming Deng</span> - <span class="hlFld-Affiliation affiliation">Department
of
Cancer Biology, Dana-Farber Cancer Institute, and Department of Biological
Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9354-5864" title="Orcid link">http://orcid.org/0000-0002-9354-5864</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hwan Geun Choi</span> - <span class="hlFld-Affiliation affiliation">Department
of
Cancer Biology, Dana-Farber Cancer Institute, and Department of Biological
Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tinghu Zhang</span> - <span class="hlFld-Affiliation affiliation">Department
of
Cancer Biology, Dana-Farber Cancer Institute, and Department of Biological
Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wenjun Zhou</span> - <span class="hlFld-Affiliation affiliation">Department
of
Cancer Biology, Dana-Farber Cancer Institute, and Department of Biological
Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jae Won Chang</span> - <span class="hlFld-Affiliation affiliation">Department
of
Cancer Biology, Dana-Farber Cancer Institute, and Department of Biological
Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hanne Kildalsen</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy, Faculty of Health Sciences, UiT The Arctic University of Norway, N-9037 Tromsø, Norway</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ole Morten Seternes</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy, Faculty of Health Sciences, UiT The Arctic University of Norway, N-9037 Tromsø, Norway</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nathanael S. Gray</span> - <span class="hlFld-Affiliation affiliation">Department
of
Cancer Biology, Dana-Farber Cancer Institute, and Department of Biological
Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5354-7403" title="Orcid link">http://orcid.org/0000-0001-5354-7403</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard A. Engh</span> - <span class="hlFld-Affiliation affiliation">The
Norwegian Structural Biology Centre, Department of Chemistry, UiT The Arctic University of Norway, N-9037 Tromsø, Norway</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6207-0560" title="Orcid link">http://orcid.org/0000-0002-6207-0560</a></span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10855" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10855" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are grateful to Dr. D’Arcangelo (Rutgers, U.S.) and Dr. Paudel (McGill, Canada) for providing expression vectors. The work was supported Northern Norway Regional Health Authority/Helse Nord RHF (A.C. and O.M.S.). We acknowledge the European Synchrotron Radiation Facility for provision of synchrotron radiation facilities. This research was supported by the Research Council of Norway through Grant 247732.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01170" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01170" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 45 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kivipelto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Strauss, E.</span></span> <span> </span><span class="NLM_article-title">Epidemiology of Alzheimer’s disease: occurrence, determinants, and strategies toward intervention</span>. <i>Dialogues Clin. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">128</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=19585947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A280%3ADC%252BD1MvntlWrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=111-128&author=C.+Qiuauthor=M.+Kivipeltoauthor=E.+von+Strauss&title=Epidemiology+of+Alzheimer%E2%80%99s+disease%3A+occurrence%2C+determinants%2C+and+strategies+toward+intervention"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention</span></div><div class="casAuthors">Qiu Chengxuan; Kivipelto Miia; von Strauss Eva</div><div class="citationInfo"><span class="NLM_cas:title">Dialogues in clinical neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">111-28</span>
        ISSN:<span class="NLM_cas:issn">1294-8322</span>.
    </div><div class="casAbstract">More than 25 million people in the world today are affected by dementia, most suffering from Alzheimer's disease.  In both developed and developing nations, Alzheimer's disease has had tremendous impact on the affected individuals, caregivers, and society.  The etiological factors, other than older age and genetic susceptibility, remain to be determined.  Nevertheless, increasing evidence strongly points to the potential risk roles of vascular risk factors and disorders (eg, cigarette smoking, midlife high blood pressure and obesity, diabetes, and cerebrovascular lesions) and the possible beneficial roles of psychosocial factors (eg, high education, active social engagement, physical exercise, and mentally stimulating activity) in the pathogenetic process and clinical manifestation of the dementing disorders.  The long-term multidomain interventions toward the optimal control of multiple vascular risk factors and the maintenance of socially integrated lifestyles and mentally stimulating activities are expected to reduce the risk or postpone the clinical onset of dementia, including Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQOCfg7MvEKGcERNNga7KD-fW6udTcc2ebRd5qlZ5M7wLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MvntlWrtw%253D%253D&md5=d8a2f709a1cc7984f05fe6f7e15ed1ef</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DC.%26aulast%3DKivipelto%26aufirst%3DM.%26aulast%3Dvon%2BStrauss%26aufirst%3DE.%26atitle%3DEpidemiology%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520occurrence%252C%2520determinants%252C%2520and%2520strategies%2520toward%2520intervention%26jtitle%3DDialogues%2520Clin.%2520Neurosci.%26date%3D2009%26volume%3D11%26spage%3D111%26epage%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease: the amyloid cascade hypothesis: an update and reappraisal</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">153</span>, <span class="refDoi"> DOI: 10.3233/JAD-2006-9S317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.3233%2FJAD-2006-9S317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=16914853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BD28XotFKkt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=151-153&author=J.+Hardy&title=Alzheimer%E2%80%99s+disease%3A+the+amyloid+cascade+hypothesis%3A+an+update+and+reappraisal&doi=10.3233%2FJAD-2006-9S317"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease: The amyloid cascade hypothesis: An update and reappraisal</span></div><div class="casAuthors">Hardy, John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">Suppl. 3</span>),
    <span class="NLM_cas:pages">151-153</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  Here I recap the scientific and personal background of the delineation of the amyloid cascade hypothesis for Alzheimer's disease that I wrote with Gerry Higgins and the events leading to the writing of that influential review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO9h63kZgivLVg90H21EOLACvtfcHk0lhtHtAvlE_ucQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotFKkt7Y%253D&md5=9c91d6b0cf34cfdffbd2b0bb4b9429d6</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3233%2FJAD-2006-9S317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2006-9S317%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520the%2520amyloid%2520cascade%2520hypothesis%253A%2520an%2520update%2520and%2520reappraisal%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2006%26volume%3D9%26spage%3D151%26epage%3D153%26doi%3D10.3233%2FJAD-2006-9S317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, G. A.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease: the amyloid cascade hypothesis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>256</i></span>,  <span class="NLM_fpage">184</span>– <span class="NLM_lpage">185</span>, <span class="refDoi"> DOI: 10.1126/science.1566067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1126%2Fscience.1566067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1566067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADyaK38Xitlarurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1992&pages=184-185&author=J.+A.+Hardyauthor=G.+A.+Higgins&title=Alzheimer%E2%80%99s+disease%3A+the+amyloid+cascade+hypothesis&doi=10.1126%2Fscience.1566067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease:  the amyloid cascade hypothesis</span></div><div class="casAuthors">Hardy, John A.; Higgins, Gerald A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">256</span>
        (<span class="NLM_cas:issue">5054</span>),
    <span class="NLM_cas:pages">184-5</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A review with 28 refs.  The hypotheses that deposition of amyloid β protein (AβP), the main component of the plaques, is the causative agent of Alzheimer's pathol. and that the neurofibrillary tangles, cell loss, vascular damage, and dementia follow as a direct result of this deposition are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqemkoU65i2CrVg90H21EOLACvtfcHk0lg3CVdAYSkTEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xitlarurg%253D&md5=0ad307ce9ecab261ed7b01e6d288682a</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1126%2Fscience.1566067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1566067%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%2BA.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520the%2520amyloid%2520cascade%2520hypothesis%26jtitle%3DScience%26date%3D1992%26volume%3D256%26spage%3D184%26epage%3D185%26doi%3D10.1126%2Fscience.1566067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chetelat, G.</span></span> <span> </span><span class="NLM_article-title">Alzheimer disease: A beta-independent processes-rethinking preclinical AD</span>. <i>Nat. Rev. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">123</span>– <span class="NLM_lpage">124</span>, <span class="refDoi"> DOI: 10.1038/nrneurol.2013.21</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1038%2Fnrneurol.2013.21" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=23399647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslGgtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=123-124&author=G.+Chetelat&title=Alzheimer+disease%3A+A+beta-independent+processes-rethinking+preclinical+AD&doi=10.1038%2Fnrneurol.2013.21"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Aβ-independent processes-rethinking preclinical AD</span></div><div class="casAuthors">Chetelat, Gael</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">123-124</span>CODEN:
                <span class="NLM_cas:coden">NRNACP</span>;
        ISSN:<span class="NLM_cas:issn">1759-4758</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The amyloid cascade hypothesis, which posits that amyloid-β accumulation is the key event in Alzheimer disease neurodegeneration, has dominated the field for 20 years.  Recent findings, however, show that neuronal-injury biomarkers are independent of amyloid-β, calling for reconsideration of the pathol. cascade and assessment of alternative therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqb4n0SkTnuerVg90H21EOLACvtfcHk0lg3CVdAYSkTEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslGgtr4%253D&md5=c365179a1f40d1fbb5027d308cdb010d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2013.21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2013.21%26sid%3Dliteratum%253Aachs%26aulast%3DChetelat%26aufirst%3DG.%26atitle%3DAlzheimer%2520disease%253A%2520A%2520beta-independent%2520processes-rethinking%2520preclinical%2520AD%26jtitle%3DNat.%2520Rev.%2520Neurol.%26date%3D2013%26volume%3D9%26spage%3D123%26epage%3D124%26doi%3D10.1038%2Fnrneurol.2013.21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Graham, W. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonito-Oliva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakmar, T. P.</span></span> <span> </span><span class="NLM_article-title">Update on Alzheimer’s disease therapy and prevention strategies</span>. <i>Annu. Rev. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">413</span>– <span class="NLM_lpage">430</span>, <span class="refDoi"> DOI: 10.1146/annurev-med-042915-103753</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1146%2Fannurev-med-042915-103753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=28099083" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1ams7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2017&pages=413-430&author=W.+V.+Grahamauthor=A.+Bonito-Olivaauthor=T.+P.+Sakmar&title=Update+on+Alzheimer%E2%80%99s+disease+therapy+and+prevention+strategies&doi=10.1146%2Fannurev-med-042915-103753"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Update on Alzheimer's Disease Therapy and Prevention Strategies</span></div><div class="casAuthors">Graham, W. Vallen; Bonito-Oliva, Alessandra; Sakmar, Thomas P.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">413-430</span>CODEN:
                <span class="NLM_cas:coden">ARMCAH</span>;
        ISSN:<span class="NLM_cas:issn">0066-4219</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is the primary cause of age-related dementia.  Effective strategies to prevent and treat AD remain elusive despite major efforts to understand its basic biol. and clin. pathophysiol.  Significant investments in therapeutic drug discovery programs over the past two decades have yielded some important insights but no blockbuster drugs to alter the course of disease.  Because significant memory loss and cognitive decline are assocd. with neuron death and loss of gray matter, esp. in the frontal cortex and hippocampus, some focus in drug development has shifted to early prevention of cellular pathol.  Although clin. trial design is challenging, due in part to a lack of robust biomarkers with predictive value, some optimism has come from the identification and study of inherited forms of early-onset AD and genetic risk factors that provide insights about mol. pathophysiol. and potential drug targets.  In addn., better understanding of the Aβ amyloid pathway and the tau pathway-leading to amyloid plaques and neurofibrillary tangles, resp., which are histopathol. hallmarks of AD-continues to drive significant drug research and development programs.  The main focus of this review is to summarize the most recent basic biol., biochem., and pharmacol. that serve as a foundation for more than 50 active advanced-phase clin. trials for AD prevention and therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9aFvSrc-Me7Vg90H21EOLACvtfcHk0liIye3e3B713A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1ams7c%253D&md5=c3a6b3e05350112d7de5cd4ec4a00f51</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1146%2Fannurev-med-042915-103753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-med-042915-103753%26sid%3Dliteratum%253Aachs%26aulast%3DGraham%26aufirst%3DW.%2BV.%26aulast%3DBonito-Oliva%26aufirst%3DA.%26aulast%3DSakmar%26aufirst%3DT.%2BP.%26atitle%3DUpdate%2520on%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapy%2520and%2520prevention%2520strategies%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D2017%26volume%3D68%26spage%3D413%26epage%3D430%26doi%3D10.1146%2Fannurev-med-042915-103753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lloret, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchsberger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giraldo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vina, J.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanisms linking amyloid beta toxicity and Tau hyperphosphorylation in Alzheimers disease</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">186</span>– <span class="NLM_lpage">191</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2015.02.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1016%2Fj.freeradbiomed.2015.02.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=25746773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVKqs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2015&pages=186-191&author=A.+Lloretauthor=T.+Fuchsbergerauthor=E.+Giraldoauthor=J.+Vina&title=Molecular+mechanisms+linking+amyloid+beta+toxicity+and+Tau+hyperphosphorylation+in+Alzheimers+disease&doi=10.1016%2Fj.freeradbiomed.2015.02.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms linking amyloid β toxicity and Tau hyperphosphorylation in Alzheimer's disease</span></div><div class="casAuthors">Lloret, A.; Fuchsberger, T.; Giraldo, E.; Vina, J.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">186-191</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Neurofibrillary tangles (aggregates of cytoskeletal Tau protein) and senile plaques (aggregates mainly formed by amyloid β peptide) are two landmark lesions in Alzheimer's disease.  Some researchers have proposed tangles, whereas others have proposed plaques, as primary lesions.  For a long time, these were thought of as independent mechanisms.  However, exptl. evidence suggests that both lesions are intimately related.  We review here some mol. pathways linking amyloid β and Tau toxicities involving, among others, glycogen synthase kinase 3β, p38, Pin1, cyclin-dependent kinase 5, and regulator of calcineurin 1.  Understanding amyloid β and Tau toxicities as part of a common pathophysiol. mechanism may help to find mol. targets to prevent or even treat the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUDCgQFZX7abVg90H21EOLACvtfcHk0liIye3e3B713A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVKqs7c%253D&md5=4e7d3e795c949e46283c9d25eb5e3492</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2015.02.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2015.02.028%26sid%3Dliteratum%253Aachs%26aulast%3DLloret%26aufirst%3DA.%26aulast%3DFuchsberger%26aufirst%3DT.%26aulast%3DGiraldo%26aufirst%3DE.%26aulast%3DVina%26aufirst%3DJ.%26atitle%3DMolecular%2520mechanisms%2520linking%2520amyloid%2520beta%2520toxicity%2520and%2520Tau%2520hyperphosphorylation%2520in%2520Alzheimers%2520disease%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2015%26volume%3D83%26spage%3D186%26epage%3D191%26doi%3D10.1016%2Fj.freeradbiomed.2015.02.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrachina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puig, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Lagran, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avila, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dierssen, M.</span></span> <span> </span><span class="NLM_article-title">Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">392</span>– <span class="NLM_lpage">400</span>, <span class="refDoi"> DOI: 10.1016/j.nbd.2005.03.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1016%2Fj.nbd.2005.03.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=16242644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFCjs7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2005&pages=392-400&author=I.+Ferrerauthor=M.+Barrachinaauthor=B.+Puigauthor=M.+M.+de+Lagranauthor=E.+Martiauthor=J.+Avilaauthor=M.+Dierssen&title=Constitutive+Dyrk1A+is+abnormally+expressed+in+Alzheimer+disease%2C+Down+syndrome%2C+Pick+disease%2C+and+related+transgenic+models&doi=10.1016%2Fj.nbd.2005.03.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models</span></div><div class="casAuthors">Ferrer, Isidro; Barrachina, Marta; Puig, Berta; Martinez de Lagran, M.; Marti, Eulalia; Avila, Jesus; Dierssen, Mara</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">392-400</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">DYRK1A, dual-specificity tyrosine-regulated kinase 1A, maps to human chromosome 21 within the Down syndrome (DS) crit. region.  Dyrk1 phosphorylates the human microtubule-assocd. protein tau at Thr212 in vitro, a residue that is phosphorylated in fetal tau and hyper-phosphorylated in Alzheimer disease (AD) and tauopathies, including Pick disease (PiD).  Furthermore, phosphorylation of Thr212 primes tau for phosphorylation by glycogen synthase kinase 3 (GSK-3).  The present study examines Dyrk1A in the cerebral cortex of sporadic AD, adult DS with assocd. AD, and PiD.  Increased Dyrk1A immunoreactivity has been found in the cytoplasm and nuclei of scattered neurons of the neocortex, entorhinal cortex, and hippocampus in AD, DS, and PiD.  Dyrk1A is found in sarkosyl-insol. fractions which are enriched in phosphorylated tau in AD brains, thus suggesting a possible assocn. of Dyrk1A with neurofibrillary tangle pathol.  Yet, no clear relationship has been obsd. between tau phosphorylation at Thr212, and GSK-3 and Dyrk1A expression in diseased brains.  Transgenic mice bearing a triple tau mutation (G272V, P301L, and R406W) and expressing hyper-phosphoyrylated tau in neurons of the entorhinal cortex, hippocampus, and cerebral neocortex show increased expression of Dyrk1A in individual neurons in the same regions.  However, transgenic mice over-expressing Dyrk1A do not show increased phosphorylation of tau at Thr212, thus suggesting that Dyrk1A over-expression does not trigger per se hyper-phosphorylation of tau at Thr212 in vivo.  The present observations indicate modifications in the expression of constitutive Dyrk1A in the cytoplasm and nuclei of neurons in various neurodegenerative diseases assocd. with tau phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW8vHkFXvWMLVg90H21EOLACvtfcHk0liIye3e3B713A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFCjs7bN&md5=dd69cd9e3cdb10618294417873670311</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2005.03.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2005.03.020%26sid%3Dliteratum%253Aachs%26aulast%3DFerrer%26aufirst%3DI.%26aulast%3DBarrachina%26aufirst%3DM.%26aulast%3DPuig%26aufirst%3DB.%26aulast%3Dde%2BLagran%26aufirst%3DM.%2BM.%26aulast%3DMarti%26aufirst%3DE.%26aulast%3DAvila%26aufirst%3DJ.%26aulast%3DDierssen%26aufirst%3DM.%26atitle%3DConstitutive%2520Dyrk1A%2520is%2520abnormally%2520expressed%2520in%2520Alzheimer%2520disease%252C%2520Down%2520syndrome%252C%2520Pick%2520disease%252C%2520and%2520related%2520transgenic%2520models%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2005%26volume%3D20%26spage%3D392%26epage%3D400%26doi%3D10.1016%2Fj.nbd.2005.03.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dierssen, M.</span></span> <span> </span><span class="NLM_article-title">Down syndrome: the brain in trisomic mode</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">844</span>– <span class="NLM_lpage">858</span>, <span class="refDoi"> DOI: 10.1038/nrn3314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1038%2Fnrn3314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=23165261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs12iur7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=844-858&author=M.+Dierssen&title=Down+syndrome%3A+the+brain+in+trisomic+mode&doi=10.1038%2Fnrn3314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Down syndrome: the brain in trisomic mode</span></div><div class="casAuthors">Dierssen, Mara</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">844-858</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Down syndrome is the most common form of intellectual disability and results from one of the most complex genetic perturbations that is compatible with survival, trisomy 21.  The study of brain dysfunction in this disorder has largely been based on a gene discovery approach, but we are now moving into an era of functional genome exploration, in which the effects of individual genes are being studied alongside the effects of deregulated non-coding genetic elements and epigenetic influences.  Also, new data from functional neuroimaging studies are challenging our views of the cognitive phenotypes assocd. with Down syndrome and their pathophysiol. correlates.  These advances hold promise for the development of treatments for intellectual disability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ7Nujmvq_XbVg90H21EOLACvtfcHk0liIye3e3B713A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs12iur7F&md5=671ad19a458c9906ff5c9dee8e0f3f26</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrn3314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3314%26sid%3Dliteratum%253Aachs%26aulast%3DDierssen%26aufirst%3DM.%26atitle%3DDown%2520syndrome%253A%2520the%2520brain%2520in%2520trisomic%2520mode%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2012%26volume%3D13%26spage%3D844%26epage%3D858%26doi%3D10.1038%2Fnrn3314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ryoo, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radnaabazar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Son, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, W. J.</span></span> <span> </span><span class="NLM_article-title">Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer’s disease</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">1333</span>– <span class="NLM_lpage">1344</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2007.05075.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1111%2Fj.1471-4159.2007.05075.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=18005339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtFCntLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2008&pages=1333-1344&author=S.+R.+Ryooauthor=H.+J.+Choauthor=H.+W.+Leeauthor=H.+K.+Jeongauthor=C.+Radnaabazarauthor=Y.+S.+Kimauthor=M.+J.+Kimauthor=M.+Y.+Sonauthor=H.+Seoauthor=S.+H.+Chungauthor=W.+J.+Song&title=Dual-specificity+tyrosine%28Y%29-phosphorylation+regulated+kinase+1A-mediated+phosphorylation+of+amyloid+precursor+protein%3A+evidence+for+a+functional+link+between+Down+syndrome+and+Alzheimer%E2%80%99s+disease&doi=10.1111%2Fj.1471-4159.2007.05075.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease</span></div><div class="casAuthors">Ryoo, Soo-Ryoon; Cho, Hyun-Jeong; Lee, Hye-Won; Jeong, Hey Kyeong; Radnaabazar, Chinzorig; Kim, Yeun-Soo; Kim, Min-Jeong; Son, Mi-Young; Seo, Hyemyung; Chung, Sul-Hee; Song, Woo-Joo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1333-1344</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Most individuals with Down Syndrome (DS) show an early-onset of Alzheimer's disease (AD), which potentially results from the presence of an extra copy of a segment of chromosome 21.  Located on chromosome 21 are the genes that encode β-amyloid (Aβ) precursor protein (APP), a key protein involved in the pathogenesis of AD, and dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A (DYRK1A), a proline-directed protein kinase that plays a crit. role in neurodevelopment.  Here, the authors describe a potential mechanism for the regulation of AD pathol. in DS brains by DYRK1A-mediated phosphorylation of APP.  The authors show that APP is phosphorylated at Thr668 by DYRK1A in vitro and in mammalian cells.  The amts. of phospho-APP and Aβ are increased in the brains of transgenic mice that over-express the human DYRK1A protein.  Furthermore, we show that the amts. of phospho-APP as well as those of APP and DYRK1A are elevated in human DS brains.  Taken together, these results reveal a potential regulatory link between APP and DYRK1A in DS brains, and suggest that the overexpression of DYRK1A in DS may play a role in accelerating AD pathogenesis through phosphorylation of APP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5GqsDKfbC6bVg90H21EOLACvtfcHk0liXgG_3Vz7PZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtFCntLc%253D&md5=ab7a959cf5a06be742d89f1afb4f635d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2007.05075.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2007.05075.x%26sid%3Dliteratum%253Aachs%26aulast%3DRyoo%26aufirst%3DS.%2BR.%26aulast%3DCho%26aufirst%3DH.%2BJ.%26aulast%3DLee%26aufirst%3DH.%2BW.%26aulast%3DJeong%26aufirst%3DH.%2BK.%26aulast%3DRadnaabazar%26aufirst%3DC.%26aulast%3DKim%26aufirst%3DY.%2BS.%26aulast%3DKim%26aufirst%3DM.%2BJ.%26aulast%3DSon%26aufirst%3DM.%2BY.%26aulast%3DSeo%26aufirst%3DH.%26aulast%3DChung%26aufirst%3DS.%2BH.%26aulast%3DSong%26aufirst%3DW.%2BJ.%26atitle%3DDual-specificity%2520tyrosine%2528Y%2529-phosphorylation%2520regulated%2520kinase%25201A-mediated%2520phosphorylation%2520of%2520amyloid%2520precursor%2520protein%253A%2520evidence%2520for%2520a%2520functional%2520link%2520between%2520Down%2520syndrome%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurochem.%26date%3D2008%26volume%3D104%26spage%3D1333%26epage%3D1344%26doi%3D10.1111%2Fj.1471-4159.2007.05075.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwen, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radnaabazar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, S. H.</span></span> <span> </span><span class="NLM_article-title">Dyrk1A-mediated phosphorylation of Presenilin 1: a functional link between Down syndrome and Alzheimer’s disease</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">574</span>– <span class="NLM_lpage">584</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2010.06769.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1111%2Fj.1471-4159.2010.06769.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=20456003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlGlsb%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2010&pages=574-584&author=Y.+S.+Ryuauthor=S.+Y.+Parkauthor=M.+S.+Jungauthor=S.+H.+Yoonauthor=M.+Y.+Kwenauthor=S.+Y.+Leeauthor=S.+H.+Choiauthor=C.+Radnaabazarauthor=M.+K.+Kimauthor=H.+Kimauthor=K.+Kimauthor=W.+J.+Songauthor=S.+H.+Chung&title=Dyrk1A-mediated+phosphorylation+of+Presenilin+1%3A+a+functional+link+between+Down+syndrome+and+Alzheimer%E2%80%99s+disease&doi=10.1111%2Fj.1471-4159.2010.06769.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Dyrk1A-mediated phosphorylation of presenilin 1: a functional link between Down syndrome and Alzheimer's disease</span></div><div class="casAuthors">Ryu, Young Shin; Park, So Young; Jung, Min-Su; Yoon, Song-Hee; Kwen, Mi-Yang; Lee, Sun-Young; Choi, Sun-Hee; Radnaabazar, Chinzorig; Kim, Mi-Kyoung; Kim, Hangun; Kim, Kwonseop; Song, Woo-Joo; Chung, Sul-Hee</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">574-584</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The dual-specificity tyrosine(Y)-phosphorylation-regulated kinase 1A (Dyrk1A) gene is located on human chromosome 21 and encodes a proline-directed protein kinase that might be responsible for mental retardation and early onset of Alzheimer's disease (AD) in Down syndrome (DS) patients.  Presenilin 1 (PS1) is a key component of the γ-secretase complex in the generation of β-amyloid (Aβ), an important trigger protein in the pathogenesis of AD.  Increased Dyrk1A expression has been reported in human AD and DS brains.  We previously showed that Dyrk1A increased Aβ prodn. in mammalian cells and transgenic mice that over-express Dyrk1A.  In this study, we describe a potential mechanism by which Aβ is increased in Dyrk1A-over-expressing DS and AD brains.  First, we show that PS1 is phosphorylated by the Dyrk1A at Thr354 and that this phosphorylation increases γ-secretase activity.  Then, using transgenic mice that over-express human Dyrk1A, we demonstrate that phospho-Thr354-PS1 (pT354-PS1) expression is enhanced when Dyrk1A level is increased.  We also show that pT354-PS1 is more stable than the unphosphorylated form of PS1.  These results reveal a potential regulatory link between Dyrk1A and PS1 in the Aβ pathway of DS and AD brains, suggesting that up-regulated Dyrk1A may accelerate AD pathogenesis through PS1 phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLqQna1ZNRMLVg90H21EOLACvtfcHk0liXgG_3Vz7PZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlGlsb%252FJ&md5=c34feb9505bd69bb8e5242e0a23e8197</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2010.06769.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2010.06769.x%26sid%3Dliteratum%253Aachs%26aulast%3DRyu%26aufirst%3DY.%2BS.%26aulast%3DPark%26aufirst%3DS.%2BY.%26aulast%3DJung%26aufirst%3DM.%2BS.%26aulast%3DYoon%26aufirst%3DS.%2BH.%26aulast%3DKwen%26aufirst%3DM.%2BY.%26aulast%3DLee%26aufirst%3DS.%2BY.%26aulast%3DChoi%26aufirst%3DS.%2BH.%26aulast%3DRadnaabazar%26aufirst%3DC.%26aulast%3DKim%26aufirst%3DM.%2BK.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DSong%26aufirst%3DW.%2BJ.%26aulast%3DChung%26aufirst%3DS.%2BH.%26atitle%3DDyrk1A-mediated%2520phosphorylation%2520of%2520Presenilin%25201%253A%2520a%2520functional%2520link%2520between%2520Down%2520syndrome%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurochem.%26date%3D2010%26volume%3D115%26spage%3D574%26epage%3D584%26doi%3D10.1111%2Fj.1471-4159.2010.06769.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wegiel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, Y. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grundke-Iqbal, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramakrishna, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, C. X.</span></span> <span> </span><span class="NLM_article-title">Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3224</span>– <span class="NLM_lpage">3233</span>, <span class="refDoi"> DOI: 10.1096/fj.07-104539</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1096%2Ffj.07-104539" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=3224-3233&author=F.+Liuauthor=Z.+H.+Liangauthor=J.+Wegielauthor=Y.+W.+Hwangauthor=K.+Iqbalauthor=I.+Grundke-Iqbalauthor=N.+Ramakrishnaauthor=C.+X.+Gong&title=Overexpression+of+Dyrk1A+contributes+to+neurofibrillary+degeneration+in+Down+syndrome&doi=10.1096%2Ffj.07-104539"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1096%2Ffj.07-104539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.07-104539%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DLiang%26aufirst%3DZ.%2BH.%26aulast%3DWegiel%26aufirst%3DJ.%26aulast%3DHwang%26aufirst%3DY.%2BW.%26aulast%3DIqbal%26aufirst%3DK.%26aulast%3DGrundke-Iqbal%26aufirst%3DI.%26aulast%3DRamakrishna%26aufirst%3DN.%26aulast%3DGong%26aufirst%3DC.%2BX.%26atitle%3DOverexpression%2520of%2520Dyrk1A%2520contributes%2520to%2520neurofibrillary%2520degeneration%2520in%2520Down%2520syndrome%26jtitle%3DFASEB%2520J.%26date%3D2008%26volume%3D22%26spage%3D3224%26epage%3D3233%26doi%3D10.1096%2Ffj.07-104539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wegiel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, C. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, Y. W.</span></span> <span> </span><span class="NLM_article-title">The role of DYRK1A in neurodegenerative diseases</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">236</span>– <span class="NLM_lpage">245</span>, <span class="refDoi"> DOI: 10.1111/j.1742-4658.2010.07955.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1111%2Fj.1742-4658.2010.07955.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=21156028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFGru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2011&pages=236-245&author=J.+Wegielauthor=C.+X.+Gongauthor=Y.+W.+Hwang&title=The+role+of+DYRK1A+in+neurodegenerative+diseases&doi=10.1111%2Fj.1742-4658.2010.07955.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The role of DYRK1A in neurodegenerative diseases</span></div><div class="casAuthors">Wegiel, Jerzy; Gong, Cheng-Xin; Hwang, Yu-Wen</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">236-245</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Recent studies indicate that the dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) gene, which is located on chromosome 21q22.2 and is overexpressed in Down syndrome (DS), may play a significant role in developmental brain defects and in early onset neurodegeneration, neuronal loss and dementia in DS.  The identification of hundreds of genes deregulated by DYRK1A overexpression and numerous cytosolic, cytoskeletal and nuclear proteins, including transcription factors, phosphorylated by DYRK1A, indicates that DYRK1A overexpression is central for the deregulation of multiple pathways in the developing and aging DS brain, with structural and functional alterations including mental retardation and dementia.  DYRK1A overexpression in DS brains may contribute to early onset neurofibrillary degeneration directly through hyperphosphorylation of tau and indirectly through phosphorylation of alternative splicing factor, leading to an imbalance between 3R-tau and 4R-tau.  The several-fold increases in the no. of DYRK1A-pos. and 3R-tau-pos. neurofibrillary tangles in DS support this hypothesis.  Moreover, the enhanced phosphorylation of amyloid precursor protein by overexpressed DYRK1A facilitates amyloidogenic amyloid precursor protein cleavage elevating Aβ40 and 42 levels, and leading to brain β-amyloidosis.  Therefore, inhibiting DYRK1A activity in DS may serve to counteract the phenotypic effects of its overexpression and is a potential method of treatment of developmental defects and the prevention of age-assocd. neurodegeneration, including Alzheimer-type pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6EhMKZ0hzPbVg90H21EOLACvtfcHk0liOyeLFRj_NIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFGru7o%253D&md5=ac857b61ce21452dac070f1c26a75d38</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2010.07955.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2010.07955.x%26sid%3Dliteratum%253Aachs%26aulast%3DWegiel%26aufirst%3DJ.%26aulast%3DGong%26aufirst%3DC.%2BX.%26aulast%3DHwang%26aufirst%3DY.%2BW.%26atitle%3DThe%2520role%2520of%2520DYRK1A%2520in%2520neurodegenerative%2520diseases%26jtitle%3DFEBS%2520J.%26date%3D2011%26volume%3D278%26spage%3D236%26epage%3D245%26doi%3D10.1111%2Fj.1742-4658.2010.07955.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belgardt, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lammert, E.</span></span> <span> </span><span class="NLM_article-title">DYRK1A: A promising drug target for islet transplant-based diabetes therapies</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">1496</span>– <span class="NLM_lpage">1498</span>, <span class="refDoi"> DOI: 10.2337/dbi16-0013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.2337%2Fdbi16-0013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2016&pages=1496-1498&author=B.+F.+Belgardtauthor=E.+Lammert&title=DYRK1A%3A+A+promising+drug+target+for+islet+transplant-based+diabetes+therapies&doi=10.2337%2Fdbi16-0013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2337%2Fdbi16-0013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdbi16-0013%26sid%3Dliteratum%253Aachs%26aulast%3DBelgardt%26aufirst%3DB.%2BF.%26aulast%3DLammert%26aufirst%3DE.%26atitle%3DDYRK1A%253A%2520A%2520promising%2520drug%2520target%2520for%2520islet%2520transplant-based%2520diabetes%2520therapies%26jtitle%3DDiabetes%26date%3D2016%26volume%3D65%26spage%3D1496%26epage%3D1498%26doi%3D10.2337%2Fdbi16-0013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dirice, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walpita, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vetere, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahraman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dancik, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clemons, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, B. K.</span></span> <span> </span><span class="NLM_article-title">Inhibition of DYRK1A stimulates human beta-cell proliferation</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">1660</span>– <span class="NLM_lpage">1671</span>, <span class="refDoi"> DOI: 10.2337/db15-1127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.2337%2Fdb15-1127" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2016&pages=1660-1671&author=E.+Diriceauthor=D.+Walpitaauthor=A.+Vetereauthor=B.+C.+Meierauthor=S.+Kahramanauthor=J.+Huauthor=V.+Dancikauthor=S.+M.+Burnsauthor=T.+J.+Gilbertauthor=D.+E.+Olsonauthor=P.+A.+Clemonsauthor=R.+N.+Kulkarniauthor=B.+K.+Wagner&title=Inhibition+of+DYRK1A+stimulates+human+beta-cell+proliferation&doi=10.2337%2Fdb15-1127"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2337%2Fdb15-1127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb15-1127%26sid%3Dliteratum%253Aachs%26aulast%3DDirice%26aufirst%3DE.%26aulast%3DWalpita%26aufirst%3DD.%26aulast%3DVetere%26aufirst%3DA.%26aulast%3DMeier%26aufirst%3DB.%2BC.%26aulast%3DKahraman%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DDancik%26aufirst%3DV.%26aulast%3DBurns%26aufirst%3DS.%2BM.%26aulast%3DGilbert%26aufirst%3DT.%2BJ.%26aulast%3DOlson%26aufirst%3DD.%2BE.%26aulast%3DClemons%26aufirst%3DP.%2BA.%26aulast%3DKulkarni%26aufirst%3DR.%2BN.%26aulast%3DWagner%26aufirst%3DB.%2BK.%26atitle%3DInhibition%2520of%2520DYRK1A%2520stimulates%2520human%2520beta-cell%2520proliferation%26jtitle%3DDiabetes%26date%3D2016%26volume%3D65%26spage%3D1660%26epage%3D1671%26doi%3D10.2337%2Fdb15-1127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez-Perez, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felsenfeld, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivendran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bender, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Ocana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. F.</span></span> <span> </span><span class="NLM_article-title">A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">383</span>– <span class="NLM_lpage">388</span>, <span class="refDoi"> DOI: 10.1038/nm.3820</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1038%2Fnm.3820" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=25751815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjvFOnsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=383-388&author=P.+Wangauthor=J.+C.+Alvarez-Perezauthor=D.+P.+Felsenfeldauthor=H.+T.+Liuauthor=S.+Sivendranauthor=A.+Benderauthor=A.+Kumarauthor=R.+Sanchezauthor=D.+K.+Scottauthor=A.+Garcia-Ocanaauthor=A.+F.+Stewart&title=A+high-throughput+chemical+screen+reveals+that+harmine-mediated+inhibition+of+DYRK1A+increases+human+pancreatic+beta+cell+replication&doi=10.1038%2Fnm.3820"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication</span></div><div class="casAuthors">Wang, Peng; Alvarez-Perez, Juan-Carlos; Felsenfeld, Dan P.; Liu, Hongtao; Sivendran, Sharmila; Bender, Aaron; Kumar, Anil; Sanchez, Roberto; Scott, Donald K.; Garcia-Ocana, Adolfo; Stewart, Andrew F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">383-388</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Types 1 and 2 diabetes affect some 380 million people worldwide.  Both ultimately result from a deficiency of functional pancreatic insulin-producing beta cells.  Beta cells proliferate in humans during a brief temporal window beginning around the time of birth, with a peak percentage (∼2%) engaged in the cell cycle in the first year of life.  In embryonic life and after early childhood, beta cell replication is barely detectable.  Whereas beta cell expansion seems an obvious therapeutic approach to beta cell deficiency, adult human beta cells have proven recalcitrant to such efforts.  Hence, there remains an urgent need for antidiabetic therapeutic agents that can induce regeneration and expansion of adult human beta cells in vivo or ex vivo.  Here, using a high-throughput small-mol. screen (HTS), we find that analogs of the small mol. harmine function as a new class of human beta cell mitogenic compds.  We also define dual-specificity tyrosine-regulated kinase-1a (DYRK1A) as the likely target of harmine and the nuclear factors of activated T cells (NFAT) family of transcription factors as likely mediators of human beta cell proliferation and differentiation.  Using three different mouse and human islet in vivo-based models, we show that harmine is able to induce beta cell proliferation, increase islet mass and improve glycemic control.  These observations suggest that harmine analogs may have unique therapeutic promise for human diabetes therapy.  Enhancing the potency and beta cell specificity of these compds. are important future challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp11xY4tql3VbVg90H21EOLACvtfcHk0liOyeLFRj_NIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjvFOnsr8%253D&md5=32a02c393defd14b8922ac9efff63389</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnm.3820&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3820%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%26aulast%3DAlvarez-Perez%26aufirst%3DJ.%2BC.%26aulast%3DFelsenfeld%26aufirst%3DD.%2BP.%26aulast%3DLiu%26aufirst%3DH.%2BT.%26aulast%3DSivendran%26aufirst%3DS.%26aulast%3DBender%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DSanchez%26aufirst%3DR.%26aulast%3DScott%26aufirst%3DD.%2BK.%26aulast%3DGarcia-Ocana%26aufirst%3DA.%26aulast%3DStewart%26aufirst%3DA.%2BF.%26atitle%3DA%2520high-throughput%2520chemical%2520screen%2520reveals%2520that%2520harmine-mediated%2520inhibition%2520of%2520DYRK1A%2520increases%2520human%2520pancreatic%2520beta%2520cell%2520replication%26jtitle%3DNat.%2520Med.%26date%3D2015%26volume%3D21%26spage%3D383%26epage%3D388%26doi%3D10.1038%2Fnm.3820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cook, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neville, M. E.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vrana, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartl, F. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roskoski, R.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Adenosine cyclic 3′,5′-monophosphate dependent protein kinase: kinetic mechanism for the bovine skeletal muscle catalytic subunit</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">5794</span>– <span class="NLM_lpage">5799</span>, <span class="refDoi"> DOI: 10.1021/bi00266a011</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00266a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADyaL38XlslOks7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1982&pages=5794-5799&author=P.+F.+Cookauthor=M.+E.+Nevilleauthor=K.+E.+Vranaauthor=F.+T.+Hartlauthor=R.+Roskoski&title=Adenosine+cyclic+3%E2%80%B2%2C5%E2%80%B2-monophosphate+dependent+protein+kinase%3A+kinetic+mechanism+for+the+bovine+skeletal+muscle+catalytic+subunit&doi=10.1021%2Fbi00266a011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine cyclic 3',5'-monophosphate dependent protein kinase:  kinetic mechanism for the bovine skeletal muscle catalytic subunit</span></div><div class="casAuthors">Cook, Paul F.; Neville, Maynard E., Jr.; Vrana, Kent E.; Hartl, F. Thomas; Roskoski, Robert, Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5794-9</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">The kinetic mechanism for cAMP-dependent protein kinase was detd. from initial velocity studies in the absence and presence of the product, MgADP, and dead-end inhibitors.  The data were consistent with random addn. of MgATP and the peptide, Leu-Arg-Arg-Ala-Ser-Leu-Gly (I), and ordered release of phospho-I and MgADP with a dead-end enzyme-MgADP-I complex.  In addn. to the metal required for nucleotide, the binding of Mg2+ to a 2nd site was also characterized.  Increasing the Mg2+ concn. resulted in a 5-6-fold decrease in Vmax in the presence or absence of 0.1M KCl.  There was a 5-fold increase in the V/KMgATPin the absence of KCl and a 13-fold increase in V/KMgATPat 0.1M KCl.  The effect of increasing free Mg2+ on Vmax and V/K was also obtained with MgITP (20% the Vmax with MgATP) and MgGTP (10% the Vmax with MgATP) as substrates.  The dissocn. const. for Mg2+ from enzyme-I-Mg2+ and central complexes was 2-3 mM.  At low concns. of free Mg2+ and no added KCl, competitive inhibitors of MgATP (Ki = 60 μM) decreased in the order adenosine = MgADP (Ki ≃ 40 μM) > AMP (Ki ≃ 8 mM).  In addn., guanosine (1 mM) and Mg triphosphate (10 mM) failed to inhibit at low or high free Mg2+.  A mechanism for nucleotide interaction was proposed based on a hydrophobic site or neg. charged group in the region of the α-phosphate in the nucleotide-binding site and the presence or absence of a neg. charge on the α-phosphate.  A spectrophotometric assay for protein kinase that couples the prodn. of MgADP to the pyruvate kinase and lactate dehydrogenase reactions was also used.  On the basis of detns. of the amt. of phosphorylatable I by spectrophotometric or radioisotopic detns., it was found that com. samples contain 25-50% nonpeptide material by wt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0iEBJc7CoG7Vg90H21EOLACvtfcHk0lgNDwgk62Xo6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XlslOks7w%253D&md5=3cb4ce74b569fd0a8df8ef7031f27101</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fbi00266a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00266a011%26sid%3Dliteratum%253Aachs%26aulast%3DCook%26aufirst%3DP.%2BF.%26aulast%3DNeville%26aufirst%3DM.%2BE.%26aulast%3DVrana%26aufirst%3DK.%2BE.%26aulast%3DHartl%26aufirst%3DF.%2BT.%26aulast%3DRoskoski%26aufirst%3DR.%26atitle%3DAdenosine%2520cyclic%25203%25E2%2580%25B2%252C5%25E2%2580%25B2-monophosphate%2520dependent%2520protein%2520kinase%253A%2520kinetic%2520mechanism%2520for%2520the%2520bovine%2520skeletal%2520muscle%2520catalytic%2520subunit%26jtitle%3DBiochemistry%26date%3D1982%26volume%3D21%26spage%3D5794%26epage%3D5799%26doi%3D10.1021%2Fbi00266a011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alexeeva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engh, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothweiler, U.</span></span> <span> </span><span class="NLM_article-title">The structure of a dual-specificity tyrosine phosphorylation-regulated kinase 1A-PKC412 complex reveals disulfide-bridge formation with the anomalous catalytic loop HRD(HCD) cysteine</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">1207</span>– <span class="NLM_lpage">1215</span>, <span class="refDoi"> DOI: 10.1107/S1399004715005106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1107%2FS1399004715005106" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2015&pages=1207-1215&author=M.+Alexeevaauthor=E.+Abergauthor=R.+A.+Enghauthor=U.+Rothweiler&title=The+structure+of+a+dual-specificity+tyrosine+phosphorylation-regulated+kinase+1A-PKC412+complex+reveals+disulfide-bridge+formation+with+the+anomalous+catalytic+loop+HRD%28HCD%29+cysteine&doi=10.1107%2FS1399004715005106"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1107%2FS1399004715005106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS1399004715005106%26sid%3Dliteratum%253Aachs%26aulast%3DAlexeeva%26aufirst%3DM.%26aulast%3DAberg%26aufirst%3DE.%26aulast%3DEngh%26aufirst%3DR.%2BA.%26aulast%3DRothweiler%26aufirst%3DU.%26atitle%3DThe%2520structure%2520of%2520a%2520dual-specificity%2520tyrosine%2520phosphorylation-regulated%2520kinase%25201A-PKC412%2520complex%2520reveals%2520disulfide-bridge%2520formation%2520with%2520the%2520anomalous%2520catalytic%2520loop%2520HRD%2528HCD%2529%2520cysteine%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2015%26volume%3D71%26spage%3D1207%26epage%3D1215%26doi%3D10.1107%2FS1399004715005106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rothweiler, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stensen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandsdal, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaksson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engh, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svendsen, J. S.</span></span> <span> </span><span class="NLM_article-title">Probing the ATP-binding pocket of protein kinase DYRK1A with benzothiazole fragment molecules</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">9814</span>– <span class="NLM_lpage">9824</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01086</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01086" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1yksr7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9814-9824&author=U.+Rothweilerauthor=W.+Stensenauthor=B.+O.+Brandsdalauthor=J.+Isakssonauthor=F.+A.+Leesonauthor=R.+A.+Enghauthor=J.+S.+Svendsen&title=Probing+the+ATP-binding+pocket+of+protein+kinase+DYRK1A+with+benzothiazole+fragment+molecules&doi=10.1021%2Facs.jmedchem.6b01086"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the ATP-Binding Pocket of Protein Kinase DYRK1A with Benzothiazole Fragment Molecules</span></div><div class="casAuthors">Rothweiler, Ulli; Stensen, Wenche; Brandsdal, Bjoern Olav; Isaksson, Johan; Leeson, Frederick Alan; Engh, Richard Alan; Svendsen, John S. Mjoeen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9814-9824</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">DYRK1A has emerged as a potential target for therapies of Alzheimer's disease using small mols.  Based on the observation of selective DYRK1A inhibition by firefly D-luciferin, we have explored static and dynamic structural properties of fragment sized variants of the benzothiazole scaffold with respect to DYRK1A using X-ray crystallog. and NMR techniques.  The compds. have excellent ligand efficiencies and show a remarkable diversity of binding modes in dynamic equil.  Binding geometries are detd. in part by interactions often considered "weak", including "orthogonal multipolar" types represented by e.g. F-CO, sulfur-aromat, and halogen-aromat interactions, together with hydrogen bonds that are modulated by variation of electron withdrawing groups.  These studies show how the benzothiazole scaffold is highly promising for the development of therapeutic DYRK1A inhibitors.  In addn., the subtleties of the binding interactions, including dynamics, show how full structural studies are required to fully interpret the essential phys. determinants of binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYSQe1_5bEjLVg90H21EOLACvtfcHk0lgNDwgk62Xo6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1yksr7P&md5=edb850b232f53b3e161a5023915972e6</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01086%26sid%3Dliteratum%253Aachs%26aulast%3DRothweiler%26aufirst%3DU.%26aulast%3DStensen%26aufirst%3DW.%26aulast%3DBrandsdal%26aufirst%3DB.%2BO.%26aulast%3DIsaksson%26aufirst%3DJ.%26aulast%3DLeeson%26aufirst%3DF.%2BA.%26aulast%3DEngh%26aufirst%3DR.%2BA.%26aulast%3DSvendsen%26aufirst%3DJ.%2BS.%26atitle%3DProbing%2520the%2520ATP-binding%2520pocket%2520of%2520protein%2520kinase%2520DYRK1A%2520with%2520benzothiazole%2520fragment%2520molecules%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D9814%26epage%3D9824%26doi%3D10.1021%2Facs.jmedchem.6b01086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tahtouh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkins, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippakopoulos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soundararajan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durieu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delhommel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberholzer, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearl, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carreaux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazureau, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span> <span> </span><span class="NLM_article-title">Selectivity, cocrystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid leucettamine B</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9312</span>– <span class="NLM_lpage">9330</span>, <span class="refDoi"> DOI: 10.1021/jm301034u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301034u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2mu7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9312-9330&author=T.+Tahtouhauthor=J.+M.+Elkinsauthor=P.+Filippakopoulosauthor=M.+Soundararajanauthor=G.+Burgyauthor=E.+Durieuauthor=C.+Cochetauthor=R.+S.+Schmidauthor=D.+C.+Loauthor=F.+Delhommelauthor=A.+E.+Oberholzerauthor=L.+H.+Pearlauthor=F.+Carreauxauthor=J.+P.+Bazureauauthor=S.+Knappauthor=L.+Meijer&title=Selectivity%2C+cocrystal+structures%2C+and+neuroprotective+properties+of+leucettines%2C+a+family+of+protein+kinase+inhibitors+derived+from+the+marine+sponge+alkaloid+leucettamine+B&doi=10.1021%2Fjm301034u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Selectivity, Cocrystal Structures, and Neuroprotective Properties of Leucettines, a Family of Protein Kinase Inhibitors Derived from the Marine Sponge Alkaloid Leucettamine B</span></div><div class="casAuthors">Tahtouh, Tania; Elkins, Jonathan M.; Filippakopoulos, Panagis; Soundararajan, Meera; Burgy, Guillaume; Durieu, Emilie; Cochet, Claude; Schmid, Ralf S.; Lo, Donald C.; Delhommel, Florent; Oberholzer, Anselm E.; Pearl, Laurence H.; Carreaux, Francois; Bazureau, Jean-Pierre; Knapp, Stefan; Meijer, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9312-9330</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">DYRKs (dual specificity, tyrosine phosphorylation regulated kinases) and CLKs (cdc2-like kinases) are implicated in the onset and development of Alzheimer's disease and Down syndrome.  The marine sponge alkaloid leucettamine B was recently identified as an inhibitor of DYRKs/CLKs.  Synthesis of analogs (leucettines) led to an optimized product, leucettine L41.  Leucettines were cocrystd. with DYRK1A, DYRK2, CLK3, PIM1, and GSK-3β.  The selectivity of L41 was studied by activity and interaction assays of recombinant kinases and affinity chromatog. and competition affinity assays.  These approaches revealed unexpected potential secondary targets such as CK2, SLK, and the lipid kinase PIKfyve/Vac14.  L41 displayed neuroprotective effects on glutamate-induced HT22 cell death.  L41 also reduced amyloid precursor protein-induced cell death in cultured rat brain slices.  The unusual multitarget selectivity of leucettines may account for their neuroprotective effects.  This family of kinase inhibitors deserves further optimization as potential therapeutics against neurodegenerative diseases such as Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOhwr44JiuCrVg90H21EOLACvtfcHk0lj2hYrifYMfwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2mu7vF&md5=a1749c347c2e8e0409d8fdd475dc70f9</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm301034u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301034u%26sid%3Dliteratum%253Aachs%26aulast%3DTahtouh%26aufirst%3DT.%26aulast%3DElkins%26aufirst%3DJ.%2BM.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DSoundararajan%26aufirst%3DM.%26aulast%3DBurgy%26aufirst%3DG.%26aulast%3DDurieu%26aufirst%3DE.%26aulast%3DCochet%26aufirst%3DC.%26aulast%3DSchmid%26aufirst%3DR.%2BS.%26aulast%3DLo%26aufirst%3DD.%2BC.%26aulast%3DDelhommel%26aufirst%3DF.%26aulast%3DOberholzer%26aufirst%3DA.%2BE.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DCarreaux%26aufirst%3DF.%26aulast%3DBazureau%26aufirst%3DJ.%2BP.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DSelectivity%252C%2520cocrystal%2520structures%252C%2520and%2520neuroprotective%2520properties%2520of%2520leucettines%252C%2520a%2520family%2520of%2520protein%2520kinase%2520inhibitors%2520derived%2520from%2520the%2520marine%2520sponge%2520alkaloid%2520leucettamine%2520B%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9312%26epage%3D9330%26doi%3D10.1021%2Fjm301034u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weisberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Development of ’DFG-out’ inhibitors of gatekeeper mutant kinases</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">5297</span>– <span class="NLM_lpage">5302</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.06.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1016%2Fj.bmcl.2012.06.036" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5297-5302&author=H.+G.+Choiauthor=J.+M.+Zhangauthor=E.+Weisbergauthor=J.+D.+Griffinauthor=T.+Simauthor=N.+S.+Gray&title=Development+of+%E2%80%99DFG-out%E2%80%99+inhibitors+of+gatekeeper+mutant+kinases&doi=10.1016%2Fj.bmcl.2012.06.036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.06.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.06.036%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DZhang%26aufirst%3DJ.%2BM.%26aulast%3DWeisberg%26aufirst%3DE.%26aulast%3DGriffin%26aufirst%3DJ.%2BD.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DDevelopment%2520of%2520%25E2%2580%2599DFG-out%25E2%2580%2599%2520inhibitors%2520of%2520gatekeeper%2520mutant%2520kinases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D5297%26epage%3D5302%26doi%3D10.1016%2Fj.bmcl.2012.06.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoreen, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hur, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabatini, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Discovery of 9-(6-aminopyridin-3-yl)-1-(3-(trifluoromethyl)-phenyl)benzo[h][1,6]naphthyridin-2(1H)-one (Torin2) as a potent, selective, and orally available mammalian target of raparnycin (mTOR) inhibitor for treatment of cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1473</span>– <span class="NLM_lpage">1480</span>, <span class="refDoi"> DOI: 10.1021/jm101520v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101520v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1473-1480&author=Q.+S.+Liuauthor=J.+H.+Wangauthor=S.+A.+Kangauthor=C.+C.+Thoreenauthor=W.+Hurauthor=T.+Ahmedauthor=D.+M.+Sabatiniauthor=N.+S.+Gray&title=Discovery+of+9-%286-aminopyridin-3-yl%29-1-%283-%28trifluoromethyl%29-phenyl%29benzo%5Bh%5D%5B1%2C6%5Dnaphthyridin-2%281H%29-one+%28Torin2%29+as+a+potent%2C+selective%2C+and+orally+available+mammalian+target+of+raparnycin+%28mTOR%29+inhibitor+for+treatment+of+cancer&doi=10.1021%2Fjm101520v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm101520v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101520v%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%2BS.%26aulast%3DWang%26aufirst%3DJ.%2BH.%26aulast%3DKang%26aufirst%3DS.%2BA.%26aulast%3DThoreen%26aufirst%3DC.%2BC.%26aulast%3DHur%26aufirst%3DW.%26aulast%3DAhmed%26aufirst%3DT.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DDiscovery%2520of%25209-%25286-aminopyridin-3-yl%2529-1-%25283-%2528trifluoromethyl%2529-phenyl%2529benzo%255Bh%255D%255B1%252C6%255Dnaphthyridin-2%25281H%2529-one%2520%2528Torin2%2529%2520as%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520available%2520mammalian%2520target%2520of%2520raparnycin%2520%2528mTOR%2529%2520inhibitor%2520for%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1473%26epage%3D1480%26doi%3D10.1021%2Fjm101520v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fruit, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herault, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besson, T.</span></span> <span> </span><span class="NLM_article-title">Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors: a survey of recent patent literature</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1183</span>– <span class="NLM_lpage">1199</span>, <span class="refDoi"> DOI: 10.1080/13543776.2017.1360285</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1080%2F13543776.2017.1360285" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=28766366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1Ojs7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=1183-1199&issue=11&author=T.+L.+Nguyenauthor=C.+Fruitauthor=Y.+Heraultauthor=L.+Meijerauthor=T.+Besson&title=Dual-specificity+tyrosine+phosphorylation-regulated+kinase+1A+%28DYRK1A%29+inhibitors%3A+a+survey+of+recent+patent+literature&doi=10.1080%2F13543776.2017.1360285"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors: a survey of recent patent literature</span></div><div class="casAuthors">Nguyen, Thu Lan; Fruit, Corinne; Herault, Yann; Meijer, Laurent; Besson, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1183-1199</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) is a eukaryotic serine-threonine protein kinase belonging to the CMGC group.  DYRK1A hyperactivity appears to contribute to the development of a no. of human malignancies and to cognitive deficits obsd. in Down syndrome and Alzheimer's disease.  As a result, the DYRK1A kinase represents an attractive target for the synthesis and optimization of pharmacol. inhibitors of potential therapeutic interest.  Like most tyrosine kinase inhibitors developed up to the market, DYRK1A inhibitors are essentially acting by competing with ATP for binding at the catalytic site of the kinase.  This paper reviews patent activity assocd. with the discovery of synthetic novel heterocyclic mols. inhibiting the catalytic activity of DYRK1A.  Despite the important role of DYRK1A in biol. processes and the growing interest in the design of new therapeutic drugs, there are only few patented synthetic DYRK1A inhibitors and most of them were and are still developed by academic research groups, sometimes with industrial partners.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotMS30KxawIbVg90H21EOLACvtfcHk0lj2hYrifYMfwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1Ojs7jO&md5=3cdf56f9f96f917133b4625dd5d4d09c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1080%2F13543776.2017.1360285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2017.1360285%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DT.%2BL.%26aulast%3DFruit%26aufirst%3DC.%26aulast%3DHerault%26aufirst%3DY.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DBesson%26aufirst%3DT.%26atitle%3DDual-specificity%2520tyrosine%2520phosphorylation-regulated%2520kinase%25201A%2520%2528DYRK1A%2529%2520inhibitors%253A%2520a%2520survey%2520of%2520recent%2520patent%2520literature%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2017%26volume%3D27%26issue%3D11%26spage%3D1183%26epage%3D1199%26doi%3D10.1080%2F13543776.2017.1360285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohnishi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiramatsu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kii, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onogi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibuya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagiwara, M.</span></span> <span> </span><span class="NLM_article-title">Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">86</span>, <span class="refDoi"> DOI: 10.1038/ncomms1090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1038%2Fncomms1090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=20981014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A280%3ADC%252BC3cbislehtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=86&author=Y.+Ogawaauthor=Y.+Nonakaauthor=T.+Gotoauthor=E.+Ohnishiauthor=T.+Hiramatsuauthor=I.+Kiiauthor=M.+Yoshidaauthor=T.+Ikuraauthor=H.+Onogiauthor=H.+Shibuyaauthor=T.+Hosoyaauthor=N.+Itoauthor=M.+Hagiwara&title=Development+of+a+novel+selective+inhibitor+of+the+Down+syndrome-related+kinase+Dyrk1A&doi=10.1038%2Fncomms1090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A</span></div><div class="casAuthors">Ogawa Yasushi; Nonaka Yosuke; Goto Toshiyasu; Ohnishi Eriko; Hiramatsu Toshiyuki; Kii Isao; Yoshida Miyo; Ikura Teikichi; Onogi Hiroshi; Shibuya Hiroshi; Hosoya Takamitsu; Ito Nobutoshi; Hagiwara Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">86</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dyrk1A (dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 1A) is a serine/threonine kinase essential for brain development and function, and its excessive activity is considered a pathogenic factor in Down syndrome.  The development of potent, selective inhibitors of Dyrk1A would help to elucidate the molecular mechanisms of normal and diseased brains, and may provide a new lead compound for molecular-targeted drug discovery.  Here, we report a novel Dyrk1A inhibitor, INDY, a benzothiazole derivative showing a potent ATP-competitive inhibitory effect with IC(50) and K(i) values of 0.24 and 0.18 μM, respectively.  X-ray crystallography of the Dyrk1A/INDY complex revealed the binding of INDY in the ATP pocket of the enzyme.  INDY effectively reversed the aberrant tau-phosphorylation and rescued the repressed NFAT (nuclear factor of activated T cell) signalling induced by Dyrk1A overexpression.  Importantly, proINDY, a prodrug of INDY, effectively recovered Xenopus embryos from head malformation induced by Dyrk1A overexpression, resulting in normally developed embryos and demonstrating the utility of proINDY in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOCqf6rsXbPtenUz0lpNqnfW6udTcc2ebwXNt3Q8ZJdrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cbislehtw%253D%253D&md5=ac1d5972bec4085de101bb86194babd1</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fncomms1090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms1090%26sid%3Dliteratum%253Aachs%26aulast%3DOgawa%26aufirst%3DY.%26aulast%3DNonaka%26aufirst%3DY.%26aulast%3DGoto%26aufirst%3DT.%26aulast%3DOhnishi%26aufirst%3DE.%26aulast%3DHiramatsu%26aufirst%3DT.%26aulast%3DKii%26aufirst%3DI.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DIkura%26aufirst%3DT.%26aulast%3DOnogi%26aufirst%3DH.%26aulast%3DShibuya%26aufirst%3DH.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DN.%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520a%2520novel%2520selective%2520inhibitor%2520of%2520the%2520Down%2520syndrome-related%2520kinase%2520Dyrk1A%26jtitle%3DNat.%2520Commun.%26date%3D2010%26volume%3D1%26spage%3D86%26doi%3D10.1038%2Fncomms1090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kii, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumida, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato-Sumida, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonamoto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kataoka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagiwara, M.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of a potent inhibitor of class 1 DYRK kinases as a suppressor of adipogenesis</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">4434</span>– <span class="NLM_lpage">4441</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.06.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1016%2Fj.bmc.2015.06.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=26145823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVeis7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=4434-4441&author=S.+Masakiauthor=I.+Kiiauthor=Y.+Sumidaauthor=T.+Kato-Sumidaauthor=Y.+Ogawaauthor=N.+Itoauthor=M.+Nakamuraauthor=R.+Sonamotoauthor=N.+Kataokaauthor=T.+Hosoyaauthor=M.+Hagiwara&title=Design+and+synthesis+of+a+potent+inhibitor+of+class+1+DYRK+kinases+as+a+suppressor+of+adipogenesis&doi=10.1016%2Fj.bmc.2015.06.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of a potent inhibitor of class 1 DYRK kinases as a suppressor of adipogenesis</span></div><div class="casAuthors">Masaki, So; Kii, Isao; Sumida, Yuto; Kato-Sumida, Tomoe; Ogawa, Yasushi; Ito, Nobutoshi; Nakamura, Mitsuhiro; Sonamoto, Rie; Kataoka, Naoyuki; Hosoya, Takamitsu; Hagiwara, Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4434-4441</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dysregulation of dual-specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) has been demonstrated in several pathol. conditions, including Alzheimer's disease and cancer progression.  It has been recently reported that a gain of function-mutation in the human DYRK1B gene exacerbates metabolic syndrome by enhancing obesity.  In the previous study, we developed an inhibitor of DYRK family kinases (INDY) and demonstrated that INDY suppresses the pathol. phenotypes induced by overexpression of DYRK1A or DYRK1B in cellular and animal models.  In this study, we designed and synthesized a novel inhibitor of DYRK family kinases based on the crystal structure of the DYRK1A/INDY complex by replacing the phenol group of INDY with dibenzofuran to produce a deriv., named BINDY.  This compd. exhibited potent and selective inhibitory activity toward DYRK family kinases in an in vitro assay.  Furthermore, treatment of 3T3-L1 pre-adipocytes with BINDY hampered adipogenesis by suppressing gene expression of the crit. transcription factors PPARγ and C/EBPα.  This study indicates the possibility of BINDY as a potential drug for metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRt6yDW_MVw7Vg90H21EOLACvtfcHk0lhZdDbwIAgzYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVeis7fF&md5=7429d22909732d8ea03f373158969dfb</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.06.018%26sid%3Dliteratum%253Aachs%26aulast%3DMasaki%26aufirst%3DS.%26aulast%3DKii%26aufirst%3DI.%26aulast%3DSumida%26aufirst%3DY.%26aulast%3DKato-Sumida%26aufirst%3DT.%26aulast%3DOgawa%26aufirst%3DY.%26aulast%3DIto%26aufirst%3DN.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DSonamoto%26aufirst%3DR.%26aulast%3DKataoka%26aufirst%3DN.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520potent%2520inhibitor%2520of%2520class%25201%2520DYRK%2520kinases%2520as%2520a%2520suppressor%2520of%2520adipogenesis%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D4434%26epage%3D4441%26doi%3D10.1016%2Fj.bmc.2015.06.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruben, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurzlbauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sippl, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bracher, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span> <span> </span><span class="NLM_article-title">Selectivity profiling and biological activity of novel beta-carbolines as potent and selective DYRK1 kinase inhibitors</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">e0132453</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0132453</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1371%2Fjournal.pone.0132453" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0132453&author=K.+Rubenauthor=A.+Wurzlbauerauthor=A.+Walteauthor=W.+Sipplauthor=F.+Bracherauthor=W.+Becker&title=Selectivity+profiling+and+biological+activity+of+novel+beta-carbolines+as+potent+and+selective+DYRK1+kinase+inhibitors&doi=10.1371%2Fjournal.pone.0132453"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0132453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0132453%26sid%3Dliteratum%253Aachs%26aulast%3DRuben%26aufirst%3DK.%26aulast%3DWurzlbauer%26aufirst%3DA.%26aulast%3DWalte%26aufirst%3DA.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DBracher%26aufirst%3DF.%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DSelectivity%2520profiling%2520and%2520biological%2520activity%2520of%2520novel%2520beta-carbolines%2520as%2520potent%2520and%2520selective%2520DYRK1%2520kinase%2520inhibitors%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0132453%26doi%3D10.1371%2Fjournal.pone.0132453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
la Torre, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Sola, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pons, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duchon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Lagran, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farre, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fito, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benejam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langohr, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pujadas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bizot, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuenca, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catuara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Covas, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blehaut, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herault, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delabar, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dierssen, M.</span></span> <span> </span><span class="NLM_article-title">Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans</span>. <i>Mol. Nutr. Food Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">278</span>– <span class="NLM_lpage">288</span>, <span class="refDoi"> DOI: 10.1002/mnfr.201300325</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1002%2Fmnfr.201300325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=24039182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A280%3ADC%252BC3sbotlGqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=278-288&author=R.+De%0Ala+Torreauthor=S.+De+Solaauthor=M.+Ponsauthor=A.+Duchonauthor=M.+M.+de+Lagranauthor=M.+Farreauthor=M.+Fitoauthor=B.+Benejamauthor=K.+Langohrauthor=J.+Rodriguezauthor=M.+Pujadasauthor=J.+C.+Bizotauthor=A.+Cuencaauthor=N.+Janelauthor=S.+Catuaraauthor=M.+I.+Covasauthor=H.+Blehautauthor=Y.+Heraultauthor=J.+M.+Delabarauthor=M.+Dierssen&title=Epigallocatechin-3-gallate%2C+a+DYRK1A+inhibitor%2C+rescues+cognitive+deficits+in+Down+syndrome+mouse+models+and+in+humans&doi=10.1002%2Fmnfr.201300325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans</span></div><div class="casAuthors">De la Torre Rafael; De Sola Susana; Pons Meritxell; Duchon Arnaud; de Lagran Maria Martinez; Farre Magi; Fito Montserrat; Benejam Bessy; Langohr Klaus; Rodriguez Joan; Pujadas Mitona; Bizot Jean Charles; Cuenca Aida; Janel Nathalie; Catuara Silvina; Covas Maria Isabel; Blehaut Henri; Herault Yann; Delabar Jean Marie; Dierssen Mara</div><div class="citationInfo"><span class="NLM_cas:title">Molecular nutrition & food research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">278-88</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">SCOPE:  Trisomy for human chromosome 21 results in Down syndrome (DS), which is among the most complex genetic perturbations leading to intellectual disability.  Accumulating data suggest that overexpression of the dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A (DYRK1A), is a critical pathogenic mechanisms in the intellectual deficit.  METHODS AND RESULTS:  Here we show that the green tea flavonol epigallocatechin-gallate (EGCG), a DYRK1A inhibitor, rescues the cognitive deficits of both segmental trisomy 16 (Ts65Dn) and transgenic mice overexpressing Dyrk1A in a trisomic or disomic genetic background, respectively.  It also significantly reverses cognitive deficits in a pilot study in DS individuals with effects on memory recognition, working memory and quality of life.  We used the mouse models to ensure that EGCG was able to reduce DYRK1A kinase activity in the hippocampus and found that it also induced significant changes in plasma homocysteine levels, which were correlated with Dyrk1A expression levels.  Thus, we could use plasma homocysteine levels as an efficacy biomarker in our human study.  CONCLUSION:  We conclude that EGCG is a promising therapeutic tool for cognitive enhancement in DS, and its efficacy may depend of Dyrk1A inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAkxE_Xpbr2b0AGQpJZWpJfW6udTcc2eaMMEwwD2DRY7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sbotlGqsQ%253D%253D&md5=5907f7c031ef2dd5b00b44e801182add</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fmnfr.201300325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmnfr.201300325%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2Bla%2BTorre%26aufirst%3DR.%26aulast%3DDe%2BSola%26aufirst%3DS.%26aulast%3DPons%26aufirst%3DM.%26aulast%3DDuchon%26aufirst%3DA.%26aulast%3Dde%2BLagran%26aufirst%3DM.%2BM.%26aulast%3DFarre%26aufirst%3DM.%26aulast%3DFito%26aufirst%3DM.%26aulast%3DBenejam%26aufirst%3DB.%26aulast%3DLangohr%26aufirst%3DK.%26aulast%3DRodriguez%26aufirst%3DJ.%26aulast%3DPujadas%26aufirst%3DM.%26aulast%3DBizot%26aufirst%3DJ.%2BC.%26aulast%3DCuenca%26aufirst%3DA.%26aulast%3DJanel%26aufirst%3DN.%26aulast%3DCatuara%26aufirst%3DS.%26aulast%3DCovas%26aufirst%3DM.%2BI.%26aulast%3DBlehaut%26aufirst%3DH.%26aulast%3DHerault%26aufirst%3DY.%26aulast%3DDelabar%26aufirst%3DJ.%2BM.%26aulast%3DDierssen%26aufirst%3DM.%26atitle%3DEpigallocatechin-3-gallate%252C%2520a%2520DYRK1A%2520inhibitor%252C%2520rescues%2520cognitive%2520deficits%2520in%2520Down%2520syndrome%2520mouse%2520models%2520and%2520in%2520humans%26jtitle%3DMol.%2520Nutr.%2520Food%2520Res.%26date%3D2014%26volume%3D58%26spage%3D278%26epage%3D288%26doi%3D10.1002%2Fmnfr.201300325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coutadeur, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benyamine, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delalonde, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Oliveira, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblond, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foucourt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casagrande, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taverne, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pando, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desire, L.</span></span> <span> </span><span class="NLM_article-title">A novel DYRK1A (dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer’s disease: effect on Tau and amyloid pathologies in vitro</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">440</span>– <span class="NLM_lpage">451</span>, <span class="refDoi"> DOI: 10.1111/jnc.13018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1111%2Fjnc.13018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=25556849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmtlKitbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2015&pages=440-451&author=S.+Coutadeurauthor=H.+Benyamineauthor=L.+Delalondeauthor=C.+de+Oliveiraauthor=B.+Leblondauthor=A.+Foucourtauthor=T.+Bessonauthor=A.+S.+Casagrandeauthor=T.+Taverneauthor=A.+Girardauthor=M.+P.+Pandoauthor=L.+Desire&title=A+novel+DYRK1A+%28dual+specificity+tyrosine+phosphorylation-regulated+kinase+1A%29+inhibitor+for+the+treatment+of+Alzheimer%E2%80%99s+disease%3A+effect+on+Tau+and+amyloid+pathologies+in+vitro&doi=10.1111%2Fjnc.13018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A novel DYRK1A (Dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologies in vitro</span></div><div class="casAuthors">Coutadeur, Severine; Benyamine, Helene; Delalonde, Laurence; de Oliveira, Catherine; Leblond, Bertrand; Foucourt, Alicia; Besson, Thierry; Casagrande, Anne-Sophie; Taverne, Thierry; Girard, Angelique; Pando, Matthew P.; Desire, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">440-451</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) gene is located within the Down Syndrome (DS) crit. region on chromosome 21 and is implicated in the generation of Tau and amyloid pathologies that are assocd. with the early onset Alzheimer's Disease (AD) obsd. in DS.  DYRK1A is also found assocd. with neurofibrillary tangles in sporadic AD and phosphorylates key AD players (Tau, amyloid precursor, protein, etc).  Thus, DYRK1A may be an important therapeutic target to modify the course of Tau and amyloid beta (Aβ) pathologies.  Here, we describe EHT 5372 (Me 9-(2,4-dichlorophenylamino) thiazolo[5,4-f]quinazoline-2-carbimidate), a novel, highly potent (IC50 = 0.22 nM) DYRK1A inhibitor with a high degree of selectivity over 339 kinases.  Models in which inhibition of DYRK1A by siRNA reduced and DYRK1A over-expression induced Tau phosphorylation or Aβ prodn. were used.  EHT 5372 inhibits DYRK1A-induced Tau phosphorylation at multiple AD-relevant sites in biochem. and cellular assays.  EHT 5372 also normalizes both Aβ-induced Tau phosphorylation and DYRK1A-stimulated Aβ prodn.  DYRK1A is thus as a key element of Aβ-mediated Tau hyperphosphorylation, which links Tau and amyloid pathologies.  EHT 5372 and other compds. in its class warrant in vivo investigation as a novel, high-potential therapy for AD and other Tau opathies.  Inhibition of the dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) is a new high-potential therapeutic approach for Alzheimer disease.  Here we describe EHT 5372, a novel potent and selective DYRK1A inhibitor.  EHT 5372 inhibits DYRK1A-induced Tau phosphorylation, Aβ prodn. and Aβ effects on phospho-Tau, including Tau aggregation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomVswt1MX4I7Vg90H21EOLACvtfcHk0ljygu4no0E1IA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmtlKitbY%253D&md5=5953fc5e56b7ea3c86ea414bd3de7863</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1111%2Fjnc.13018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.13018%26sid%3Dliteratum%253Aachs%26aulast%3DCoutadeur%26aufirst%3DS.%26aulast%3DBenyamine%26aufirst%3DH.%26aulast%3DDelalonde%26aufirst%3DL.%26aulast%3Dde%2BOliveira%26aufirst%3DC.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DFoucourt%26aufirst%3DA.%26aulast%3DBesson%26aufirst%3DT.%26aulast%3DCasagrande%26aufirst%3DA.%2BS.%26aulast%3DTaverne%26aufirst%3DT.%26aulast%3DGirard%26aufirst%3DA.%26aulast%3DPando%26aufirst%3DM.%2BP.%26aulast%3DDesire%26aufirst%3DL.%26atitle%3DA%2520novel%2520DYRK1A%2520%2528dual%2520specificity%2520tyrosine%2520phosphorylation-regulated%2520kinase%25201A%2529%2520inhibitor%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520effect%2520on%2520Tau%2520and%2520amyloid%2520pathologies%2520in%2520vitro%26jtitle%3DJ.%2520Neurochem.%26date%3D2015%26volume%3D133%26spage%3D440%26epage%3D451%26doi%3D10.1111%2Fjnc.13018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaikuad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diharce, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foucourt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblond, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casagrande, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desire, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besson, T.</span></span> <span> </span><span class="NLM_article-title">An unusual binding model of the methyl 9-anilinothiazolo[5,4-f] quinazoline-2-carbimidates (EHT 1610 and EHT 5372) confers high selectivity for dual-specificity tyrosine phosphorylation-regulated kinases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10315</span>– <span class="NLM_lpage">10321</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01083</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01083" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslWjtr%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10315-10321&author=A.+Chaikuadauthor=J.+Diharceauthor=M.+Schroderauthor=A.+Foucourtauthor=B.+Leblondauthor=A.+S.+Casagrandeauthor=L.+Desireauthor=P.+Bonnetauthor=S.+Knappauthor=T.+Besson&title=An+unusual+binding+model+of+the+methyl+9-anilinothiazolo%5B5%2C4-f%5D+quinazoline-2-carbimidates+%28EHT+1610+and+EHT+5372%29+confers+high+selectivity+for+dual-specificity+tyrosine+phosphorylation-regulated+kinases&doi=10.1021%2Facs.jmedchem.6b01083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">An Unusual Binding Model of the Methyl 9-Anilinothiazolo[5,4-f] quinazoline-2-carbimidates (EHT 1610 and EHT 5372) Confers High Selectivity for Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases</span></div><div class="casAuthors">Chaikuad, Apirat; Diharce, Julien; Schroder, Martin; Foucourt, Alicia; Leblond, Bertrand; Casagrande, Anne-Sophie; Desire, Laurent; Bonnet, Pascal; Knapp, Stefan; Besson, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10315-10321</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Me 9-anilinothiazolo[5,4-f]quinazoline-2-carbimidates 1 (EHT 5372) and 2 (EHT 1610) are strong inhibitors of DYRK's family kinases.  The crystal structures of the complex revealed a non-canonical binding mode of compd. 1 and 2 in DYRK2 explaining the remarkable selectivity and potency of these inhibitors.  The structural data and comparison presented here provide therefore a template for further improvement of this inhibitor class and for the development of novel inhibitors selectively targeting DYRK kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp91_JqCRXGqLVg90H21EOLACvtfcHk0ljygu4no0E1IA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslWjtr%252FM&md5=856551b47ad21c90c55563b064001358</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01083%26sid%3Dliteratum%253Aachs%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DDiharce%26aufirst%3DJ.%26aulast%3DSchroder%26aufirst%3DM.%26aulast%3DFoucourt%26aufirst%3DA.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DCasagrande%26aufirst%3DA.%2BS.%26aulast%3DDesire%26aufirst%3DL.%26aulast%3DBonnet%26aufirst%3DP.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBesson%26aufirst%3DT.%26atitle%3DAn%2520unusual%2520binding%2520model%2520of%2520the%2520methyl%25209-anilinothiazolo%255B5%252C4-f%255D%2520quinazoline-2-carbimidates%2520%2528EHT%25201610%2520and%2520EHT%25205372%2529%2520confers%2520high%2520selectivity%2520for%2520dual-specificity%2520tyrosine%2520phosphorylation-regulated%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10315%26epage%3D10321%26doi%3D10.1021%2Facs.jmedchem.6b01083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naert, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferre, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meunier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malmstrom, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Givalois, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carreaux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazureau, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span> <span> </span><span class="NLM_article-title">Leucettine L41, a DYRK1A-preferential DYRKs/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric A beta(25–35) peptide administration in mice</span>. <i>Eur. Neuropsychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2170</span>– <span class="NLM_lpage">2182</span>, <span class="refDoi"> DOI: 10.1016/j.euroneuro.2015.03.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1016%2Fj.euroneuro.2015.03.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=26381812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsFemsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2170-2182&author=G.+Naertauthor=V.+Ferreauthor=J.+Meunierauthor=E.+Kellerauthor=S.+Malmstromauthor=L.+Givaloisauthor=F.+Carreauxauthor=J.+P.+Bazureauauthor=T.+Maurice&title=Leucettine+L41%2C+a+DYRK1A-preferential+DYRKs%2FCLKs+inhibitor%2C+prevents+memory+impairments+and+neurotoxicity+induced+by+oligomeric+A+beta%2825%E2%80%9335%29+peptide+administration+in+mice&doi=10.1016%2Fj.euroneuro.2015.03.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Leucettine L41, a DYRK1A-preferential DYRKs/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric Aβ25-35 peptide administration in mice</span></div><div class="casAuthors">Naert, Gaelle; Ferre, Valentine; Meunier, Johann; Keller, Emeline; Malmstrom, Susanna; Givalois, Laurent; Carreaux, Francois; Bazureau, Jean-Pierre; Maurice, Tangui</div><div class="citationInfo"><span class="NLM_cas:title">European Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2170-2182</span>CODEN:
                <span class="NLM_cas:coden">EURNE8</span>;
        ISSN:<span class="NLM_cas:issn">0924-977X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dual-specificity tyrosine phosphorylation-regulated kinases (DYRKs) and cdc2-like kinases (CLKs) are implicated in the onset and progression of Down syndrome (DS) and Alzheimer's disease (AD).  DYRK1A has emerged as a possible link between amyloid-β (Aβ) and Tau, the major pathol. proteins in AD.  We here assessed the neuroprotective potential of a novel inhibitor of DYRKs/CLKs.  The Leucettine L41, acting preferentially on DYRK1A, was tested in Aβ25-35-treated mice, a nontransgenic model of AD-like toxicity.  We co-injected intracerebroventricularly oligomeric Aβ25-35 peptide and L41 in Swiss male mice.  After 7 days, they were submitted to behavioral tests addressing spatial and non-spatial, short- and long-term memories.  The oxidative stress, apoptotic markers, kinases involved in Tau phosphorylation, and synaptic integrity were analyzed by Western blot and ELISA in the hippocampus.  L41, tested at 0.4, 1.2, 4 μg, prevented the Aβ25-35-induced memory deficits in the Y-maze, passive avoidance and water-maze tests, with the most active dose being 4 μg.  The inhibitor prevented the Aβ25-35-induced oxidative stress, as revealed by measures of lipid peroxidn. levels and reactive oxygen species accumulation, and abolished Aβ25-35-induced expression of pro-apoptotic markers.  L41 prevented the Aβ25-35-induced decrease of AKT activation and increase of glycogen synthase kinase-3β (GSK-3β) activation, resulting in a decrease of Tau phosphorylation.  Finally, L41 restored Aβ25-35-reduced levels of synaptic markers.  The novel DYRK1A-preferential inhibitor L41 therefore prevented Aβ25-35-induced memory impairments and neurotoxicity in the mouse hippocampus.  These in vivo data highlighted particularly DYRK1A as a major kinase involved in Aβ pathol. and suggested therapeutic developments for DYRK1A inhibitors in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSRN-4HYiJs7Vg90H21EOLACvtfcHk0liIloWg1kOLwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsFemsro%253D&md5=0ddd499193f1ef57d02b46a39f225abb</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.euroneuro.2015.03.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.euroneuro.2015.03.018%26sid%3Dliteratum%253Aachs%26aulast%3DNaert%26aufirst%3DG.%26aulast%3DFerre%26aufirst%3DV.%26aulast%3DMeunier%26aufirst%3DJ.%26aulast%3DKeller%26aufirst%3DE.%26aulast%3DMalmstrom%26aufirst%3DS.%26aulast%3DGivalois%26aufirst%3DL.%26aulast%3DCarreaux%26aufirst%3DF.%26aulast%3DBazureau%26aufirst%3DJ.%2BP.%26aulast%3DMaurice%26aufirst%3DT.%26atitle%3DLeucettine%2520L41%252C%2520a%2520DYRK1A-preferential%2520DYRKs%252FCLKs%2520inhibitor%252C%2520prevents%2520memory%2520impairments%2520and%2520neurotoxicity%2520induced%2520by%2520oligomeric%2520A%2520beta%252825%25E2%2580%259335%2529%2520peptide%2520administration%2520in%2520mice%26jtitle%3DEur.%2520Neuropsychopharmacol.%26date%3D2015%26volume%3D25%26spage%3D2170%26epage%3D2182%26doi%3D10.1016%2Fj.euroneuro.2015.03.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rothweiler, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eriksson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stensen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engh, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svendsen, J. S.</span></span> <span> </span><span class="NLM_article-title">Luciferin and derivatives as a DYRK selective scaffold for the design of protein kinase inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">140</span>– <span class="NLM_lpage">148</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.02.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1016%2Fj.ejmech.2015.02.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=25768698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjsFGjsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2015&pages=140-148&author=U.+Rothweilerauthor=J.+Erikssonauthor=W.+Stensenauthor=F.+Leesonauthor=R.+A.+Enghauthor=J.+S.+Svendsen&title=Luciferin+and+derivatives+as+a+DYRK+selective+scaffold+for+the+design+of+protein+kinase+inhibitors&doi=10.1016%2Fj.ejmech.2015.02.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Luciferin and derivatives as a DYRK selective scaffold for the design of protein kinase inhibitors</span></div><div class="casAuthors">Rothweiler, Ulli; Eriksson, Jonas; Stensen, Wenche; Leeson, Frederick; Engh, Richard A.; Svendsen, John S.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">140-148</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">D-Luciferin is widely used as a substrate in luciferase catalyzed bioluminescence assays for in vitro studies.  However, little is known about cross reactivity and potential interference of D-luciferin with other enzymes.  The authors serendipitously found that firefly luciferin inhibited the CDK2/Cyclin A protein kinase.  Inhibition profiling of D-luciferin over a 103-protein kinase panel showed significant inhibition of a small set of protein kinases, in particular the DYRK-family, but also other members of the CMGC-group, including ERK8 and CK2.  Inhibition profiling on a 16-member focused library derived from D-luciferin confirms that D-luciferin represents a DYRK-selective chemotype of fragment-like mol. wt.  Thus, observation of its inhibitory activity and the initial SAR information reported here promise to be useful for further design of protein kinase inhibitors with related scaffolds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqEtt2EfYajrVg90H21EOLACvtfcHk0lhM9w5dAwfK8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjsFGjsL4%253D&md5=5d3fd3650bf11958c7e60a5656b28dfd</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.02.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.02.035%26sid%3Dliteratum%253Aachs%26aulast%3DRothweiler%26aufirst%3DU.%26aulast%3DEriksson%26aufirst%3DJ.%26aulast%3DStensen%26aufirst%3DW.%26aulast%3DLeeson%26aufirst%3DF.%26aulast%3DEngh%26aufirst%3DR.%2BA.%26aulast%3DSvendsen%26aufirst%3DJ.%2BS.%26atitle%3DLuciferin%2520and%2520derivatives%2520as%2520a%2520DYRK%2520selective%2520scaffold%2520for%2520the%2520design%2520of%2520protein%2520kinase%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D94%26spage%3D140%26epage%3D148%26doi%3D10.1016%2Fj.ejmech.2015.02.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kii, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumida, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonamoto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato-Sumida, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koike, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibuya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagiwara, M.</span></span> <span> </span><span class="NLM_article-title">Selective inhibition of the kinase DYRK1A by targeting its folding process</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">11391</span>, <span class="refDoi"> DOI: 10.1038/ncomms11391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1038%2Fncomms11391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=27102360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC28XmslShtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=11391&author=I.+Kiiauthor=Y.+Sumidaauthor=T.+Gotoauthor=R.+Sonamotoauthor=Y.+Okunoauthor=S.+Yoshidaauthor=T.+Kato-Sumidaauthor=Y.+Koikeauthor=M.+Abeauthor=Y.+Nonakaauthor=T.+Ikuraauthor=N.+Itoauthor=H.+Shibuyaauthor=T.+Hosoyaauthor=M.+Hagiwara&title=Selective+inhibition+of+the+kinase+DYRK1A+by+targeting+its+folding+process&doi=10.1038%2Fncomms11391"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of the kinase DYRK1A by targeting its folding process</span></div><div class="casAuthors">Kii, Isao; Sumida, Yuto; Goto, Toshiyasu; Sonamoto, Rie; Okuno, Yukiko; Yoshida, Suguru; Kato-Sumida, Tomoe; Koike, Yuka; Abe, Minako; Nonaka, Yosuke; Ikura, Teikichi; Ito, Nobutoshi; Shibuya, Hiroshi; Hosoya, Takamitsu; Hagiwara, Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11391</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autophosphorylation of amino-acid residues is part of the folding process of various protein kinases.  Conventional chem. screening of mature kinases has missed inhibitors that selectively interfere with the folding process.  Here we report a cell-based assay that evaluates inhibition of a kinase at a transitional state during the folding process and identify a folding intermediate-selective inhibitor of dual-specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A), which we refer to as FINDY.  FINDY suppresses intramol. autophosphorylation of Ser97 in DYRK1A in cultured cells, leading to its degrdn., but does not inhibit substrate phosphorylation catalyzed by the mature kinase.  FINDY also suppresses Ser97 autophosphorylation of recombinant DYRK1A, suggesting direct inhibition, and shows high selectivity for DYRK1A over other DYRK family members.  In addn., FINDY rescues DYRK1A-induced developmental malformations in Xenopus laevis embryos.  Our study demonstrates that transitional folding intermediates of protein kinases can be targeted by small mols., and paves the way for developing novel types of kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE2gsAsp-YjLVg90H21EOLACvtfcHk0lhM9w5dAwfK8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmslShtr8%253D&md5=5d64de412dd168a415a3da052d3afedc</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fncomms11391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms11391%26sid%3Dliteratum%253Aachs%26aulast%3DKii%26aufirst%3DI.%26aulast%3DSumida%26aufirst%3DY.%26aulast%3DGoto%26aufirst%3DT.%26aulast%3DSonamoto%26aufirst%3DR.%26aulast%3DOkuno%26aufirst%3DY.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DKato-Sumida%26aufirst%3DT.%26aulast%3DKoike%26aufirst%3DY.%26aulast%3DAbe%26aufirst%3DM.%26aulast%3DNonaka%26aufirst%3DY.%26aulast%3DIkura%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DN.%26aulast%3DShibuya%26aufirst%3DH.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DSelective%2520inhibition%2520of%2520the%2520kinase%2520DYRK1A%2520by%2520targeting%2520its%2520folding%2520process%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D11391%26doi%3D10.1038%2Fncomms11391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of 3,5-disubstituted 7-azaindoles as Trk inhibitors with anticancer and antiangiogenic activities</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">5337</span>– <span class="NLM_lpage">5349</span>, <span class="refDoi"> DOI: 10.1021/jm3002982</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3002982" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5337-5349&author=S.+Hongauthor=J.+Kimauthor=J.+H.+Seoauthor=K.+H.+Jungauthor=S.+S.+Hongauthor=S.+Hong&title=Design%2C+synthesis%2C+and+evaluation+of+3%2C5-disubstituted+7-azaindoles+as+Trk+inhibitors+with+anticancer+and+antiangiogenic+activities&doi=10.1021%2Fjm3002982"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm3002982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3002982%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DSeo%26aufirst%3DJ.%2BH.%26aulast%3DJung%26aufirst%3DK.%2BH.%26aulast%3DHong%26aufirst%3DS.%2BS.%26aulast%3DHong%26aufirst%3DS.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%25203%252C5-disubstituted%25207-azaindoles%2520as%2520Trk%2520inhibitors%2520with%2520anticancer%2520and%2520antiangiogenic%2520activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5337%26epage%3D5349%26doi%3D10.1021%2Fjm3002982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. G.</span>; <span class="NLM_string-name">Sim, T.</span>; <span class="NLM_string-name">Gray, N.</span>; <span class="NLM_string-name">Zhou, W.</span>; <span class="NLM_string-name">Chang, J. W.</span>; <span class="NLM_string-name">Zhang, J.</span>; <span class="NLM_string-name">Weisberg, E.</span></span> <span> </span><span class="NLM_article-title">Fused Heterocyclic Compounds and Their Uses</span>. PCT Int. Appl. <span class="NLM_patent">WO 2010144909 A1</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=H.+G.+Choi&author=T.+Sim&author=N.+Gray&author=W.+Zhou&author=J.+W.+Chang&author=J.+Zhang&author=E.+Weisberg&title=Fused+Heterocyclic+Compounds+and+Their+Uses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DH.%2BG.%26atitle%3DFused%2520Heterocyclic%2520Compounds%2520and%2520Their%2520Uses%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miduturu, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwiatkowski, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brault, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippakopoulos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwaller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrgard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarrinkar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">High-throughput kinase profiling: a more efficient approach toward the discovery of new kinase inhibitors</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">868</span>– <span class="NLM_lpage">879</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2011.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1016%2Fj.chembiol.2011.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=21802008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsFarurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=868-879&author=C.+V.+Miduturuauthor=X.+Dengauthor=N.+Kwiatkowskiauthor=W.+Yangauthor=L.+Braultauthor=P.+Filippakopoulosauthor=E.+Chungauthor=Q.+Yangauthor=J.+Schwallerauthor=S.+Knappauthor=R.+W.+Kingauthor=J.+D.+Leeauthor=S.+Herrgardauthor=P.+Zarrinkarauthor=N.+S.+Gray&title=High-throughput+kinase+profiling%3A+a+more+efficient+approach+toward+the+discovery+of+new+kinase+inhibitors&doi=10.1016%2Fj.chembiol.2011.05.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">High-Throughput Kinase Profiling: A More Efficient Approach toward the Discovery of New Kinase Inhibitors</span></div><div class="casAuthors">Miduturu, Chandrasekhar V.; Deng, Xianming; Kwiatkowski, Nicholas; Yang, Wannian; Brault, Laurent; Filippakopoulos, Panagis; Chung, Eunah; Yang, Qingkai; Schwaller, Juerg; Knapp, Stefan; King, Randall W.; Lee, Jiing-Dwan; Herrgard, Sanna; Zarrinkar, Patrick; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">868-879</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Selective protein kinase inhibitors have only been developed against a small no. of kinase targets.  Here we demonstrate that "high-throughput kinase profiling" is an efficient method for the discovery of lead compds. for established as well as unexplored kinase targets.  We screened a library of 118 compds. constituting two distinct scaffolds (furan-thiazolidinediones and pyrimido-diazepines) against a panel of 353 kinases.  A distinct kinase selectivity profile was obsd. for each scaffold.  Selective inhibitors were identified with submicromolar cellular activity against PIM1, ERK5, ACK1, MPS1, PLK1-3, and Aurora A,B kinases.  In addn., we identified potent inhibitors for so far unexplored kinases such as DRAK1, HIPK2, and DCAMKL1 that await further evaluation.  This inhibitor-centric approach permits comprehensive assessment of a scaffold of interest and represents an efficient and general strategy for identifying new selective kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKLvN9eLNvybVg90H21EOLACvtfcHk0lgv9A6u0Nm8Uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsFarurw%253D&md5=d62a4771b1215551f3913b93d6eca7ee</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DMiduturu%26aufirst%3DC.%2BV.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DKwiatkowski%26aufirst%3DN.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DBrault%26aufirst%3DL.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DChung%26aufirst%3DE.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DSchwaller%26aufirst%3DJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DKing%26aufirst%3DR.%2BW.%26aulast%3DLee%26aufirst%3DJ.%2BD.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DZarrinkar%26aufirst%3DP.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DHigh-throughput%2520kinase%2520profiling%253A%2520a%2520more%2520efficient%2520approach%2520toward%2520the%2520discovery%2520of%2520new%2520kinase%2520inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D868%26epage%3D879%26doi%3D10.1016%2Fj.chembiol.2011.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoreen, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hur, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabatini, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Discovery of 9-(6-aminopyridin-3-yl)-1-(3-(trifluoromethyl)phenyl)benzo[h][1,6]naphthyridin-2(1H)-one (Torin2) as a potent, selective, and orally available mammalian target of rapamycin (mTOR) inhibitor for treatment of cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1473</span>– <span class="NLM_lpage">1480</span>, <span class="refDoi"> DOI: 10.1021/jm101520v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101520v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvFeis7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1473-1480&author=Q.+Liuauthor=J.+Wangauthor=S.+A.+Kangauthor=C.+C.+Thoreenauthor=W.+Hurauthor=T.+Ahmedauthor=D.+M.+Sabatiniauthor=N.+S.+Gray&title=Discovery+of+9-%286-aminopyridin-3-yl%29-1-%283-%28trifluoromethyl%29phenyl%29benzo%5Bh%5D%5B1%2C6%5Dnaphthyridin-2%281H%29-one+%28Torin2%29+as+a+potent%2C+selective%2C+and+orally+available+mammalian+target+of+rapamycin+%28mTOR%29+inhibitor+for+treatment+of+cancer&doi=10.1021%2Fjm101520v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 9-(6-Aminopyridin-3-yl)-1-(3-(trifluoromethyl)phenyl)benzo[h][1,6]naphthyridin-2(1H)-one (Torin2) as a potent, selective, and orally available mammalian target of rapamycin (mTOR) inhibitor for treatment of cancer</span></div><div class="casAuthors">Liu, Qingsong; Wang, Jinhua; Kang, Seong A.; Thoreen, Carson C.; Hur, Wooyoung; Ahmed, Tausif; Sabatini, David M.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1473-1480</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The mTOR mediated PI3K/AKT/mTOR signal transduction pathway has been demonstrated to play a key role in a broad spectrum of cancers.  Starting from the mTOR selective inhibitor 1 (Torin1), a focused medicinal chem. effort led to the discovery of an improved mTOR inhibitor 3 (Torin2, I), which possesses an EC50 of 0.25 nM for inhibiting cellular mTOR activity.  Compd. 3 exhibited 800-fold selectivity over PI3K (EC50: 200 nM) and over 100-fold binding selectivity relative to 440 other protein kinases.  Compd. 3 has significantly improved bioavailability (54%), metabolic stability, and plasma exposure relative to compd. 1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpznkwEqQGOULVg90H21EOLACvtfcHk0lgv9A6u0Nm8Uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvFeis7c%253D&md5=845ed4ca35e5544954db71cd6813528e</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm101520v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101520v%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DS.%2BA.%26aulast%3DThoreen%26aufirst%3DC.%2BC.%26aulast%3DHur%26aufirst%3DW.%26aulast%3DAhmed%26aufirst%3DT.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DDiscovery%2520of%25209-%25286-aminopyridin-3-yl%2529-1-%25283-%2528trifluoromethyl%2529phenyl%2529benzo%255Bh%255D%255B1%252C6%255Dnaphthyridin-2%25281H%2529-one%2520%2528Torin2%2529%2520as%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520available%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%2520inhibitor%2520for%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1473%26epage%3D1480%26doi%3D10.1021%2Fjm101520v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redmond, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urisman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burlingame, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pak, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jovicic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gitler, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seeley, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddique, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigio, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trojanowski, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, E. J.</span></span> <span> </span><span class="NLM_article-title">Activation of HIPK2 promotes ER stress-mediated neurodegeneration in amyotrophic lateral sclerosis</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">41</span>– <span class="NLM_lpage">55</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2016.05.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1016%2Fj.neuron.2016.05.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2016&pages=41-55&author=S.+Leeauthor=Y.+Shangauthor=S.+A.+Redmondauthor=A.+Urismanauthor=A.+A.+Tangauthor=K.+H.+Liauthor=A.+L.+Burlingameauthor=R.+A.+Pakauthor=A.+Jovicicauthor=A.+D.+Gitlerauthor=J.+Wangauthor=N.+S.+Grayauthor=W.+W.+Seeleyauthor=T.+Siddiqueauthor=E.+H.+Bigioauthor=V.+M.+Leeauthor=J.+Q.+Trojanowskiauthor=J.+R.+Chanauthor=E.+J.+Huang&title=Activation+of+HIPK2+promotes+ER+stress-mediated+neurodegeneration+in+amyotrophic+lateral+sclerosis&doi=10.1016%2Fj.neuron.2016.05.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2016.05.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2016.05.021%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%26aulast%3DShang%26aufirst%3DY.%26aulast%3DRedmond%26aufirst%3DS.%2BA.%26aulast%3DUrisman%26aufirst%3DA.%26aulast%3DTang%26aufirst%3DA.%2BA.%26aulast%3DLi%26aufirst%3DK.%2BH.%26aulast%3DBurlingame%26aufirst%3DA.%2BL.%26aulast%3DPak%26aufirst%3DR.%2BA.%26aulast%3DJovicic%26aufirst%3DA.%26aulast%3DGitler%26aufirst%3DA.%2BD.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DSeeley%26aufirst%3DW.%2BW.%26aulast%3DSiddique%26aufirst%3DT.%26aulast%3DBigio%26aufirst%3DE.%2BH.%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DChan%26aufirst%3DJ.%2BR.%26aulast%3DHuang%26aufirst%3DE.%2BJ.%26atitle%3DActivation%2520of%2520HIPK2%2520promotes%2520ER%2520stress-mediated%2520neurodegeneration%2520in%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DNeuron%26date%3D2016%26volume%3D91%26spage%3D41%26epage%3D55%26doi%3D10.1016%2Fj.neuron.2016.05.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruce, I.</span>; <span class="NLM_string-name">Budd, E.</span>; <span class="NLM_string-name">Edwards, L.</span>; <span class="NLM_string-name">Howsham, C.</span></span> <span> </span><span class="NLM_article-title">Pyridines and Pyrazines as Inhibitors of Pi3k</span>. PCT Int. Appl. <span class="NLM_patent">WO 2009115517 A2</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=I.+Bruce&author=E.+Budd&author=L.+Edwards&author=C.+Howsham&title=Pyridines+and+Pyrazines+as+Inhibitors+of+Pi3k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBruce%26aufirst%3DI.%26atitle%3DPyridines%2520and%2520Pyrazines%2520as%2520Inhibitors%2520of%2520Pi3k%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krug, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinemann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, U.</span></span> <span> </span><span class="NLM_article-title">XDSAPP: a graphical user interface for the convenient processing of diffraction data using XDS</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">568</span>– <span class="NLM_lpage">572</span>, <span class="refDoi"> DOI: 10.1107/S0021889812011715</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1107%2FS0021889812011715" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsFGmtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2012&pages=568-572&author=M.+Krugauthor=M.+S.+Weissauthor=U.+Heinemannauthor=U.+Mueller&title=XDSAPP%3A+a+graphical+user+interface+for+the+convenient+processing+of+diffraction+data+using+XDS&doi=10.1107%2FS0021889812011715"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">XDSAPP: a graphical user interface for the convenient processing of diffraction data using XDS</span></div><div class="casAuthors">Krug, Michael; Weiss, Manfred S.; Heinemann, Udo; Mueller, Uwe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">568-572</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">XDSAPP is a Tcl/Tk-based graphical user interface for the easy and convenient processing of diffraction data sets using XDS.  It provides easy access to all XDS functionalities, automates the data processing and generates graphical plots of various data set statistics provided by XDS.  By incorporating addnl. software, further information on certain features of the data set, such as radiation decay during data collection or the presence of pseudo-translational symmetry and/or twinning, can be obtained.  Intensity files suitable for CCP4, CNS and SHELX are generated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCqFLQ2J-k07Vg90H21EOLACvtfcHk0lj318xk1os6sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnsFGmtLo%253D&md5=8f0b78fdea7ed6cc580de9eb561e8b9e</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1107%2FS0021889812011715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889812011715%26sid%3Dliteratum%253Aachs%26aulast%3DKrug%26aufirst%3DM.%26aulast%3DWeiss%26aufirst%3DM.%2BS.%26aulast%3DHeinemann%26aufirst%3DU.%26aulast%3DMueller%26aufirst%3DU.%26atitle%3DXDSAPP%253A%2520a%2520graphical%2520user%2520interface%2520for%2520the%2520convenient%2520processing%2520of%2520diffraction%2520data%2520using%2520XDS%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2012%26volume%3D45%26spage%3D568%26epage%3D572%26doi%3D10.1107%2FS0021889812011715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afonine, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunkoczi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echols, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Headd, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapral, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oeffner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwart, P. H.</span></span> <span> </span><span class="NLM_article-title">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1107/S0907444909052925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunkocziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.+W.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grosse-Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=PHENIX%3A+a+comprehensive+Python-based+system+for+macromolecular+structure+solution&doi=10.1107%2FS0907444909052925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0lj318xk1os6sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunkoczi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.%2BW.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DPHENIX%253A%2520a%2520comprehensive%2520Python-based%2520system%2520for%2520macromolecular%2520structure%2520solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D213%26epage%3D221%26doi%3D10.1107%2FS0907444909052925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodson, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keegan, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krissinel, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNicholas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannu, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potterton, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, K. S.</span></span> <span> </span><span class="NLM_article-title">Overview of the CCP4 suite and current developments</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">242</span>, <span class="refDoi"> DOI: 10.1107/S0907444910045749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1107%2FS0907444910045749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=21460441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=235-242&author=M.+D.+Winnauthor=C.+C.+Ballardauthor=K.+D.+Cowtanauthor=E.+J.+Dodsonauthor=P.+Emsleyauthor=P.+R.+Evansauthor=R.+M.+Keeganauthor=E.+B.+Krissinelauthor=A.+G.+Leslieauthor=A.+McCoyauthor=S.+J.+McNicholasauthor=G.+N.+Murshudovauthor=N.+S.+Pannuauthor=E.+A.+Pottertonauthor=H.+R.+Powellauthor=R.+J.+Readauthor=A.+Vaginauthor=K.+S.+Wilson&title=Overview+of+the+CCP4+suite+and+current+developments&doi=10.1107%2FS0907444910045749"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the CCP4 suite and current developments</span></div><div class="casAuthors">Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.; Dodson, Eleanor J.; Emsley, Paul; Evans, Phil R.; Keegan, Ronan M.; Krissinel, Eugene B.; Leslie, Andrew G. W.; McCoy, Airlie; McNicholas, Stuart J.; Murshudov, Garib N.; Pannu, Navraj S.; Potterton, Elizabeth A.; Powell, Harold R.; Read, Randy J.; Vagin, Alexei; Wilson, Keith S.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  The CCP4 (Collaborative Computational Project, No. 4) software suite is a collection of programs and assocd. data and software libraries which can be used for macromol. structure detn. by X-ray crystallog.  The suite is designed to be flexible, allowing users a no. of methods of achieving their aims.  The programs are from a wide variety of sources but are connected by a common infrastructure provided by std. file formats, data objects and graphical interfaces.  Structure soln. by macromol. crystallog. is becoming increasingly automated and the CCP4 suite includes several automation pipelines.  After giving a brief description of the evolution of CCP4 over the last 30 years, an overview of the current suite is given.  While detailed descriptions are given in the accompanying articles, here it is shown how the individual programs contribute to a complete software package.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_wWMMIol6UrVg90H21EOLACvtfcHk0lj318xk1os6sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D&md5=c407e4d47bef46864be336d60147c17d</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1107%2FS0907444910045749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910045749%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DBallard%26aufirst%3DC.%2BC.%26aulast%3DCowtan%26aufirst%3DK.%2BD.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DKeegan%26aufirst%3DR.%2BM.%26aulast%3DKrissinel%26aufirst%3DE.%2BB.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%26aulast%3DMcCoy%26aufirst%3DA.%26aulast%3DMcNicholas%26aufirst%3DS.%2BJ.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DPotterton%26aufirst%3DE.%2BA.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26atitle%3DOverview%2520of%2520the%2520CCP4%2520suite%2520and%2520current%2520developments%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D235%26epage%3D242%26doi%3D10.1107%2FS0907444910045749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skubak, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebedev, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannu, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholls, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A. A.</span></span> <span> </span><span class="NLM_article-title">REFMAC5 for the refinement of macromolecular crystal structures</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1107/S0907444911001314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1107%2FS0907444911001314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=21460454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=355-367&author=G.+N.+Murshudovauthor=P.+Skubakauthor=A.+A.+Lebedevauthor=N.+S.+Pannuauthor=R.+A.+Steinerauthor=R.+A.+Nichollsauthor=M.+D.+Winnauthor=F.+Longauthor=A.+A.+Vagin&title=REFMAC5+for+the+refinement+of+macromolecular+crystal+structures&doi=10.1107%2FS0907444911001314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">REFMAC5 for the refinement of macromolecular crystal structures</span></div><div class="casAuthors">Murshudov, Garib N.; Skubak, Pavol; Lebedev, Andrey A.; Pannu, Navraj S.; Steiner, Roberto A.; Nicholls, Robert A.; Winn, Martyn D.; Long, Fei; Vagin, Alexei A.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">355-367</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">This paper describes various components of the macromol. crystallog. refinement program REFMAC5, which is distributed as part of the CCP4 suite.  REFMAC5 utilizes different likelihood functions depending on the diffraction data employed (amplitudes or intensities), the presence of twinning and the availability of SAD/SIRAS exptl. diffraction data.  To ensure chem. and structural integrity of the refined model, REFMAC5 offers several classes of restraints and choices of model parameterization.  Reliable models at resolns. at least as low as 4 Å can be achieved thanks to low-resoln. refinement tools such as secondary-structure restraints, restraints to known homologous structures, automatic global and local NCS restraints, 'jelly-body' restraints and the use of novel long-range restraints on at. displacement parameters (ADPs) based on the Kullback-Leibler divergence.  REFMAC5 addnl. offers TLS parameterization and, when high-resoln. data are available, fast refinement of anisotropic ADPs.  Refinement in the presence of twinning is performed in a fully automated fashion.  REFMAC5 is a flexible and highly optimized refinement package that is ideally suited for refinement across the entire resoln. spectrum encountered in macromol. crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5Jq-i2qIq5rVg90H21EOLACvtfcHk0ljq4cARdK81iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D&md5=f8f3202d246908500057ad7c71015b7b</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1107%2FS0907444911001314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911001314%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DSkubak%26aufirst%3DP.%26aulast%3DLebedev%26aufirst%3DA.%2BA.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DSteiner%26aufirst%3DR.%2BA.%26aulast%3DNicholls%26aufirst%3DR.%2BA.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DLong%26aufirst%3DF.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26atitle%3DREFMAC5%2520for%2520the%2520refinement%2520of%2520macromolecular%2520crystal%2520structures%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D355%26epage%3D367%26doi%3D10.1107%2FS0907444911001314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and development of Coot</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0ljq4cARdK81iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yabut, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domogauer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcangelo, G.</span></span> <span> </span><span class="NLM_article-title">Dyrk1A overexpression inhibits proliferation and induces premature neuronal differentiation of neural progenitor cells</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">4004</span>– <span class="NLM_lpage">4014</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.4711-09.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1523%2FJNEUROSCI.4711-09.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=20237271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvVantLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=4004-4014&author=O.+Yabutauthor=J.+Domogauerauthor=G.+D%E2%80%99Arcangelo&title=Dyrk1A+overexpression+inhibits+proliferation+and+induces+premature+neuronal+differentiation+of+neural+progenitor+cells&doi=10.1523%2FJNEUROSCI.4711-09.2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Dyrk1A overexpression inhibits proliferation and induces premature neuronal differentiation of neural progenitor cells</span></div><div class="casAuthors">Yabut, Odessa; Domogauer, Jason; D'Arcangelo, Gabriella</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4004-4014</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Dyrk1A is a member of the mammalian Dyrk [dual-specificity tyrosine-(Y)-phosphorylation regulated kinase] family of protein kinases that is expressed at high levels in the brain, but its role in the development and function of this organ is not well understood.  The human DYRK1A gene is located on trisomic chromosome 21 in Down syndrome (DS) patients, leading to its overexpression.  Dyrk1A is also overexpressed in animal models of DS and in gene-specific transgenic mice that consistently exhibit cognitive impairment.  To elucidate the cellular and mol. mechanisms that are affected by increased levels of Dyrk1A in the developing brain, we overexpressed this kinase in the embryonic mouse neocortex using the in utero electroporation technique.  We found that Dyrk1A overexpression inhibits neural cell proliferation and promotes premature neuronal differentiation in the developing cerebral cortex without affecting cell fate and layer positioning.  These effects are dependent on the Dyrk1A kinase activity and are mediated by the nuclear export and degrdn. of cyclin D1.  This study identifies specific Dyrk1A-induced mechanisms that disrupt the normal process of corticogenesis and possibly contribute to cognitive impairment obsd. in DS patients and animal models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiDJCyOeZkjLVg90H21EOLACvtfcHk0ljq4cARdK81iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvVantLs%253D&md5=78bb38762bdf2aa1b98be076ce56c209</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4711-09.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4711-09.2010%26sid%3Dliteratum%253Aachs%26aulast%3DYabut%26aufirst%3DO.%26aulast%3DDomogauer%26aufirst%3DJ.%26aulast%3DD%25E2%2580%2599Arcangelo%26aufirst%3DG.%26atitle%3DDyrk1A%2520overexpression%2520inhibits%2520proliferation%2520and%2520induces%2520premature%2520neuronal%2520differentiation%2520of%2520neural%2520progenitor%2520cells%26jtitle%3DJ.%2520Neurosci.%26date%3D2010%26volume%3D30%26spage%3D4004%26epage%3D4014%26doi%3D10.1523%2FJNEUROSCI.4711-09.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paudel, H. K.</span></span> <span> </span><span class="NLM_article-title">Glycogen synthase kinase 3 beta phosphorylates Alzheimer’s disease-specific Ser(396) of microtubule-associated protein tau by a sequential mechanism</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">3125</span>– <span class="NLM_lpage">3133</span>, <span class="refDoi"> DOI: 10.1021/bi051634r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi051634r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=3125-3133&author=T.+Liauthor=H.+K.+Paudel&title=Glycogen+synthase+kinase+3+beta+phosphorylates+Alzheimer%E2%80%99s+disease-specific+Ser%28396%29+of+microtubule-associated+protein+tau+by+a+sequential+mechanism&doi=10.1021%2Fbi051634r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fbi051634r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi051634r%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DT.%26aulast%3DPaudel%26aufirst%3DH.%2BK.%26atitle%3DGlycogen%2520synthase%2520kinase%25203%2520beta%2520phosphorylates%2520Alzheimer%25E2%2580%2599s%2520disease-specific%2520Ser%2528396%2529%2520of%2520microtubule-associated%2520protein%2520tau%2520by%2520a%2520sequential%2520mechanism%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D3125%26epage%3D3133%26doi%3D10.1021%2Fbi051634r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skytte
Rasmussen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mouilleron, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar Shrestha, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowitz Larsen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abudu Princely, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Reilly, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sjottem, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tooze, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamark, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansen, T.</span></span> <span> </span><span class="NLM_article-title">ATG4B contains a C-terminal LIR motif important for binding and efficient cleavage of mammalian orthologs of yeast Atg8</span>. <i>Autophagy</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">834</span>– <span class="NLM_lpage">853</span>, <span class="refDoi"> DOI: 10.1080/15548627.2017.1287651</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1080%2F15548627.2017.1287651" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=834-853&author=M.+Skytte%0ARasmussenauthor=S.+Mouilleronauthor=B.+Kumar+Shresthaauthor=M.+Wirthauthor=R.+Leeauthor=K.+Bowitz+Larsenauthor=Y.+Abudu+Princelyauthor=N.+O%E2%80%99Reillyauthor=E.+Sjottemauthor=S.+A.+Toozeauthor=T.+Lamarkauthor=T.+Johansen&title=ATG4B+contains+a+C-terminal+LIR+motif+important+for+binding+and+efficient+cleavage+of+mammalian+orthologs+of+yeast+Atg8&doi=10.1080%2F15548627.2017.1287651"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1080%2F15548627.2017.1287651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15548627.2017.1287651%26sid%3Dliteratum%253Aachs%26aulast%3DSkytte%2BRasmussen%26aufirst%3DM.%26aulast%3DMouilleron%26aufirst%3DS.%26aulast%3DKumar%2BShrestha%26aufirst%3DB.%26aulast%3DWirth%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DR.%26aulast%3DBowitz%2BLarsen%26aufirst%3DK.%26aulast%3DAbudu%2BPrincely%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DN.%26aulast%3DSjottem%26aufirst%3DE.%26aulast%3DTooze%26aufirst%3DS.%2BA.%26aulast%3DLamark%26aufirst%3DT.%26aulast%3DJohansen%26aufirst%3DT.%26atitle%3DATG4B%2520contains%2520a%2520C-terminal%2520LIR%2520motif%2520important%2520for%2520binding%2520and%2520efficient%2520cleavage%2520of%2520mammalian%2520orthologs%2520of%2520yeast%2520Atg8%26jtitle%3DAutophagy%26date%3D2017%26volume%3D13%26spage%3D834%26epage%3D853%26doi%3D10.1080%2F15548627.2017.1287651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 9 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">David Lee Walmsley, James B. Murray, Pawel Dokurno, Andrew J. Massey, Karen Benwell, Andrea Fiumana, Nicolas Foloppe, Stuart Ray, Julia Smith, Allan E. Surgenor, Thomas Edmonds, Didier Demarles, Mike Burbridge, Francisco Cruzalegui, Andras Kotschy, <span class="NLM_string-name hlFld-ContribAuthor">Roderick E. Hubbard</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-Derived Selective Inhibitors of Dual-Specificity Kinases DYRK1A and DYRK1B. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (13)
                                     , 8971-8991. <a href="https://doi.org/10.1021/acs.jmedchem.1c00024" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00024%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFragment-Derived%252BSelective%252BInhibitors%252Bof%252BDual-Specificity%252BKinases%252BDYRK1A%252Band%252BDYRK1B%26aulast%3DLee%2BWalmsley%26aufirst%3DDavid%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D07012021%26date%3D18062021%26volume%3D64%26issue%3D13%26spage%3D8971%26epage%3D8991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Csaba Weber, Melinda Sipos, Attila Paczal, Balazs Balint, Vilibald Kun, Nicolas Foloppe, Pawel Dokurno, Andrew J. Massey, David Lee Walmsley, Roderick E. Hubbard, James Murray, Karen Benwell, Thomas Edmonds, Didier Demarles, Alain Bruno, Mike Burbridge, Francisco Cruzalegui, <span class="NLM_string-name hlFld-ContribAuthor">Andras Kotschy</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Guided Discovery of Potent and Selective DYRK1A Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (10)
                                     , 6745-6764. <a href="https://doi.org/10.1021/acs.jmedchem.1c00023" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00023%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Guided%252BDiscovery%252Bof%252BPotent%252Band%252BSelective%252BDYRK1A%252BInhibitors%26aulast%3DWeber%26aufirst%3DCsaba%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D07012021%26date%3D12052021%26volume%3D64%26issue%3D10%26spage%3D6745%26epage%3D6764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhouling Xie, Xiaoxiao Yang, Yajun Duan, Jihong Han, <span class="NLM_string-name hlFld-ContribAuthor">Chenzhong Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1283-1345. <a href="https://doi.org/10.1021/acs.jmedchem.0c01511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNononcologic%252BDiseases%26aulast%3DXie%26aufirst%3DZhouling%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29082020%26date%3D22012021%26volume%3D64%26issue%3D3%26spage%3D1283%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Areum  Park</span>, <span class="hlFld-ContribAuthor ">Jieon  Hwang</span>, <span class="hlFld-ContribAuthor ">Joo-Youn  Lee</span>, <span class="hlFld-ContribAuthor ">Eun Ji  Heo</span>, <span class="hlFld-ContribAuthor ">Yoon-Ju  Na</span>, <span class="hlFld-ContribAuthor ">Sein  Kang</span>, <span class="hlFld-ContribAuthor ">Kyu-Sung  Jeong</span>, <span class="hlFld-ContribAuthor ">Ki Young  Kim</span>, <span class="hlFld-ContribAuthor ">Sang Joon  Shin</span>, <span class="hlFld-ContribAuthor ">Hyuk  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of novel 1H-Pyrazolo[3,4-b]pyridine derivatives as DYRK 1A/1B inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>47 </em>, 128226. <a href="https://doi.org/10.1016/j.bmcl.2021.128226" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128226</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128226%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Bof%252Bnovel%252B1H-Pyrazolo%25255B3%25252C4-b%25255Dpyridine%252Bderivatives%252Bas%252BDYRK%252B1A%25252F1B%252Binhibitors%26aulast%3DPark%26aufirst%3DAreum%26date%3D2021%26volume%3D47%26spage%3D128226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mattias F.  Lindberg</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>. </span><span class="cited-content_cbyCitation_article-title">Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (11)
                                     , 6047. <a href="https://doi.org/10.3390/ijms22116047" title="DOI URL">https://doi.org/10.3390/ijms22116047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22116047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22116047%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DDual-Specificity%25252C%252BTyrosine%252BPhosphorylation-Regulated%252BKinases%252B%252528DYRKs%252529%252Band%252Bcdc2-Like%252BKinases%252B%252528CLKs%252529%252Bin%252BHuman%252BDisease%25252C%252Ban%252BOverview%26aulast%3DLindberg%26aufirst%3DMattias%2BF.%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D11%26spage%3D6047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vijay Kumar  Bhardwaj</span>, <span class="hlFld-ContribAuthor ">Rahul  Singh</span>, <span class="hlFld-ContribAuthor ">Jatin  Sharma</span>, <span class="hlFld-ContribAuthor ">Pralay  Das</span>, <span class="hlFld-ContribAuthor ">Rituraj  Purohit</span>. </span><span class="cited-content_cbyCitation_article-title">Structural based study to identify new potential inhibitors for dual specificity tyrosine-phosphorylation- regulated kinase. </span><span class="cited-content_cbyCitation_journal-name">Computer Methods and Programs in Biomedicine</span><span> <strong>2020,</strong> <em>194 </em>, 105494. <a href="https://doi.org/10.1016/j.cmpb.2020.105494" title="DOI URL">https://doi.org/10.1016/j.cmpb.2020.105494</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cmpb.2020.105494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cmpb.2020.105494%26sid%3Dliteratum%253Aachs%26jtitle%3DComputer%2520Methods%2520and%2520Programs%2520in%2520Biomedicine%26atitle%3DStructural%252Bbased%252Bstudy%252Bto%252Bidentify%252Bnew%252Bpotential%252Binhibitors%252Bfor%252Bdual%252Bspecificity%252Btyrosine-phosphorylation-%252Bregulated%252Bkinase%26aulast%3DBhardwaj%26aufirst%3DVijay%2BKumar%26date%3D2020%26volume%3D194%26spage%3D105494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yvonnick  Loidreau</span>, <span class="hlFld-ContribAuthor ">Carole  Dubouilh-Benard</span>, <span class="hlFld-ContribAuthor ">Marie-Renée  Nourrisson</span>, <span class="hlFld-ContribAuthor ">Nadège  Loaëc</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">Thierry  Besson</span>, <span class="hlFld-ContribAuthor ">Pascal  Marchand</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring Kinase Inhibition Properties of 9H-pyrimido[5,4-b]- and [4,5-b]indol-4-amine Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2020,</strong> <em>13 </em>
                                    (5)
                                     , 89. <a href="https://doi.org/10.3390/ph13050089" title="DOI URL">https://doi.org/10.3390/ph13050089</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph13050089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph13050089%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DExploring%252BKinase%252BInhibition%252BProperties%252Bof%252B9H-pyrimido%25255B5%25252C4-b%25255D-%252Band%252B%25255B4%25252C5-b%25255Dindol-4-amine%252BDerivatives%26aulast%3DLoidreau%26aufirst%3DYvonnick%26date%3D2020%26date%3D2020%26volume%3D13%26issue%3D5%26spage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul A.  Allegretti</span>, <span class="hlFld-ContribAuthor ">Timothy M.  Horton</span>, <span class="hlFld-ContribAuthor ">Yassan  Abdolazimi</span>, <span class="hlFld-ContribAuthor ">Hannah P.  Moeller</span>, <span class="hlFld-ContribAuthor ">Benjamin  Yeh</span>, <span class="hlFld-ContribAuthor ">Matthew  Caffet</span>, <span class="hlFld-ContribAuthor ">Guillermina  Michel</span>, <span class="hlFld-ContribAuthor ">Mark  Smith</span>, <span class="hlFld-ContribAuthor ">Justin P.  Annes</span>. </span><span class="cited-content_cbyCitation_article-title">Generation of highly potent DYRK1A-dependent inducers of human β-Cell replication via Multi-Dimensional compound optimization. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (1)
                                     , 115193. <a href="https://doi.org/10.1016/j.bmc.2019.115193" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.115193</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.115193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.115193%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DGeneration%252Bof%252Bhighly%252Bpotent%252BDYRK1A-dependent%252Binducers%252Bof%252Bhuman%252B%2525CE%2525B2-Cell%252Breplication%252Bvia%252BMulti-Dimensional%252Bcompound%252Boptimization%26aulast%3DAllegretti%26aufirst%3DPaul%2BA.%26date%3D2020%26volume%3D28%26issue%3D1%26spage%3D115193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Corinne  Fruit</span>, <span class="hlFld-ContribAuthor ">Florence  Couly</span>, <span class="hlFld-ContribAuthor ">Rahul  Bhansali</span>, <span class="hlFld-ContribAuthor ">Malini  Rammohan</span>, <span class="hlFld-ContribAuthor ">Mattias F.  Lindberg</span>, <span class="hlFld-ContribAuthor ">John D.  Crispino</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">Thierry  Besson</span>. </span><span class="cited-content_cbyCitation_article-title">Biological Characterization of 8-Cyclopropyl-2-(pyridin-3-yl)thiazolo[5,4-f]quinazolin-9(8H)-one, a Promising Inhibitor of DYRK1A. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2019,</strong> <em>12 </em>
                                    (4)
                                     , 185. <a href="https://doi.org/10.3390/ph12040185" title="DOI URL">https://doi.org/10.3390/ph12040185</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph12040185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph12040185%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DBiological%252BCharacterization%252Bof%252B8-Cyclopropyl-2-%252528pyridin-3-yl%252529thiazolo%25255B5%25252C4-f%25255Dquinazolin-9%2525288H%252529-one%25252C%252Ba%252BPromising%252BInhibitor%252Bof%252BDYRK1A%26aulast%3DFruit%26aufirst%3DCorinne%26date%3D2019%26date%3D2019%26volume%3D12%26issue%3D4%26spage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/medium/jm-2017-01847p_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01847&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/medium/jm-2017-01847p_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of the nine novel DYRK1A inhibitors, representing six different core scaffolds. <b>AC12</b> and <b>AC15</b> share one core structure, and <b>AC24</b>, <b>AC25</b>, and <b>AC28</b> share a second type of core structure.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01847&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/medium/jm-2017-01847p_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Inhibition of DYRK1A dependent tau T212 phosphorylation by different compounds. NCI-H1299 cells were transfected with expression vector encoding FLAG-tagged tau in combination with either empty expression vector or EGFP-tagged DYRK1A. Twenty hours after transfection the cells were incubated for 2 h with vehicle (−) or the indicated inhibitor concentration before the cells were harvested. Phosphorylated T212 tau was detected by Western blotting using the polyclonal anti-phospho T212 tau antibody (44-740G, Invitrogen). Total FLAG-tau was detected by using a monoclonal M2 anti-FLAG antibody (F1804, Sigma-Aldrich) and EGFP-DYRK1A by a polyclonal anti-GFP antibody (Sc-8334, Santa-Cruz).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01847&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/medium/jm-2017-01847p_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Binding pocket of DYRK1A bound to nine different inhibitors. The electron density for the inhibitor (2<i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> map) is shown at 1σ. The inhibitors form hydrogen bonds to E239 and L241, and <b>AC20</b>, <b>AC22</b>, and <b>AC27</b> form an H-bond to K188. Inhibitors <b>AC12</b> and <b>AC15</b> have a hydrogen bond acceptor group oriented toward K188. Most of the inhibitors are shown as they bind to chain A of the four protein molecules in the asymmetric unit of DYRK1A. The two exceptions are <b>AC23</b> where the inhibitor is shown bound in chain B, and <b>AC27</b> with the inhibitor shown in chain D. In the <b>AC23</b> crystal structure, only chain B has a water clearly visible in the electron density that could form bridging H-bonds between the inhibitor and K188 or D307. In the <b>AC27</b> crystal structure chain D has a water molecule, which connects the inhibitor to the hinge. There is no clear electron density for a water in the other chains; however, some diffuse electron density might suggest water molecules at these positions in the other chains too. PDB codes for DYRK1A complexes are the following: <b>AC12</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIF">6EIF</a>; <b>AC15</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EJ4">6EJ4</a>; <b>AC20</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIJ">6EIJ</a>; <b>AC22</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIL">6EIL</a>; <b>AC23</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIP">6EIP</a>; <b>AC24</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIQ">6EIQ</a>; <b>AC25</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIR">6EIR</a>; <b>AC27</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIS">6EIS</a>; <b>AC28</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIV">6EIV</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01847&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/medium/jm-2017-01847p_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Superposition of the binding pockets and inhibitors of the four chains in the asymmetric unit of DYRK1A of each inhibitor: <b>AC24</b> (green, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIQ">6EIQ</a>) with <b>AC25</b> (cyan, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIR">6EIR</a>) and <b>AC28</b> (violet, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIV">6EIV</a>). Although the general pose of each inhibitor remains similar, some differences are evident between the individual pockets. <b>AC24</b> has the greatest conservation of geometry, while especially the acrylamide groups of <b>AC25</b> and <b>AC28</b> show more variation, reflected also by lower electron density for these parts.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01847&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/medium/jm-2017-01847p_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Kinome binding plots for the nine compounds. The levels of binding were measured at concentrations of 10 μM (except for <b>AC27</b>, measured at 1 μM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01847&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/medium/jm-2017-01847p_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. NFAT Luc reporter assay. The plot is normalized to the basal activity of the luciferase. Numbers indicate the fold of increase in luciferase activity upon inhibition of DYRK1A (A). The most active compound <b>AC27</b> shows a 1.5-fold increase in luciferase activity at 50 nM. For comparison harmine is included in the same assay (<b>B</b>). Even though harmine reached a higher activity and does not display the drop in activity as <b>AC27</b> at higher concentrations toward DYRK1A, <b>AC27</b> is active at much lower concentrations. 100 nM <b>AC27</b> leads to the same activity as 5 μM harmine, making <b>AC27</b> nearly 50 times more active than harmine in this particular cellular assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01847&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/medium/jm-2017-01847p_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Orientation and interaction of the inhibitors in the binding pocket. (A) Superimposition of <b>AC12</b> (cyan, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIF">6EIF</a>), <b>AC15</b> (pink, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EJ4">6EJ4</a>), and <b>AC22</b> (green, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIL">6EIL</a>). The methoxy group of <b>AC22</b> displaces the inhibitor away from the hinge, weakening binding. (B) Superposition of <b>AC20</b> (green, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIJ">6EIJ</a>) with 5-hydroxybenzothiazole (blue, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5A3X">5A3X</a>), and 6-cyanobenzothiazole (magenta, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5A4T">5A4T</a>). <b>AC20</b> binds with its 5-substiuted pyridothiazole in the same orientation as the 6-cyanobenzothiazole and, unlike 5-hydroxy-benzothiazole or INDY, does not make sulfur aromatic ring interactions with the gatekeeper phenylalanine. The three compounds also have differing selectivity profiles. While <b>AC12</b> and <b>AC15</b> are more nearly pan kinome inhibitors (targeting many different kinases), <b>AC22</b> is much more discriminating, with however a greatly reduced inhibitory strength.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01847&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/medium/jm-2017-01847p_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Water mediated binding of <b>AC23</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIP">6EIP</a>) and <b>AC27</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIS">6EIS</a>) to DYRK1A. The structure of the inhibitor in the ATP pocket of DYRK1A includes a water molecule that enables bridging interactions between the inhibitor and the K188, E203, and D307 for <b>AC23</b> and between the inhibitor and the hinge carbonyl of E239 and amide nitrogen of L241 for <b>AC27</b>. There is no clear electron density for a water in the other chains; however, some diffuse electron density suggests it to be present there also.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01847&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/medium/jm-2017-01847p_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Comparison of the binding of AC27 (light green, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIS">6EIS</a>) with EHT1610 (red, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LXD">5LXD</a>) and EHT5372 (magenta, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LXC">5LXC</a>) (DYRK1A, salmon; DYRK2, gray).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01847&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/medium/jm-2017-01847p_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>AC24</b> and <b>AC25</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.7b01847/20180907/images/large/jm-2017-01847p_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01847&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reaction conditions: (a) 1.0 equiv of thiophosgene, 5.0 equiv of TEA, CHCl<sub>3</sub>, rt, 3 h, 94%; (b) (1) 2.4 equiv of NH<sub>2</sub>CN, 1.5 equiv of <i>t</i>-BuOK, acetonitrile, 0 °C to rt, 1 h; (2) 1.0 equiv of 2-bromo-1-phenylethan-1-one, rt, 4 h, 96%; (c) 1) 2.4 equiv of NH<sub>2</sub>CN, 1.5 equiv of <i>t</i>-BuOK, acetonitrile, 0 °C to rt, 1 h; (2) 1.0 equiv of 2-bromo-1-(4-nitrophenyl)ethan-1-one, rt, 4 h, 47%; (d) 1.0 equiv of (Boc)<sub>2</sub>O, 0.3 equiv of DMAP, 2.0 equiv of DIEA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 days, 89%; (e) (1) 1.05 equiv of PtO<sub>2</sub>, H<sub>2</sub>, MeOH, rt, 1 h; (2) 1.27 equiv of acryloyl chloride, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 0.5 h; (3) TFA, 0 °C to rt, 1 h, 46%.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i36">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21634" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21634" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 45 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kivipelto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Strauss, E.</span></span> <span> </span><span class="NLM_article-title">Epidemiology of Alzheimer’s disease: occurrence, determinants, and strategies toward intervention</span>. <i>Dialogues Clin. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">128</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=19585947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A280%3ADC%252BD1MvntlWrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=111-128&author=C.+Qiuauthor=M.+Kivipeltoauthor=E.+von+Strauss&title=Epidemiology+of+Alzheimer%E2%80%99s+disease%3A+occurrence%2C+determinants%2C+and+strategies+toward+intervention"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention</span></div><div class="casAuthors">Qiu Chengxuan; Kivipelto Miia; von Strauss Eva</div><div class="citationInfo"><span class="NLM_cas:title">Dialogues in clinical neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">111-28</span>
        ISSN:<span class="NLM_cas:issn">1294-8322</span>.
    </div><div class="casAbstract">More than 25 million people in the world today are affected by dementia, most suffering from Alzheimer's disease.  In both developed and developing nations, Alzheimer's disease has had tremendous impact on the affected individuals, caregivers, and society.  The etiological factors, other than older age and genetic susceptibility, remain to be determined.  Nevertheless, increasing evidence strongly points to the potential risk roles of vascular risk factors and disorders (eg, cigarette smoking, midlife high blood pressure and obesity, diabetes, and cerebrovascular lesions) and the possible beneficial roles of psychosocial factors (eg, high education, active social engagement, physical exercise, and mentally stimulating activity) in the pathogenetic process and clinical manifestation of the dementing disorders.  The long-term multidomain interventions toward the optimal control of multiple vascular risk factors and the maintenance of socially integrated lifestyles and mentally stimulating activities are expected to reduce the risk or postpone the clinical onset of dementia, including Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQOCfg7MvEKGcERNNga7KD-fW6udTcc2eZ1p-Ro--FY4bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MvntlWrtw%253D%253D&md5=d8a2f709a1cc7984f05fe6f7e15ed1ef</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DC.%26aulast%3DKivipelto%26aufirst%3DM.%26aulast%3Dvon%2BStrauss%26aufirst%3DE.%26atitle%3DEpidemiology%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520occurrence%252C%2520determinants%252C%2520and%2520strategies%2520toward%2520intervention%26jtitle%3DDialogues%2520Clin.%2520Neurosci.%26date%3D2009%26volume%3D11%26spage%3D111%26epage%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease: the amyloid cascade hypothesis: an update and reappraisal</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">153</span>, <span class="refDoi"> DOI: 10.3233/JAD-2006-9S317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.3233%2FJAD-2006-9S317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=16914853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BD28XotFKkt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=151-153&author=J.+Hardy&title=Alzheimer%E2%80%99s+disease%3A+the+amyloid+cascade+hypothesis%3A+an+update+and+reappraisal&doi=10.3233%2FJAD-2006-9S317"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease: The amyloid cascade hypothesis: An update and reappraisal</span></div><div class="casAuthors">Hardy, John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">Suppl. 3</span>),
    <span class="NLM_cas:pages">151-153</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  Here I recap the scientific and personal background of the delineation of the amyloid cascade hypothesis for Alzheimer's disease that I wrote with Gerry Higgins and the events leading to the writing of that influential review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO9h63kZgivLVg90H21EOLACvtfcHk0lh7y0F-LAcFfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotFKkt7Y%253D&md5=9c91d6b0cf34cfdffbd2b0bb4b9429d6</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3233%2FJAD-2006-9S317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2006-9S317%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520the%2520amyloid%2520cascade%2520hypothesis%253A%2520an%2520update%2520and%2520reappraisal%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2006%26volume%3D9%26spage%3D151%26epage%3D153%26doi%3D10.3233%2FJAD-2006-9S317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, G. A.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease: the amyloid cascade hypothesis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>256</i></span>,  <span class="NLM_fpage">184</span>– <span class="NLM_lpage">185</span>, <span class="refDoi"> DOI: 10.1126/science.1566067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1126%2Fscience.1566067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1566067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADyaK38Xitlarurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1992&pages=184-185&author=J.+A.+Hardyauthor=G.+A.+Higgins&title=Alzheimer%E2%80%99s+disease%3A+the+amyloid+cascade+hypothesis&doi=10.1126%2Fscience.1566067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease:  the amyloid cascade hypothesis</span></div><div class="casAuthors">Hardy, John A.; Higgins, Gerald A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">256</span>
        (<span class="NLM_cas:issue">5054</span>),
    <span class="NLM_cas:pages">184-5</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A review with 28 refs.  The hypotheses that deposition of amyloid β protein (AβP), the main component of the plaques, is the causative agent of Alzheimer's pathol. and that the neurofibrillary tangles, cell loss, vascular damage, and dementia follow as a direct result of this deposition are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqemkoU65i2CrVg90H21EOLACvtfcHk0lgnzfUyjjpJPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xitlarurg%253D&md5=0ad307ce9ecab261ed7b01e6d288682a</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1126%2Fscience.1566067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1566067%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%2BA.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520the%2520amyloid%2520cascade%2520hypothesis%26jtitle%3DScience%26date%3D1992%26volume%3D256%26spage%3D184%26epage%3D185%26doi%3D10.1126%2Fscience.1566067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chetelat, G.</span></span> <span> </span><span class="NLM_article-title">Alzheimer disease: A beta-independent processes-rethinking preclinical AD</span>. <i>Nat. Rev. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">123</span>– <span class="NLM_lpage">124</span>, <span class="refDoi"> DOI: 10.1038/nrneurol.2013.21</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1038%2Fnrneurol.2013.21" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=23399647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslGgtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=123-124&author=G.+Chetelat&title=Alzheimer+disease%3A+A+beta-independent+processes-rethinking+preclinical+AD&doi=10.1038%2Fnrneurol.2013.21"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Aβ-independent processes-rethinking preclinical AD</span></div><div class="casAuthors">Chetelat, Gael</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">123-124</span>CODEN:
                <span class="NLM_cas:coden">NRNACP</span>;
        ISSN:<span class="NLM_cas:issn">1759-4758</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The amyloid cascade hypothesis, which posits that amyloid-β accumulation is the key event in Alzheimer disease neurodegeneration, has dominated the field for 20 years.  Recent findings, however, show that neuronal-injury biomarkers are independent of amyloid-β, calling for reconsideration of the pathol. cascade and assessment of alternative therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqb4n0SkTnuerVg90H21EOLACvtfcHk0lgnzfUyjjpJPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslGgtr4%253D&md5=c365179a1f40d1fbb5027d308cdb010d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2013.21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2013.21%26sid%3Dliteratum%253Aachs%26aulast%3DChetelat%26aufirst%3DG.%26atitle%3DAlzheimer%2520disease%253A%2520A%2520beta-independent%2520processes-rethinking%2520preclinical%2520AD%26jtitle%3DNat.%2520Rev.%2520Neurol.%26date%3D2013%26volume%3D9%26spage%3D123%26epage%3D124%26doi%3D10.1038%2Fnrneurol.2013.21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Graham, W. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonito-Oliva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakmar, T. P.</span></span> <span> </span><span class="NLM_article-title">Update on Alzheimer’s disease therapy and prevention strategies</span>. <i>Annu. Rev. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">413</span>– <span class="NLM_lpage">430</span>, <span class="refDoi"> DOI: 10.1146/annurev-med-042915-103753</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1146%2Fannurev-med-042915-103753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=28099083" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1ams7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2017&pages=413-430&author=W.+V.+Grahamauthor=A.+Bonito-Olivaauthor=T.+P.+Sakmar&title=Update+on+Alzheimer%E2%80%99s+disease+therapy+and+prevention+strategies&doi=10.1146%2Fannurev-med-042915-103753"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Update on Alzheimer's Disease Therapy and Prevention Strategies</span></div><div class="casAuthors">Graham, W. Vallen; Bonito-Oliva, Alessandra; Sakmar, Thomas P.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">413-430</span>CODEN:
                <span class="NLM_cas:coden">ARMCAH</span>;
        ISSN:<span class="NLM_cas:issn">0066-4219</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is the primary cause of age-related dementia.  Effective strategies to prevent and treat AD remain elusive despite major efforts to understand its basic biol. and clin. pathophysiol.  Significant investments in therapeutic drug discovery programs over the past two decades have yielded some important insights but no blockbuster drugs to alter the course of disease.  Because significant memory loss and cognitive decline are assocd. with neuron death and loss of gray matter, esp. in the frontal cortex and hippocampus, some focus in drug development has shifted to early prevention of cellular pathol.  Although clin. trial design is challenging, due in part to a lack of robust biomarkers with predictive value, some optimism has come from the identification and study of inherited forms of early-onset AD and genetic risk factors that provide insights about mol. pathophysiol. and potential drug targets.  In addn., better understanding of the Aβ amyloid pathway and the tau pathway-leading to amyloid plaques and neurofibrillary tangles, resp., which are histopathol. hallmarks of AD-continues to drive significant drug research and development programs.  The main focus of this review is to summarize the most recent basic biol., biochem., and pharmacol. that serve as a foundation for more than 50 active advanced-phase clin. trials for AD prevention and therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9aFvSrc-Me7Vg90H21EOLACvtfcHk0lgnzfUyjjpJPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1ams7c%253D&md5=c3a6b3e05350112d7de5cd4ec4a00f51</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1146%2Fannurev-med-042915-103753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-med-042915-103753%26sid%3Dliteratum%253Aachs%26aulast%3DGraham%26aufirst%3DW.%2BV.%26aulast%3DBonito-Oliva%26aufirst%3DA.%26aulast%3DSakmar%26aufirst%3DT.%2BP.%26atitle%3DUpdate%2520on%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapy%2520and%2520prevention%2520strategies%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D2017%26volume%3D68%26spage%3D413%26epage%3D430%26doi%3D10.1146%2Fannurev-med-042915-103753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lloret, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchsberger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giraldo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vina, J.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanisms linking amyloid beta toxicity and Tau hyperphosphorylation in Alzheimers disease</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">186</span>– <span class="NLM_lpage">191</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2015.02.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1016%2Fj.freeradbiomed.2015.02.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=25746773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVKqs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2015&pages=186-191&author=A.+Lloretauthor=T.+Fuchsbergerauthor=E.+Giraldoauthor=J.+Vina&title=Molecular+mechanisms+linking+amyloid+beta+toxicity+and+Tau+hyperphosphorylation+in+Alzheimers+disease&doi=10.1016%2Fj.freeradbiomed.2015.02.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms linking amyloid β toxicity and Tau hyperphosphorylation in Alzheimer's disease</span></div><div class="casAuthors">Lloret, A.; Fuchsberger, T.; Giraldo, E.; Vina, J.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">186-191</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Neurofibrillary tangles (aggregates of cytoskeletal Tau protein) and senile plaques (aggregates mainly formed by amyloid β peptide) are two landmark lesions in Alzheimer's disease.  Some researchers have proposed tangles, whereas others have proposed plaques, as primary lesions.  For a long time, these were thought of as independent mechanisms.  However, exptl. evidence suggests that both lesions are intimately related.  We review here some mol. pathways linking amyloid β and Tau toxicities involving, among others, glycogen synthase kinase 3β, p38, Pin1, cyclin-dependent kinase 5, and regulator of calcineurin 1.  Understanding amyloid β and Tau toxicities as part of a common pathophysiol. mechanism may help to find mol. targets to prevent or even treat the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUDCgQFZX7abVg90H21EOLACvtfcHk0ljSbevt49LbsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVKqs7c%253D&md5=4e7d3e795c949e46283c9d25eb5e3492</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2015.02.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2015.02.028%26sid%3Dliteratum%253Aachs%26aulast%3DLloret%26aufirst%3DA.%26aulast%3DFuchsberger%26aufirst%3DT.%26aulast%3DGiraldo%26aufirst%3DE.%26aulast%3DVina%26aufirst%3DJ.%26atitle%3DMolecular%2520mechanisms%2520linking%2520amyloid%2520beta%2520toxicity%2520and%2520Tau%2520hyperphosphorylation%2520in%2520Alzheimers%2520disease%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2015%26volume%3D83%26spage%3D186%26epage%3D191%26doi%3D10.1016%2Fj.freeradbiomed.2015.02.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrachina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puig, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Lagran, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avila, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dierssen, M.</span></span> <span> </span><span class="NLM_article-title">Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">392</span>– <span class="NLM_lpage">400</span>, <span class="refDoi"> DOI: 10.1016/j.nbd.2005.03.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1016%2Fj.nbd.2005.03.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=16242644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFCjs7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2005&pages=392-400&author=I.+Ferrerauthor=M.+Barrachinaauthor=B.+Puigauthor=M.+M.+de+Lagranauthor=E.+Martiauthor=J.+Avilaauthor=M.+Dierssen&title=Constitutive+Dyrk1A+is+abnormally+expressed+in+Alzheimer+disease%2C+Down+syndrome%2C+Pick+disease%2C+and+related+transgenic+models&doi=10.1016%2Fj.nbd.2005.03.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models</span></div><div class="casAuthors">Ferrer, Isidro; Barrachina, Marta; Puig, Berta; Martinez de Lagran, M.; Marti, Eulalia; Avila, Jesus; Dierssen, Mara</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">392-400</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">DYRK1A, dual-specificity tyrosine-regulated kinase 1A, maps to human chromosome 21 within the Down syndrome (DS) crit. region.  Dyrk1 phosphorylates the human microtubule-assocd. protein tau at Thr212 in vitro, a residue that is phosphorylated in fetal tau and hyper-phosphorylated in Alzheimer disease (AD) and tauopathies, including Pick disease (PiD).  Furthermore, phosphorylation of Thr212 primes tau for phosphorylation by glycogen synthase kinase 3 (GSK-3).  The present study examines Dyrk1A in the cerebral cortex of sporadic AD, adult DS with assocd. AD, and PiD.  Increased Dyrk1A immunoreactivity has been found in the cytoplasm and nuclei of scattered neurons of the neocortex, entorhinal cortex, and hippocampus in AD, DS, and PiD.  Dyrk1A is found in sarkosyl-insol. fractions which are enriched in phosphorylated tau in AD brains, thus suggesting a possible assocn. of Dyrk1A with neurofibrillary tangle pathol.  Yet, no clear relationship has been obsd. between tau phosphorylation at Thr212, and GSK-3 and Dyrk1A expression in diseased brains.  Transgenic mice bearing a triple tau mutation (G272V, P301L, and R406W) and expressing hyper-phosphoyrylated tau in neurons of the entorhinal cortex, hippocampus, and cerebral neocortex show increased expression of Dyrk1A in individual neurons in the same regions.  However, transgenic mice over-expressing Dyrk1A do not show increased phosphorylation of tau at Thr212, thus suggesting that Dyrk1A over-expression does not trigger per se hyper-phosphorylation of tau at Thr212 in vivo.  The present observations indicate modifications in the expression of constitutive Dyrk1A in the cytoplasm and nuclei of neurons in various neurodegenerative diseases assocd. with tau phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW8vHkFXvWMLVg90H21EOLACvtfcHk0ljSbevt49LbsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFCjs7bN&md5=dd69cd9e3cdb10618294417873670311</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2005.03.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2005.03.020%26sid%3Dliteratum%253Aachs%26aulast%3DFerrer%26aufirst%3DI.%26aulast%3DBarrachina%26aufirst%3DM.%26aulast%3DPuig%26aufirst%3DB.%26aulast%3Dde%2BLagran%26aufirst%3DM.%2BM.%26aulast%3DMarti%26aufirst%3DE.%26aulast%3DAvila%26aufirst%3DJ.%26aulast%3DDierssen%26aufirst%3DM.%26atitle%3DConstitutive%2520Dyrk1A%2520is%2520abnormally%2520expressed%2520in%2520Alzheimer%2520disease%252C%2520Down%2520syndrome%252C%2520Pick%2520disease%252C%2520and%2520related%2520transgenic%2520models%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2005%26volume%3D20%26spage%3D392%26epage%3D400%26doi%3D10.1016%2Fj.nbd.2005.03.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dierssen, M.</span></span> <span> </span><span class="NLM_article-title">Down syndrome: the brain in trisomic mode</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">844</span>– <span class="NLM_lpage">858</span>, <span class="refDoi"> DOI: 10.1038/nrn3314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1038%2Fnrn3314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=23165261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs12iur7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=844-858&author=M.+Dierssen&title=Down+syndrome%3A+the+brain+in+trisomic+mode&doi=10.1038%2Fnrn3314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Down syndrome: the brain in trisomic mode</span></div><div class="casAuthors">Dierssen, Mara</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">844-858</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Down syndrome is the most common form of intellectual disability and results from one of the most complex genetic perturbations that is compatible with survival, trisomy 21.  The study of brain dysfunction in this disorder has largely been based on a gene discovery approach, but we are now moving into an era of functional genome exploration, in which the effects of individual genes are being studied alongside the effects of deregulated non-coding genetic elements and epigenetic influences.  Also, new data from functional neuroimaging studies are challenging our views of the cognitive phenotypes assocd. with Down syndrome and their pathophysiol. correlates.  These advances hold promise for the development of treatments for intellectual disability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ7Nujmvq_XbVg90H21EOLACvtfcHk0ljSbevt49LbsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs12iur7F&md5=671ad19a458c9906ff5c9dee8e0f3f26</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrn3314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3314%26sid%3Dliteratum%253Aachs%26aulast%3DDierssen%26aufirst%3DM.%26atitle%3DDown%2520syndrome%253A%2520the%2520brain%2520in%2520trisomic%2520mode%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2012%26volume%3D13%26spage%3D844%26epage%3D858%26doi%3D10.1038%2Fnrn3314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ryoo, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radnaabazar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Son, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, W. J.</span></span> <span> </span><span class="NLM_article-title">Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer’s disease</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">1333</span>– <span class="NLM_lpage">1344</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2007.05075.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1111%2Fj.1471-4159.2007.05075.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=18005339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtFCntLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2008&pages=1333-1344&author=S.+R.+Ryooauthor=H.+J.+Choauthor=H.+W.+Leeauthor=H.+K.+Jeongauthor=C.+Radnaabazarauthor=Y.+S.+Kimauthor=M.+J.+Kimauthor=M.+Y.+Sonauthor=H.+Seoauthor=S.+H.+Chungauthor=W.+J.+Song&title=Dual-specificity+tyrosine%28Y%29-phosphorylation+regulated+kinase+1A-mediated+phosphorylation+of+amyloid+precursor+protein%3A+evidence+for+a+functional+link+between+Down+syndrome+and+Alzheimer%E2%80%99s+disease&doi=10.1111%2Fj.1471-4159.2007.05075.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease</span></div><div class="casAuthors">Ryoo, Soo-Ryoon; Cho, Hyun-Jeong; Lee, Hye-Won; Jeong, Hey Kyeong; Radnaabazar, Chinzorig; Kim, Yeun-Soo; Kim, Min-Jeong; Son, Mi-Young; Seo, Hyemyung; Chung, Sul-Hee; Song, Woo-Joo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1333-1344</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Most individuals with Down Syndrome (DS) show an early-onset of Alzheimer's disease (AD), which potentially results from the presence of an extra copy of a segment of chromosome 21.  Located on chromosome 21 are the genes that encode β-amyloid (Aβ) precursor protein (APP), a key protein involved in the pathogenesis of AD, and dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A (DYRK1A), a proline-directed protein kinase that plays a crit. role in neurodevelopment.  Here, the authors describe a potential mechanism for the regulation of AD pathol. in DS brains by DYRK1A-mediated phosphorylation of APP.  The authors show that APP is phosphorylated at Thr668 by DYRK1A in vitro and in mammalian cells.  The amts. of phospho-APP and Aβ are increased in the brains of transgenic mice that over-express the human DYRK1A protein.  Furthermore, we show that the amts. of phospho-APP as well as those of APP and DYRK1A are elevated in human DS brains.  Taken together, these results reveal a potential regulatory link between APP and DYRK1A in DS brains, and suggest that the overexpression of DYRK1A in DS may play a role in accelerating AD pathogenesis through phosphorylation of APP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5GqsDKfbC6bVg90H21EOLACvtfcHk0ljSbevt49LbsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtFCntLc%253D&md5=ab7a959cf5a06be742d89f1afb4f635d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2007.05075.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2007.05075.x%26sid%3Dliteratum%253Aachs%26aulast%3DRyoo%26aufirst%3DS.%2BR.%26aulast%3DCho%26aufirst%3DH.%2BJ.%26aulast%3DLee%26aufirst%3DH.%2BW.%26aulast%3DJeong%26aufirst%3DH.%2BK.%26aulast%3DRadnaabazar%26aufirst%3DC.%26aulast%3DKim%26aufirst%3DY.%2BS.%26aulast%3DKim%26aufirst%3DM.%2BJ.%26aulast%3DSon%26aufirst%3DM.%2BY.%26aulast%3DSeo%26aufirst%3DH.%26aulast%3DChung%26aufirst%3DS.%2BH.%26aulast%3DSong%26aufirst%3DW.%2BJ.%26atitle%3DDual-specificity%2520tyrosine%2528Y%2529-phosphorylation%2520regulated%2520kinase%25201A-mediated%2520phosphorylation%2520of%2520amyloid%2520precursor%2520protein%253A%2520evidence%2520for%2520a%2520functional%2520link%2520between%2520Down%2520syndrome%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurochem.%26date%3D2008%26volume%3D104%26spage%3D1333%26epage%3D1344%26doi%3D10.1111%2Fj.1471-4159.2007.05075.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwen, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radnaabazar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, S. H.</span></span> <span> </span><span class="NLM_article-title">Dyrk1A-mediated phosphorylation of Presenilin 1: a functional link between Down syndrome and Alzheimer’s disease</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">574</span>– <span class="NLM_lpage">584</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2010.06769.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1111%2Fj.1471-4159.2010.06769.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=20456003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlGlsb%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2010&pages=574-584&author=Y.+S.+Ryuauthor=S.+Y.+Parkauthor=M.+S.+Jungauthor=S.+H.+Yoonauthor=M.+Y.+Kwenauthor=S.+Y.+Leeauthor=S.+H.+Choiauthor=C.+Radnaabazarauthor=M.+K.+Kimauthor=H.+Kimauthor=K.+Kimauthor=W.+J.+Songauthor=S.+H.+Chung&title=Dyrk1A-mediated+phosphorylation+of+Presenilin+1%3A+a+functional+link+between+Down+syndrome+and+Alzheimer%E2%80%99s+disease&doi=10.1111%2Fj.1471-4159.2010.06769.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Dyrk1A-mediated phosphorylation of presenilin 1: a functional link between Down syndrome and Alzheimer's disease</span></div><div class="casAuthors">Ryu, Young Shin; Park, So Young; Jung, Min-Su; Yoon, Song-Hee; Kwen, Mi-Yang; Lee, Sun-Young; Choi, Sun-Hee; Radnaabazar, Chinzorig; Kim, Mi-Kyoung; Kim, Hangun; Kim, Kwonseop; Song, Woo-Joo; Chung, Sul-Hee</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">574-584</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The dual-specificity tyrosine(Y)-phosphorylation-regulated kinase 1A (Dyrk1A) gene is located on human chromosome 21 and encodes a proline-directed protein kinase that might be responsible for mental retardation and early onset of Alzheimer's disease (AD) in Down syndrome (DS) patients.  Presenilin 1 (PS1) is a key component of the γ-secretase complex in the generation of β-amyloid (Aβ), an important trigger protein in the pathogenesis of AD.  Increased Dyrk1A expression has been reported in human AD and DS brains.  We previously showed that Dyrk1A increased Aβ prodn. in mammalian cells and transgenic mice that over-express Dyrk1A.  In this study, we describe a potential mechanism by which Aβ is increased in Dyrk1A-over-expressing DS and AD brains.  First, we show that PS1 is phosphorylated by the Dyrk1A at Thr354 and that this phosphorylation increases γ-secretase activity.  Then, using transgenic mice that over-express human Dyrk1A, we demonstrate that phospho-Thr354-PS1 (pT354-PS1) expression is enhanced when Dyrk1A level is increased.  We also show that pT354-PS1 is more stable than the unphosphorylated form of PS1.  These results reveal a potential regulatory link between Dyrk1A and PS1 in the Aβ pathway of DS and AD brains, suggesting that up-regulated Dyrk1A may accelerate AD pathogenesis through PS1 phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLqQna1ZNRMLVg90H21EOLACvtfcHk0lgKzUpQ-WciEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlGlsb%252FJ&md5=c34feb9505bd69bb8e5242e0a23e8197</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2010.06769.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2010.06769.x%26sid%3Dliteratum%253Aachs%26aulast%3DRyu%26aufirst%3DY.%2BS.%26aulast%3DPark%26aufirst%3DS.%2BY.%26aulast%3DJung%26aufirst%3DM.%2BS.%26aulast%3DYoon%26aufirst%3DS.%2BH.%26aulast%3DKwen%26aufirst%3DM.%2BY.%26aulast%3DLee%26aufirst%3DS.%2BY.%26aulast%3DChoi%26aufirst%3DS.%2BH.%26aulast%3DRadnaabazar%26aufirst%3DC.%26aulast%3DKim%26aufirst%3DM.%2BK.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DSong%26aufirst%3DW.%2BJ.%26aulast%3DChung%26aufirst%3DS.%2BH.%26atitle%3DDyrk1A-mediated%2520phosphorylation%2520of%2520Presenilin%25201%253A%2520a%2520functional%2520link%2520between%2520Down%2520syndrome%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurochem.%26date%3D2010%26volume%3D115%26spage%3D574%26epage%3D584%26doi%3D10.1111%2Fj.1471-4159.2010.06769.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wegiel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, Y. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grundke-Iqbal, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramakrishna, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, C. X.</span></span> <span> </span><span class="NLM_article-title">Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3224</span>– <span class="NLM_lpage">3233</span>, <span class="refDoi"> DOI: 10.1096/fj.07-104539</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1096%2Ffj.07-104539" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=3224-3233&author=F.+Liuauthor=Z.+H.+Liangauthor=J.+Wegielauthor=Y.+W.+Hwangauthor=K.+Iqbalauthor=I.+Grundke-Iqbalauthor=N.+Ramakrishnaauthor=C.+X.+Gong&title=Overexpression+of+Dyrk1A+contributes+to+neurofibrillary+degeneration+in+Down+syndrome&doi=10.1096%2Ffj.07-104539"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1096%2Ffj.07-104539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.07-104539%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DLiang%26aufirst%3DZ.%2BH.%26aulast%3DWegiel%26aufirst%3DJ.%26aulast%3DHwang%26aufirst%3DY.%2BW.%26aulast%3DIqbal%26aufirst%3DK.%26aulast%3DGrundke-Iqbal%26aufirst%3DI.%26aulast%3DRamakrishna%26aufirst%3DN.%26aulast%3DGong%26aufirst%3DC.%2BX.%26atitle%3DOverexpression%2520of%2520Dyrk1A%2520contributes%2520to%2520neurofibrillary%2520degeneration%2520in%2520Down%2520syndrome%26jtitle%3DFASEB%2520J.%26date%3D2008%26volume%3D22%26spage%3D3224%26epage%3D3233%26doi%3D10.1096%2Ffj.07-104539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wegiel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, C. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, Y. W.</span></span> <span> </span><span class="NLM_article-title">The role of DYRK1A in neurodegenerative diseases</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">236</span>– <span class="NLM_lpage">245</span>, <span class="refDoi"> DOI: 10.1111/j.1742-4658.2010.07955.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1111%2Fj.1742-4658.2010.07955.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=21156028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFGru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2011&pages=236-245&author=J.+Wegielauthor=C.+X.+Gongauthor=Y.+W.+Hwang&title=The+role+of+DYRK1A+in+neurodegenerative+diseases&doi=10.1111%2Fj.1742-4658.2010.07955.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The role of DYRK1A in neurodegenerative diseases</span></div><div class="casAuthors">Wegiel, Jerzy; Gong, Cheng-Xin; Hwang, Yu-Wen</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">236-245</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Recent studies indicate that the dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) gene, which is located on chromosome 21q22.2 and is overexpressed in Down syndrome (DS), may play a significant role in developmental brain defects and in early onset neurodegeneration, neuronal loss and dementia in DS.  The identification of hundreds of genes deregulated by DYRK1A overexpression and numerous cytosolic, cytoskeletal and nuclear proteins, including transcription factors, phosphorylated by DYRK1A, indicates that DYRK1A overexpression is central for the deregulation of multiple pathways in the developing and aging DS brain, with structural and functional alterations including mental retardation and dementia.  DYRK1A overexpression in DS brains may contribute to early onset neurofibrillary degeneration directly through hyperphosphorylation of tau and indirectly through phosphorylation of alternative splicing factor, leading to an imbalance between 3R-tau and 4R-tau.  The several-fold increases in the no. of DYRK1A-pos. and 3R-tau-pos. neurofibrillary tangles in DS support this hypothesis.  Moreover, the enhanced phosphorylation of amyloid precursor protein by overexpressed DYRK1A facilitates amyloidogenic amyloid precursor protein cleavage elevating Aβ40 and 42 levels, and leading to brain β-amyloidosis.  Therefore, inhibiting DYRK1A activity in DS may serve to counteract the phenotypic effects of its overexpression and is a potential method of treatment of developmental defects and the prevention of age-assocd. neurodegeneration, including Alzheimer-type pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6EhMKZ0hzPbVg90H21EOLACvtfcHk0lgKzUpQ-WciEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFGru7o%253D&md5=ac857b61ce21452dac070f1c26a75d38</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2010.07955.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2010.07955.x%26sid%3Dliteratum%253Aachs%26aulast%3DWegiel%26aufirst%3DJ.%26aulast%3DGong%26aufirst%3DC.%2BX.%26aulast%3DHwang%26aufirst%3DY.%2BW.%26atitle%3DThe%2520role%2520of%2520DYRK1A%2520in%2520neurodegenerative%2520diseases%26jtitle%3DFEBS%2520J.%26date%3D2011%26volume%3D278%26spage%3D236%26epage%3D245%26doi%3D10.1111%2Fj.1742-4658.2010.07955.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belgardt, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lammert, E.</span></span> <span> </span><span class="NLM_article-title">DYRK1A: A promising drug target for islet transplant-based diabetes therapies</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">1496</span>– <span class="NLM_lpage">1498</span>, <span class="refDoi"> DOI: 10.2337/dbi16-0013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.2337%2Fdbi16-0013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2016&pages=1496-1498&author=B.+F.+Belgardtauthor=E.+Lammert&title=DYRK1A%3A+A+promising+drug+target+for+islet+transplant-based+diabetes+therapies&doi=10.2337%2Fdbi16-0013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2337%2Fdbi16-0013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdbi16-0013%26sid%3Dliteratum%253Aachs%26aulast%3DBelgardt%26aufirst%3DB.%2BF.%26aulast%3DLammert%26aufirst%3DE.%26atitle%3DDYRK1A%253A%2520A%2520promising%2520drug%2520target%2520for%2520islet%2520transplant-based%2520diabetes%2520therapies%26jtitle%3DDiabetes%26date%3D2016%26volume%3D65%26spage%3D1496%26epage%3D1498%26doi%3D10.2337%2Fdbi16-0013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dirice, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walpita, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vetere, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahraman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dancik, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clemons, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, B. K.</span></span> <span> </span><span class="NLM_article-title">Inhibition of DYRK1A stimulates human beta-cell proliferation</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">1660</span>– <span class="NLM_lpage">1671</span>, <span class="refDoi"> DOI: 10.2337/db15-1127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.2337%2Fdb15-1127" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2016&pages=1660-1671&author=E.+Diriceauthor=D.+Walpitaauthor=A.+Vetereauthor=B.+C.+Meierauthor=S.+Kahramanauthor=J.+Huauthor=V.+Dancikauthor=S.+M.+Burnsauthor=T.+J.+Gilbertauthor=D.+E.+Olsonauthor=P.+A.+Clemonsauthor=R.+N.+Kulkarniauthor=B.+K.+Wagner&title=Inhibition+of+DYRK1A+stimulates+human+beta-cell+proliferation&doi=10.2337%2Fdb15-1127"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2337%2Fdb15-1127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb15-1127%26sid%3Dliteratum%253Aachs%26aulast%3DDirice%26aufirst%3DE.%26aulast%3DWalpita%26aufirst%3DD.%26aulast%3DVetere%26aufirst%3DA.%26aulast%3DMeier%26aufirst%3DB.%2BC.%26aulast%3DKahraman%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DDancik%26aufirst%3DV.%26aulast%3DBurns%26aufirst%3DS.%2BM.%26aulast%3DGilbert%26aufirst%3DT.%2BJ.%26aulast%3DOlson%26aufirst%3DD.%2BE.%26aulast%3DClemons%26aufirst%3DP.%2BA.%26aulast%3DKulkarni%26aufirst%3DR.%2BN.%26aulast%3DWagner%26aufirst%3DB.%2BK.%26atitle%3DInhibition%2520of%2520DYRK1A%2520stimulates%2520human%2520beta-cell%2520proliferation%26jtitle%3DDiabetes%26date%3D2016%26volume%3D65%26spage%3D1660%26epage%3D1671%26doi%3D10.2337%2Fdb15-1127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez-Perez, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felsenfeld, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivendran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bender, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Ocana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. F.</span></span> <span> </span><span class="NLM_article-title">A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">383</span>– <span class="NLM_lpage">388</span>, <span class="refDoi"> DOI: 10.1038/nm.3820</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1038%2Fnm.3820" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=25751815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjvFOnsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=383-388&author=P.+Wangauthor=J.+C.+Alvarez-Perezauthor=D.+P.+Felsenfeldauthor=H.+T.+Liuauthor=S.+Sivendranauthor=A.+Benderauthor=A.+Kumarauthor=R.+Sanchezauthor=D.+K.+Scottauthor=A.+Garcia-Ocanaauthor=A.+F.+Stewart&title=A+high-throughput+chemical+screen+reveals+that+harmine-mediated+inhibition+of+DYRK1A+increases+human+pancreatic+beta+cell+replication&doi=10.1038%2Fnm.3820"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication</span></div><div class="casAuthors">Wang, Peng; Alvarez-Perez, Juan-Carlos; Felsenfeld, Dan P.; Liu, Hongtao; Sivendran, Sharmila; Bender, Aaron; Kumar, Anil; Sanchez, Roberto; Scott, Donald K.; Garcia-Ocana, Adolfo; Stewart, Andrew F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">383-388</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Types 1 and 2 diabetes affect some 380 million people worldwide.  Both ultimately result from a deficiency of functional pancreatic insulin-producing beta cells.  Beta cells proliferate in humans during a brief temporal window beginning around the time of birth, with a peak percentage (∼2%) engaged in the cell cycle in the first year of life.  In embryonic life and after early childhood, beta cell replication is barely detectable.  Whereas beta cell expansion seems an obvious therapeutic approach to beta cell deficiency, adult human beta cells have proven recalcitrant to such efforts.  Hence, there remains an urgent need for antidiabetic therapeutic agents that can induce regeneration and expansion of adult human beta cells in vivo or ex vivo.  Here, using a high-throughput small-mol. screen (HTS), we find that analogs of the small mol. harmine function as a new class of human beta cell mitogenic compds.  We also define dual-specificity tyrosine-regulated kinase-1a (DYRK1A) as the likely target of harmine and the nuclear factors of activated T cells (NFAT) family of transcription factors as likely mediators of human beta cell proliferation and differentiation.  Using three different mouse and human islet in vivo-based models, we show that harmine is able to induce beta cell proliferation, increase islet mass and improve glycemic control.  These observations suggest that harmine analogs may have unique therapeutic promise for human diabetes therapy.  Enhancing the potency and beta cell specificity of these compds. are important future challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp11xY4tql3VbVg90H21EOLACvtfcHk0lg8G-Sf4-xufw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjvFOnsr8%253D&md5=32a02c393defd14b8922ac9efff63389</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnm.3820&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3820%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%26aulast%3DAlvarez-Perez%26aufirst%3DJ.%2BC.%26aulast%3DFelsenfeld%26aufirst%3DD.%2BP.%26aulast%3DLiu%26aufirst%3DH.%2BT.%26aulast%3DSivendran%26aufirst%3DS.%26aulast%3DBender%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DSanchez%26aufirst%3DR.%26aulast%3DScott%26aufirst%3DD.%2BK.%26aulast%3DGarcia-Ocana%26aufirst%3DA.%26aulast%3DStewart%26aufirst%3DA.%2BF.%26atitle%3DA%2520high-throughput%2520chemical%2520screen%2520reveals%2520that%2520harmine-mediated%2520inhibition%2520of%2520DYRK1A%2520increases%2520human%2520pancreatic%2520beta%2520cell%2520replication%26jtitle%3DNat.%2520Med.%26date%3D2015%26volume%3D21%26spage%3D383%26epage%3D388%26doi%3D10.1038%2Fnm.3820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cook, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neville, M. E.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vrana, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartl, F. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roskoski, R.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Adenosine cyclic 3′,5′-monophosphate dependent protein kinase: kinetic mechanism for the bovine skeletal muscle catalytic subunit</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">5794</span>– <span class="NLM_lpage">5799</span>, <span class="refDoi"> DOI: 10.1021/bi00266a011</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00266a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADyaL38XlslOks7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1982&pages=5794-5799&author=P.+F.+Cookauthor=M.+E.+Nevilleauthor=K.+E.+Vranaauthor=F.+T.+Hartlauthor=R.+Roskoski&title=Adenosine+cyclic+3%E2%80%B2%2C5%E2%80%B2-monophosphate+dependent+protein+kinase%3A+kinetic+mechanism+for+the+bovine+skeletal+muscle+catalytic+subunit&doi=10.1021%2Fbi00266a011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine cyclic 3',5'-monophosphate dependent protein kinase:  kinetic mechanism for the bovine skeletal muscle catalytic subunit</span></div><div class="casAuthors">Cook, Paul F.; Neville, Maynard E., Jr.; Vrana, Kent E.; Hartl, F. Thomas; Roskoski, Robert, Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5794-9</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">The kinetic mechanism for cAMP-dependent protein kinase was detd. from initial velocity studies in the absence and presence of the product, MgADP, and dead-end inhibitors.  The data were consistent with random addn. of MgATP and the peptide, Leu-Arg-Arg-Ala-Ser-Leu-Gly (I), and ordered release of phospho-I and MgADP with a dead-end enzyme-MgADP-I complex.  In addn. to the metal required for nucleotide, the binding of Mg2+ to a 2nd site was also characterized.  Increasing the Mg2+ concn. resulted in a 5-6-fold decrease in Vmax in the presence or absence of 0.1M KCl.  There was a 5-fold increase in the V/KMgATPin the absence of KCl and a 13-fold increase in V/KMgATPat 0.1M KCl.  The effect of increasing free Mg2+ on Vmax and V/K was also obtained with MgITP (20% the Vmax with MgATP) and MgGTP (10% the Vmax with MgATP) as substrates.  The dissocn. const. for Mg2+ from enzyme-I-Mg2+ and central complexes was 2-3 mM.  At low concns. of free Mg2+ and no added KCl, competitive inhibitors of MgATP (Ki = 60 μM) decreased in the order adenosine = MgADP (Ki ≃ 40 μM) > AMP (Ki ≃ 8 mM).  In addn., guanosine (1 mM) and Mg triphosphate (10 mM) failed to inhibit at low or high free Mg2+.  A mechanism for nucleotide interaction was proposed based on a hydrophobic site or neg. charged group in the region of the α-phosphate in the nucleotide-binding site and the presence or absence of a neg. charge on the α-phosphate.  A spectrophotometric assay for protein kinase that couples the prodn. of MgADP to the pyruvate kinase and lactate dehydrogenase reactions was also used.  On the basis of detns. of the amt. of phosphorylatable I by spectrophotometric or radioisotopic detns., it was found that com. samples contain 25-50% nonpeptide material by wt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0iEBJc7CoG7Vg90H21EOLACvtfcHk0lg8G-Sf4-xufw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XlslOks7w%253D&md5=3cb4ce74b569fd0a8df8ef7031f27101</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fbi00266a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00266a011%26sid%3Dliteratum%253Aachs%26aulast%3DCook%26aufirst%3DP.%2BF.%26aulast%3DNeville%26aufirst%3DM.%2BE.%26aulast%3DVrana%26aufirst%3DK.%2BE.%26aulast%3DHartl%26aufirst%3DF.%2BT.%26aulast%3DRoskoski%26aufirst%3DR.%26atitle%3DAdenosine%2520cyclic%25203%25E2%2580%25B2%252C5%25E2%2580%25B2-monophosphate%2520dependent%2520protein%2520kinase%253A%2520kinetic%2520mechanism%2520for%2520the%2520bovine%2520skeletal%2520muscle%2520catalytic%2520subunit%26jtitle%3DBiochemistry%26date%3D1982%26volume%3D21%26spage%3D5794%26epage%3D5799%26doi%3D10.1021%2Fbi00266a011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alexeeva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engh, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothweiler, U.</span></span> <span> </span><span class="NLM_article-title">The structure of a dual-specificity tyrosine phosphorylation-regulated kinase 1A-PKC412 complex reveals disulfide-bridge formation with the anomalous catalytic loop HRD(HCD) cysteine</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">1207</span>– <span class="NLM_lpage">1215</span>, <span class="refDoi"> DOI: 10.1107/S1399004715005106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1107%2FS1399004715005106" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2015&pages=1207-1215&author=M.+Alexeevaauthor=E.+Abergauthor=R.+A.+Enghauthor=U.+Rothweiler&title=The+structure+of+a+dual-specificity+tyrosine+phosphorylation-regulated+kinase+1A-PKC412+complex+reveals+disulfide-bridge+formation+with+the+anomalous+catalytic+loop+HRD%28HCD%29+cysteine&doi=10.1107%2FS1399004715005106"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1107%2FS1399004715005106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS1399004715005106%26sid%3Dliteratum%253Aachs%26aulast%3DAlexeeva%26aufirst%3DM.%26aulast%3DAberg%26aufirst%3DE.%26aulast%3DEngh%26aufirst%3DR.%2BA.%26aulast%3DRothweiler%26aufirst%3DU.%26atitle%3DThe%2520structure%2520of%2520a%2520dual-specificity%2520tyrosine%2520phosphorylation-regulated%2520kinase%25201A-PKC412%2520complex%2520reveals%2520disulfide-bridge%2520formation%2520with%2520the%2520anomalous%2520catalytic%2520loop%2520HRD%2528HCD%2529%2520cysteine%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2015%26volume%3D71%26spage%3D1207%26epage%3D1215%26doi%3D10.1107%2FS1399004715005106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rothweiler, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stensen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandsdal, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaksson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engh, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svendsen, J. S.</span></span> <span> </span><span class="NLM_article-title">Probing the ATP-binding pocket of protein kinase DYRK1A with benzothiazole fragment molecules</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">9814</span>– <span class="NLM_lpage">9824</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01086</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01086" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1yksr7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9814-9824&author=U.+Rothweilerauthor=W.+Stensenauthor=B.+O.+Brandsdalauthor=J.+Isakssonauthor=F.+A.+Leesonauthor=R.+A.+Enghauthor=J.+S.+Svendsen&title=Probing+the+ATP-binding+pocket+of+protein+kinase+DYRK1A+with+benzothiazole+fragment+molecules&doi=10.1021%2Facs.jmedchem.6b01086"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the ATP-Binding Pocket of Protein Kinase DYRK1A with Benzothiazole Fragment Molecules</span></div><div class="casAuthors">Rothweiler, Ulli; Stensen, Wenche; Brandsdal, Bjoern Olav; Isaksson, Johan; Leeson, Frederick Alan; Engh, Richard Alan; Svendsen, John S. Mjoeen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9814-9824</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">DYRK1A has emerged as a potential target for therapies of Alzheimer's disease using small mols.  Based on the observation of selective DYRK1A inhibition by firefly D-luciferin, we have explored static and dynamic structural properties of fragment sized variants of the benzothiazole scaffold with respect to DYRK1A using X-ray crystallog. and NMR techniques.  The compds. have excellent ligand efficiencies and show a remarkable diversity of binding modes in dynamic equil.  Binding geometries are detd. in part by interactions often considered "weak", including "orthogonal multipolar" types represented by e.g. F-CO, sulfur-aromat, and halogen-aromat interactions, together with hydrogen bonds that are modulated by variation of electron withdrawing groups.  These studies show how the benzothiazole scaffold is highly promising for the development of therapeutic DYRK1A inhibitors.  In addn., the subtleties of the binding interactions, including dynamics, show how full structural studies are required to fully interpret the essential phys. determinants of binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYSQe1_5bEjLVg90H21EOLACvtfcHk0lhrXylnjtysEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1yksr7P&md5=edb850b232f53b3e161a5023915972e6</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01086%26sid%3Dliteratum%253Aachs%26aulast%3DRothweiler%26aufirst%3DU.%26aulast%3DStensen%26aufirst%3DW.%26aulast%3DBrandsdal%26aufirst%3DB.%2BO.%26aulast%3DIsaksson%26aufirst%3DJ.%26aulast%3DLeeson%26aufirst%3DF.%2BA.%26aulast%3DEngh%26aufirst%3DR.%2BA.%26aulast%3DSvendsen%26aufirst%3DJ.%2BS.%26atitle%3DProbing%2520the%2520ATP-binding%2520pocket%2520of%2520protein%2520kinase%2520DYRK1A%2520with%2520benzothiazole%2520fragment%2520molecules%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D9814%26epage%3D9824%26doi%3D10.1021%2Facs.jmedchem.6b01086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tahtouh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkins, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippakopoulos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soundararajan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durieu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delhommel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberholzer, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearl, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carreaux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazureau, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span> <span> </span><span class="NLM_article-title">Selectivity, cocrystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid leucettamine B</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9312</span>– <span class="NLM_lpage">9330</span>, <span class="refDoi"> DOI: 10.1021/jm301034u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301034u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2mu7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9312-9330&author=T.+Tahtouhauthor=J.+M.+Elkinsauthor=P.+Filippakopoulosauthor=M.+Soundararajanauthor=G.+Burgyauthor=E.+Durieuauthor=C.+Cochetauthor=R.+S.+Schmidauthor=D.+C.+Loauthor=F.+Delhommelauthor=A.+E.+Oberholzerauthor=L.+H.+Pearlauthor=F.+Carreauxauthor=J.+P.+Bazureauauthor=S.+Knappauthor=L.+Meijer&title=Selectivity%2C+cocrystal+structures%2C+and+neuroprotective+properties+of+leucettines%2C+a+family+of+protein+kinase+inhibitors+derived+from+the+marine+sponge+alkaloid+leucettamine+B&doi=10.1021%2Fjm301034u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Selectivity, Cocrystal Structures, and Neuroprotective Properties of Leucettines, a Family of Protein Kinase Inhibitors Derived from the Marine Sponge Alkaloid Leucettamine B</span></div><div class="casAuthors">Tahtouh, Tania; Elkins, Jonathan M.; Filippakopoulos, Panagis; Soundararajan, Meera; Burgy, Guillaume; Durieu, Emilie; Cochet, Claude; Schmid, Ralf S.; Lo, Donald C.; Delhommel, Florent; Oberholzer, Anselm E.; Pearl, Laurence H.; Carreaux, Francois; Bazureau, Jean-Pierre; Knapp, Stefan; Meijer, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9312-9330</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">DYRKs (dual specificity, tyrosine phosphorylation regulated kinases) and CLKs (cdc2-like kinases) are implicated in the onset and development of Alzheimer's disease and Down syndrome.  The marine sponge alkaloid leucettamine B was recently identified as an inhibitor of DYRKs/CLKs.  Synthesis of analogs (leucettines) led to an optimized product, leucettine L41.  Leucettines were cocrystd. with DYRK1A, DYRK2, CLK3, PIM1, and GSK-3β.  The selectivity of L41 was studied by activity and interaction assays of recombinant kinases and affinity chromatog. and competition affinity assays.  These approaches revealed unexpected potential secondary targets such as CK2, SLK, and the lipid kinase PIKfyve/Vac14.  L41 displayed neuroprotective effects on glutamate-induced HT22 cell death.  L41 also reduced amyloid precursor protein-induced cell death in cultured rat brain slices.  The unusual multitarget selectivity of leucettines may account for their neuroprotective effects.  This family of kinase inhibitors deserves further optimization as potential therapeutics against neurodegenerative diseases such as Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOhwr44JiuCrVg90H21EOLACvtfcHk0lhrXylnjtysEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2mu7vF&md5=a1749c347c2e8e0409d8fdd475dc70f9</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm301034u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301034u%26sid%3Dliteratum%253Aachs%26aulast%3DTahtouh%26aufirst%3DT.%26aulast%3DElkins%26aufirst%3DJ.%2BM.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DSoundararajan%26aufirst%3DM.%26aulast%3DBurgy%26aufirst%3DG.%26aulast%3DDurieu%26aufirst%3DE.%26aulast%3DCochet%26aufirst%3DC.%26aulast%3DSchmid%26aufirst%3DR.%2BS.%26aulast%3DLo%26aufirst%3DD.%2BC.%26aulast%3DDelhommel%26aufirst%3DF.%26aulast%3DOberholzer%26aufirst%3DA.%2BE.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DCarreaux%26aufirst%3DF.%26aulast%3DBazureau%26aufirst%3DJ.%2BP.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DSelectivity%252C%2520cocrystal%2520structures%252C%2520and%2520neuroprotective%2520properties%2520of%2520leucettines%252C%2520a%2520family%2520of%2520protein%2520kinase%2520inhibitors%2520derived%2520from%2520the%2520marine%2520sponge%2520alkaloid%2520leucettamine%2520B%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9312%26epage%3D9330%26doi%3D10.1021%2Fjm301034u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weisberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Development of ’DFG-out’ inhibitors of gatekeeper mutant kinases</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">5297</span>– <span class="NLM_lpage">5302</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.06.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1016%2Fj.bmcl.2012.06.036" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5297-5302&author=H.+G.+Choiauthor=J.+M.+Zhangauthor=E.+Weisbergauthor=J.+D.+Griffinauthor=T.+Simauthor=N.+S.+Gray&title=Development+of+%E2%80%99DFG-out%E2%80%99+inhibitors+of+gatekeeper+mutant+kinases&doi=10.1016%2Fj.bmcl.2012.06.036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.06.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.06.036%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DZhang%26aufirst%3DJ.%2BM.%26aulast%3DWeisberg%26aufirst%3DE.%26aulast%3DGriffin%26aufirst%3DJ.%2BD.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DDevelopment%2520of%2520%25E2%2580%2599DFG-out%25E2%2580%2599%2520inhibitors%2520of%2520gatekeeper%2520mutant%2520kinases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D5297%26epage%3D5302%26doi%3D10.1016%2Fj.bmcl.2012.06.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoreen, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hur, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabatini, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Discovery of 9-(6-aminopyridin-3-yl)-1-(3-(trifluoromethyl)-phenyl)benzo[h][1,6]naphthyridin-2(1H)-one (Torin2) as a potent, selective, and orally available mammalian target of raparnycin (mTOR) inhibitor for treatment of cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1473</span>– <span class="NLM_lpage">1480</span>, <span class="refDoi"> DOI: 10.1021/jm101520v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101520v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1473-1480&author=Q.+S.+Liuauthor=J.+H.+Wangauthor=S.+A.+Kangauthor=C.+C.+Thoreenauthor=W.+Hurauthor=T.+Ahmedauthor=D.+M.+Sabatiniauthor=N.+S.+Gray&title=Discovery+of+9-%286-aminopyridin-3-yl%29-1-%283-%28trifluoromethyl%29-phenyl%29benzo%5Bh%5D%5B1%2C6%5Dnaphthyridin-2%281H%29-one+%28Torin2%29+as+a+potent%2C+selective%2C+and+orally+available+mammalian+target+of+raparnycin+%28mTOR%29+inhibitor+for+treatment+of+cancer&doi=10.1021%2Fjm101520v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm101520v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101520v%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%2BS.%26aulast%3DWang%26aufirst%3DJ.%2BH.%26aulast%3DKang%26aufirst%3DS.%2BA.%26aulast%3DThoreen%26aufirst%3DC.%2BC.%26aulast%3DHur%26aufirst%3DW.%26aulast%3DAhmed%26aufirst%3DT.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DDiscovery%2520of%25209-%25286-aminopyridin-3-yl%2529-1-%25283-%2528trifluoromethyl%2529-phenyl%2529benzo%255Bh%255D%255B1%252C6%255Dnaphthyridin-2%25281H%2529-one%2520%2528Torin2%2529%2520as%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520available%2520mammalian%2520target%2520of%2520raparnycin%2520%2528mTOR%2529%2520inhibitor%2520for%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1473%26epage%3D1480%26doi%3D10.1021%2Fjm101520v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fruit, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herault, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besson, T.</span></span> <span> </span><span class="NLM_article-title">Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors: a survey of recent patent literature</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1183</span>– <span class="NLM_lpage">1199</span>, <span class="refDoi"> DOI: 10.1080/13543776.2017.1360285</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1080%2F13543776.2017.1360285" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=28766366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1Ojs7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=1183-1199&issue=11&author=T.+L.+Nguyenauthor=C.+Fruitauthor=Y.+Heraultauthor=L.+Meijerauthor=T.+Besson&title=Dual-specificity+tyrosine+phosphorylation-regulated+kinase+1A+%28DYRK1A%29+inhibitors%3A+a+survey+of+recent+patent+literature&doi=10.1080%2F13543776.2017.1360285"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors: a survey of recent patent literature</span></div><div class="casAuthors">Nguyen, Thu Lan; Fruit, Corinne; Herault, Yann; Meijer, Laurent; Besson, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1183-1199</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) is a eukaryotic serine-threonine protein kinase belonging to the CMGC group.  DYRK1A hyperactivity appears to contribute to the development of a no. of human malignancies and to cognitive deficits obsd. in Down syndrome and Alzheimer's disease.  As a result, the DYRK1A kinase represents an attractive target for the synthesis and optimization of pharmacol. inhibitors of potential therapeutic interest.  Like most tyrosine kinase inhibitors developed up to the market, DYRK1A inhibitors are essentially acting by competing with ATP for binding at the catalytic site of the kinase.  This paper reviews patent activity assocd. with the discovery of synthetic novel heterocyclic mols. inhibiting the catalytic activity of DYRK1A.  Despite the important role of DYRK1A in biol. processes and the growing interest in the design of new therapeutic drugs, there are only few patented synthetic DYRK1A inhibitors and most of them were and are still developed by academic research groups, sometimes with industrial partners.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotMS30KxawIbVg90H21EOLACvtfcHk0lj3__ucBdRYfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1Ojs7jO&md5=3cdf56f9f96f917133b4625dd5d4d09c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1080%2F13543776.2017.1360285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2017.1360285%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DT.%2BL.%26aulast%3DFruit%26aufirst%3DC.%26aulast%3DHerault%26aufirst%3DY.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DBesson%26aufirst%3DT.%26atitle%3DDual-specificity%2520tyrosine%2520phosphorylation-regulated%2520kinase%25201A%2520%2528DYRK1A%2529%2520inhibitors%253A%2520a%2520survey%2520of%2520recent%2520patent%2520literature%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2017%26volume%3D27%26issue%3D11%26spage%3D1183%26epage%3D1199%26doi%3D10.1080%2F13543776.2017.1360285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohnishi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiramatsu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kii, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onogi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibuya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagiwara, M.</span></span> <span> </span><span class="NLM_article-title">Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">86</span>, <span class="refDoi"> DOI: 10.1038/ncomms1090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1038%2Fncomms1090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=20981014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A280%3ADC%252BC3cbislehtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=86&author=Y.+Ogawaauthor=Y.+Nonakaauthor=T.+Gotoauthor=E.+Ohnishiauthor=T.+Hiramatsuauthor=I.+Kiiauthor=M.+Yoshidaauthor=T.+Ikuraauthor=H.+Onogiauthor=H.+Shibuyaauthor=T.+Hosoyaauthor=N.+Itoauthor=M.+Hagiwara&title=Development+of+a+novel+selective+inhibitor+of+the+Down+syndrome-related+kinase+Dyrk1A&doi=10.1038%2Fncomms1090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A</span></div><div class="casAuthors">Ogawa Yasushi; Nonaka Yosuke; Goto Toshiyasu; Ohnishi Eriko; Hiramatsu Toshiyuki; Kii Isao; Yoshida Miyo; Ikura Teikichi; Onogi Hiroshi; Shibuya Hiroshi; Hosoya Takamitsu; Ito Nobutoshi; Hagiwara Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">86</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dyrk1A (dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 1A) is a serine/threonine kinase essential for brain development and function, and its excessive activity is considered a pathogenic factor in Down syndrome.  The development of potent, selective inhibitors of Dyrk1A would help to elucidate the molecular mechanisms of normal and diseased brains, and may provide a new lead compound for molecular-targeted drug discovery.  Here, we report a novel Dyrk1A inhibitor, INDY, a benzothiazole derivative showing a potent ATP-competitive inhibitory effect with IC(50) and K(i) values of 0.24 and 0.18 μM, respectively.  X-ray crystallography of the Dyrk1A/INDY complex revealed the binding of INDY in the ATP pocket of the enzyme.  INDY effectively reversed the aberrant tau-phosphorylation and rescued the repressed NFAT (nuclear factor of activated T cell) signalling induced by Dyrk1A overexpression.  Importantly, proINDY, a prodrug of INDY, effectively recovered Xenopus embryos from head malformation induced by Dyrk1A overexpression, resulting in normally developed embryos and demonstrating the utility of proINDY in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOCqf6rsXbPtenUz0lpNqnfW6udTcc2eYm7ozPFzVfPrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cbislehtw%253D%253D&md5=ac1d5972bec4085de101bb86194babd1</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fncomms1090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms1090%26sid%3Dliteratum%253Aachs%26aulast%3DOgawa%26aufirst%3DY.%26aulast%3DNonaka%26aufirst%3DY.%26aulast%3DGoto%26aufirst%3DT.%26aulast%3DOhnishi%26aufirst%3DE.%26aulast%3DHiramatsu%26aufirst%3DT.%26aulast%3DKii%26aufirst%3DI.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DIkura%26aufirst%3DT.%26aulast%3DOnogi%26aufirst%3DH.%26aulast%3DShibuya%26aufirst%3DH.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DN.%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520a%2520novel%2520selective%2520inhibitor%2520of%2520the%2520Down%2520syndrome-related%2520kinase%2520Dyrk1A%26jtitle%3DNat.%2520Commun.%26date%3D2010%26volume%3D1%26spage%3D86%26doi%3D10.1038%2Fncomms1090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kii, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumida, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato-Sumida, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonamoto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kataoka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagiwara, M.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of a potent inhibitor of class 1 DYRK kinases as a suppressor of adipogenesis</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">4434</span>– <span class="NLM_lpage">4441</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.06.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1016%2Fj.bmc.2015.06.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=26145823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVeis7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=4434-4441&author=S.+Masakiauthor=I.+Kiiauthor=Y.+Sumidaauthor=T.+Kato-Sumidaauthor=Y.+Ogawaauthor=N.+Itoauthor=M.+Nakamuraauthor=R.+Sonamotoauthor=N.+Kataokaauthor=T.+Hosoyaauthor=M.+Hagiwara&title=Design+and+synthesis+of+a+potent+inhibitor+of+class+1+DYRK+kinases+as+a+suppressor+of+adipogenesis&doi=10.1016%2Fj.bmc.2015.06.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of a potent inhibitor of class 1 DYRK kinases as a suppressor of adipogenesis</span></div><div class="casAuthors">Masaki, So; Kii, Isao; Sumida, Yuto; Kato-Sumida, Tomoe; Ogawa, Yasushi; Ito, Nobutoshi; Nakamura, Mitsuhiro; Sonamoto, Rie; Kataoka, Naoyuki; Hosoya, Takamitsu; Hagiwara, Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4434-4441</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dysregulation of dual-specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) has been demonstrated in several pathol. conditions, including Alzheimer's disease and cancer progression.  It has been recently reported that a gain of function-mutation in the human DYRK1B gene exacerbates metabolic syndrome by enhancing obesity.  In the previous study, we developed an inhibitor of DYRK family kinases (INDY) and demonstrated that INDY suppresses the pathol. phenotypes induced by overexpression of DYRK1A or DYRK1B in cellular and animal models.  In this study, we designed and synthesized a novel inhibitor of DYRK family kinases based on the crystal structure of the DYRK1A/INDY complex by replacing the phenol group of INDY with dibenzofuran to produce a deriv., named BINDY.  This compd. exhibited potent and selective inhibitory activity toward DYRK family kinases in an in vitro assay.  Furthermore, treatment of 3T3-L1 pre-adipocytes with BINDY hampered adipogenesis by suppressing gene expression of the crit. transcription factors PPARγ and C/EBPα.  This study indicates the possibility of BINDY as a potential drug for metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRt6yDW_MVw7Vg90H21EOLACvtfcHk0lj3__ucBdRYfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVeis7fF&md5=7429d22909732d8ea03f373158969dfb</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.06.018%26sid%3Dliteratum%253Aachs%26aulast%3DMasaki%26aufirst%3DS.%26aulast%3DKii%26aufirst%3DI.%26aulast%3DSumida%26aufirst%3DY.%26aulast%3DKato-Sumida%26aufirst%3DT.%26aulast%3DOgawa%26aufirst%3DY.%26aulast%3DIto%26aufirst%3DN.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DSonamoto%26aufirst%3DR.%26aulast%3DKataoka%26aufirst%3DN.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520potent%2520inhibitor%2520of%2520class%25201%2520DYRK%2520kinases%2520as%2520a%2520suppressor%2520of%2520adipogenesis%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D4434%26epage%3D4441%26doi%3D10.1016%2Fj.bmc.2015.06.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruben, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurzlbauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sippl, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bracher, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span> <span> </span><span class="NLM_article-title">Selectivity profiling and biological activity of novel beta-carbolines as potent and selective DYRK1 kinase inhibitors</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">e0132453</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0132453</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1371%2Fjournal.pone.0132453" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0132453&author=K.+Rubenauthor=A.+Wurzlbauerauthor=A.+Walteauthor=W.+Sipplauthor=F.+Bracherauthor=W.+Becker&title=Selectivity+profiling+and+biological+activity+of+novel+beta-carbolines+as+potent+and+selective+DYRK1+kinase+inhibitors&doi=10.1371%2Fjournal.pone.0132453"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0132453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0132453%26sid%3Dliteratum%253Aachs%26aulast%3DRuben%26aufirst%3DK.%26aulast%3DWurzlbauer%26aufirst%3DA.%26aulast%3DWalte%26aufirst%3DA.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DBracher%26aufirst%3DF.%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DSelectivity%2520profiling%2520and%2520biological%2520activity%2520of%2520novel%2520beta-carbolines%2520as%2520potent%2520and%2520selective%2520DYRK1%2520kinase%2520inhibitors%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0132453%26doi%3D10.1371%2Fjournal.pone.0132453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
la Torre, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Sola, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pons, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duchon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Lagran, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farre, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fito, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benejam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langohr, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pujadas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bizot, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuenca, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catuara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Covas, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blehaut, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herault, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delabar, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dierssen, M.</span></span> <span> </span><span class="NLM_article-title">Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans</span>. <i>Mol. Nutr. Food Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">278</span>– <span class="NLM_lpage">288</span>, <span class="refDoi"> DOI: 10.1002/mnfr.201300325</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1002%2Fmnfr.201300325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=24039182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A280%3ADC%252BC3sbotlGqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=278-288&author=R.+De%0Ala+Torreauthor=S.+De+Solaauthor=M.+Ponsauthor=A.+Duchonauthor=M.+M.+de+Lagranauthor=M.+Farreauthor=M.+Fitoauthor=B.+Benejamauthor=K.+Langohrauthor=J.+Rodriguezauthor=M.+Pujadasauthor=J.+C.+Bizotauthor=A.+Cuencaauthor=N.+Janelauthor=S.+Catuaraauthor=M.+I.+Covasauthor=H.+Blehautauthor=Y.+Heraultauthor=J.+M.+Delabarauthor=M.+Dierssen&title=Epigallocatechin-3-gallate%2C+a+DYRK1A+inhibitor%2C+rescues+cognitive+deficits+in+Down+syndrome+mouse+models+and+in+humans&doi=10.1002%2Fmnfr.201300325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans</span></div><div class="casAuthors">De la Torre Rafael; De Sola Susana; Pons Meritxell; Duchon Arnaud; de Lagran Maria Martinez; Farre Magi; Fito Montserrat; Benejam Bessy; Langohr Klaus; Rodriguez Joan; Pujadas Mitona; Bizot Jean Charles; Cuenca Aida; Janel Nathalie; Catuara Silvina; Covas Maria Isabel; Blehaut Henri; Herault Yann; Delabar Jean Marie; Dierssen Mara</div><div class="citationInfo"><span class="NLM_cas:title">Molecular nutrition & food research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">278-88</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">SCOPE:  Trisomy for human chromosome 21 results in Down syndrome (DS), which is among the most complex genetic perturbations leading to intellectual disability.  Accumulating data suggest that overexpression of the dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A (DYRK1A), is a critical pathogenic mechanisms in the intellectual deficit.  METHODS AND RESULTS:  Here we show that the green tea flavonol epigallocatechin-gallate (EGCG), a DYRK1A inhibitor, rescues the cognitive deficits of both segmental trisomy 16 (Ts65Dn) and transgenic mice overexpressing Dyrk1A in a trisomic or disomic genetic background, respectively.  It also significantly reverses cognitive deficits in a pilot study in DS individuals with effects on memory recognition, working memory and quality of life.  We used the mouse models to ensure that EGCG was able to reduce DYRK1A kinase activity in the hippocampus and found that it also induced significant changes in plasma homocysteine levels, which were correlated with Dyrk1A expression levels.  Thus, we could use plasma homocysteine levels as an efficacy biomarker in our human study.  CONCLUSION:  We conclude that EGCG is a promising therapeutic tool for cognitive enhancement in DS, and its efficacy may depend of Dyrk1A inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAkxE_Xpbr2b0AGQpJZWpJfW6udTcc2eYlFwXsUHPcerntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sbotlGqsQ%253D%253D&md5=5907f7c031ef2dd5b00b44e801182add</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fmnfr.201300325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmnfr.201300325%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2Bla%2BTorre%26aufirst%3DR.%26aulast%3DDe%2BSola%26aufirst%3DS.%26aulast%3DPons%26aufirst%3DM.%26aulast%3DDuchon%26aufirst%3DA.%26aulast%3Dde%2BLagran%26aufirst%3DM.%2BM.%26aulast%3DFarre%26aufirst%3DM.%26aulast%3DFito%26aufirst%3DM.%26aulast%3DBenejam%26aufirst%3DB.%26aulast%3DLangohr%26aufirst%3DK.%26aulast%3DRodriguez%26aufirst%3DJ.%26aulast%3DPujadas%26aufirst%3DM.%26aulast%3DBizot%26aufirst%3DJ.%2BC.%26aulast%3DCuenca%26aufirst%3DA.%26aulast%3DJanel%26aufirst%3DN.%26aulast%3DCatuara%26aufirst%3DS.%26aulast%3DCovas%26aufirst%3DM.%2BI.%26aulast%3DBlehaut%26aufirst%3DH.%26aulast%3DHerault%26aufirst%3DY.%26aulast%3DDelabar%26aufirst%3DJ.%2BM.%26aulast%3DDierssen%26aufirst%3DM.%26atitle%3DEpigallocatechin-3-gallate%252C%2520a%2520DYRK1A%2520inhibitor%252C%2520rescues%2520cognitive%2520deficits%2520in%2520Down%2520syndrome%2520mouse%2520models%2520and%2520in%2520humans%26jtitle%3DMol.%2520Nutr.%2520Food%2520Res.%26date%3D2014%26volume%3D58%26spage%3D278%26epage%3D288%26doi%3D10.1002%2Fmnfr.201300325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coutadeur, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benyamine, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delalonde, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Oliveira, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblond, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foucourt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casagrande, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taverne, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pando, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desire, L.</span></span> <span> </span><span class="NLM_article-title">A novel DYRK1A (dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer’s disease: effect on Tau and amyloid pathologies in vitro</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">440</span>– <span class="NLM_lpage">451</span>, <span class="refDoi"> DOI: 10.1111/jnc.13018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1111%2Fjnc.13018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=25556849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmtlKitbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2015&pages=440-451&author=S.+Coutadeurauthor=H.+Benyamineauthor=L.+Delalondeauthor=C.+de+Oliveiraauthor=B.+Leblondauthor=A.+Foucourtauthor=T.+Bessonauthor=A.+S.+Casagrandeauthor=T.+Taverneauthor=A.+Girardauthor=M.+P.+Pandoauthor=L.+Desire&title=A+novel+DYRK1A+%28dual+specificity+tyrosine+phosphorylation-regulated+kinase+1A%29+inhibitor+for+the+treatment+of+Alzheimer%E2%80%99s+disease%3A+effect+on+Tau+and+amyloid+pathologies+in+vitro&doi=10.1111%2Fjnc.13018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A novel DYRK1A (Dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologies in vitro</span></div><div class="casAuthors">Coutadeur, Severine; Benyamine, Helene; Delalonde, Laurence; de Oliveira, Catherine; Leblond, Bertrand; Foucourt, Alicia; Besson, Thierry; Casagrande, Anne-Sophie; Taverne, Thierry; Girard, Angelique; Pando, Matthew P.; Desire, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">440-451</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) gene is located within the Down Syndrome (DS) crit. region on chromosome 21 and is implicated in the generation of Tau and amyloid pathologies that are assocd. with the early onset Alzheimer's Disease (AD) obsd. in DS.  DYRK1A is also found assocd. with neurofibrillary tangles in sporadic AD and phosphorylates key AD players (Tau, amyloid precursor, protein, etc).  Thus, DYRK1A may be an important therapeutic target to modify the course of Tau and amyloid beta (Aβ) pathologies.  Here, we describe EHT 5372 (Me 9-(2,4-dichlorophenylamino) thiazolo[5,4-f]quinazoline-2-carbimidate), a novel, highly potent (IC50 = 0.22 nM) DYRK1A inhibitor with a high degree of selectivity over 339 kinases.  Models in which inhibition of DYRK1A by siRNA reduced and DYRK1A over-expression induced Tau phosphorylation or Aβ prodn. were used.  EHT 5372 inhibits DYRK1A-induced Tau phosphorylation at multiple AD-relevant sites in biochem. and cellular assays.  EHT 5372 also normalizes both Aβ-induced Tau phosphorylation and DYRK1A-stimulated Aβ prodn.  DYRK1A is thus as a key element of Aβ-mediated Tau hyperphosphorylation, which links Tau and amyloid pathologies.  EHT 5372 and other compds. in its class warrant in vivo investigation as a novel, high-potential therapy for AD and other Tau opathies.  Inhibition of the dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) is a new high-potential therapeutic approach for Alzheimer disease.  Here we describe EHT 5372, a novel potent and selective DYRK1A inhibitor.  EHT 5372 inhibits DYRK1A-induced Tau phosphorylation, Aβ prodn. and Aβ effects on phospho-Tau, including Tau aggregation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomVswt1MX4I7Vg90H21EOLACvtfcHk0lic1DHeVi3A5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmtlKitbY%253D&md5=5953fc5e56b7ea3c86ea414bd3de7863</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1111%2Fjnc.13018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.13018%26sid%3Dliteratum%253Aachs%26aulast%3DCoutadeur%26aufirst%3DS.%26aulast%3DBenyamine%26aufirst%3DH.%26aulast%3DDelalonde%26aufirst%3DL.%26aulast%3Dde%2BOliveira%26aufirst%3DC.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DFoucourt%26aufirst%3DA.%26aulast%3DBesson%26aufirst%3DT.%26aulast%3DCasagrande%26aufirst%3DA.%2BS.%26aulast%3DTaverne%26aufirst%3DT.%26aulast%3DGirard%26aufirst%3DA.%26aulast%3DPando%26aufirst%3DM.%2BP.%26aulast%3DDesire%26aufirst%3DL.%26atitle%3DA%2520novel%2520DYRK1A%2520%2528dual%2520specificity%2520tyrosine%2520phosphorylation-regulated%2520kinase%25201A%2529%2520inhibitor%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520effect%2520on%2520Tau%2520and%2520amyloid%2520pathologies%2520in%2520vitro%26jtitle%3DJ.%2520Neurochem.%26date%3D2015%26volume%3D133%26spage%3D440%26epage%3D451%26doi%3D10.1111%2Fjnc.13018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaikuad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diharce, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foucourt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblond, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casagrande, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desire, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besson, T.</span></span> <span> </span><span class="NLM_article-title">An unusual binding model of the methyl 9-anilinothiazolo[5,4-f] quinazoline-2-carbimidates (EHT 1610 and EHT 5372) confers high selectivity for dual-specificity tyrosine phosphorylation-regulated kinases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10315</span>– <span class="NLM_lpage">10321</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01083</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01083" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslWjtr%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10315-10321&author=A.+Chaikuadauthor=J.+Diharceauthor=M.+Schroderauthor=A.+Foucourtauthor=B.+Leblondauthor=A.+S.+Casagrandeauthor=L.+Desireauthor=P.+Bonnetauthor=S.+Knappauthor=T.+Besson&title=An+unusual+binding+model+of+the+methyl+9-anilinothiazolo%5B5%2C4-f%5D+quinazoline-2-carbimidates+%28EHT+1610+and+EHT+5372%29+confers+high+selectivity+for+dual-specificity+tyrosine+phosphorylation-regulated+kinases&doi=10.1021%2Facs.jmedchem.6b01083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">An Unusual Binding Model of the Methyl 9-Anilinothiazolo[5,4-f] quinazoline-2-carbimidates (EHT 1610 and EHT 5372) Confers High Selectivity for Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases</span></div><div class="casAuthors">Chaikuad, Apirat; Diharce, Julien; Schroder, Martin; Foucourt, Alicia; Leblond, Bertrand; Casagrande, Anne-Sophie; Desire, Laurent; Bonnet, Pascal; Knapp, Stefan; Besson, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10315-10321</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Me 9-anilinothiazolo[5,4-f]quinazoline-2-carbimidates 1 (EHT 5372) and 2 (EHT 1610) are strong inhibitors of DYRK's family kinases.  The crystal structures of the complex revealed a non-canonical binding mode of compd. 1 and 2 in DYRK2 explaining the remarkable selectivity and potency of these inhibitors.  The structural data and comparison presented here provide therefore a template for further improvement of this inhibitor class and for the development of novel inhibitors selectively targeting DYRK kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp91_JqCRXGqLVg90H21EOLACvtfcHk0liY_4w9ENlUKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslWjtr%252FM&md5=856551b47ad21c90c55563b064001358</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01083%26sid%3Dliteratum%253Aachs%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DDiharce%26aufirst%3DJ.%26aulast%3DSchroder%26aufirst%3DM.%26aulast%3DFoucourt%26aufirst%3DA.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DCasagrande%26aufirst%3DA.%2BS.%26aulast%3DDesire%26aufirst%3DL.%26aulast%3DBonnet%26aufirst%3DP.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBesson%26aufirst%3DT.%26atitle%3DAn%2520unusual%2520binding%2520model%2520of%2520the%2520methyl%25209-anilinothiazolo%255B5%252C4-f%255D%2520quinazoline-2-carbimidates%2520%2528EHT%25201610%2520and%2520EHT%25205372%2529%2520confers%2520high%2520selectivity%2520for%2520dual-specificity%2520tyrosine%2520phosphorylation-regulated%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10315%26epage%3D10321%26doi%3D10.1021%2Facs.jmedchem.6b01083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naert, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferre, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meunier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malmstrom, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Givalois, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carreaux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazureau, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span> <span> </span><span class="NLM_article-title">Leucettine L41, a DYRK1A-preferential DYRKs/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric A beta(25–35) peptide administration in mice</span>. <i>Eur. Neuropsychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2170</span>– <span class="NLM_lpage">2182</span>, <span class="refDoi"> DOI: 10.1016/j.euroneuro.2015.03.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1016%2Fj.euroneuro.2015.03.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=26381812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsFemsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2170-2182&author=G.+Naertauthor=V.+Ferreauthor=J.+Meunierauthor=E.+Kellerauthor=S.+Malmstromauthor=L.+Givaloisauthor=F.+Carreauxauthor=J.+P.+Bazureauauthor=T.+Maurice&title=Leucettine+L41%2C+a+DYRK1A-preferential+DYRKs%2FCLKs+inhibitor%2C+prevents+memory+impairments+and+neurotoxicity+induced+by+oligomeric+A+beta%2825%E2%80%9335%29+peptide+administration+in+mice&doi=10.1016%2Fj.euroneuro.2015.03.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Leucettine L41, a DYRK1A-preferential DYRKs/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric Aβ25-35 peptide administration in mice</span></div><div class="casAuthors">Naert, Gaelle; Ferre, Valentine; Meunier, Johann; Keller, Emeline; Malmstrom, Susanna; Givalois, Laurent; Carreaux, Francois; Bazureau, Jean-Pierre; Maurice, Tangui</div><div class="citationInfo"><span class="NLM_cas:title">European Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2170-2182</span>CODEN:
                <span class="NLM_cas:coden">EURNE8</span>;
        ISSN:<span class="NLM_cas:issn">0924-977X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dual-specificity tyrosine phosphorylation-regulated kinases (DYRKs) and cdc2-like kinases (CLKs) are implicated in the onset and progression of Down syndrome (DS) and Alzheimer's disease (AD).  DYRK1A has emerged as a possible link between amyloid-β (Aβ) and Tau, the major pathol. proteins in AD.  We here assessed the neuroprotective potential of a novel inhibitor of DYRKs/CLKs.  The Leucettine L41, acting preferentially on DYRK1A, was tested in Aβ25-35-treated mice, a nontransgenic model of AD-like toxicity.  We co-injected intracerebroventricularly oligomeric Aβ25-35 peptide and L41 in Swiss male mice.  After 7 days, they were submitted to behavioral tests addressing spatial and non-spatial, short- and long-term memories.  The oxidative stress, apoptotic markers, kinases involved in Tau phosphorylation, and synaptic integrity were analyzed by Western blot and ELISA in the hippocampus.  L41, tested at 0.4, 1.2, 4 μg, prevented the Aβ25-35-induced memory deficits in the Y-maze, passive avoidance and water-maze tests, with the most active dose being 4 μg.  The inhibitor prevented the Aβ25-35-induced oxidative stress, as revealed by measures of lipid peroxidn. levels and reactive oxygen species accumulation, and abolished Aβ25-35-induced expression of pro-apoptotic markers.  L41 prevented the Aβ25-35-induced decrease of AKT activation and increase of glycogen synthase kinase-3β (GSK-3β) activation, resulting in a decrease of Tau phosphorylation.  Finally, L41 restored Aβ25-35-reduced levels of synaptic markers.  The novel DYRK1A-preferential inhibitor L41 therefore prevented Aβ25-35-induced memory impairments and neurotoxicity in the mouse hippocampus.  These in vivo data highlighted particularly DYRK1A as a major kinase involved in Aβ pathol. and suggested therapeutic developments for DYRK1A inhibitors in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSRN-4HYiJs7Vg90H21EOLACvtfcHk0liY_4w9ENlUKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsFemsro%253D&md5=0ddd499193f1ef57d02b46a39f225abb</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.euroneuro.2015.03.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.euroneuro.2015.03.018%26sid%3Dliteratum%253Aachs%26aulast%3DNaert%26aufirst%3DG.%26aulast%3DFerre%26aufirst%3DV.%26aulast%3DMeunier%26aufirst%3DJ.%26aulast%3DKeller%26aufirst%3DE.%26aulast%3DMalmstrom%26aufirst%3DS.%26aulast%3DGivalois%26aufirst%3DL.%26aulast%3DCarreaux%26aufirst%3DF.%26aulast%3DBazureau%26aufirst%3DJ.%2BP.%26aulast%3DMaurice%26aufirst%3DT.%26atitle%3DLeucettine%2520L41%252C%2520a%2520DYRK1A-preferential%2520DYRKs%252FCLKs%2520inhibitor%252C%2520prevents%2520memory%2520impairments%2520and%2520neurotoxicity%2520induced%2520by%2520oligomeric%2520A%2520beta%252825%25E2%2580%259335%2529%2520peptide%2520administration%2520in%2520mice%26jtitle%3DEur.%2520Neuropsychopharmacol.%26date%3D2015%26volume%3D25%26spage%3D2170%26epage%3D2182%26doi%3D10.1016%2Fj.euroneuro.2015.03.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rothweiler, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eriksson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stensen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engh, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svendsen, J. S.</span></span> <span> </span><span class="NLM_article-title">Luciferin and derivatives as a DYRK selective scaffold for the design of protein kinase inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">140</span>– <span class="NLM_lpage">148</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.02.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1016%2Fj.ejmech.2015.02.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=25768698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjsFGjsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2015&pages=140-148&author=U.+Rothweilerauthor=J.+Erikssonauthor=W.+Stensenauthor=F.+Leesonauthor=R.+A.+Enghauthor=J.+S.+Svendsen&title=Luciferin+and+derivatives+as+a+DYRK+selective+scaffold+for+the+design+of+protein+kinase+inhibitors&doi=10.1016%2Fj.ejmech.2015.02.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Luciferin and derivatives as a DYRK selective scaffold for the design of protein kinase inhibitors</span></div><div class="casAuthors">Rothweiler, Ulli; Eriksson, Jonas; Stensen, Wenche; Leeson, Frederick; Engh, Richard A.; Svendsen, John S.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">140-148</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">D-Luciferin is widely used as a substrate in luciferase catalyzed bioluminescence assays for in vitro studies.  However, little is known about cross reactivity and potential interference of D-luciferin with other enzymes.  The authors serendipitously found that firefly luciferin inhibited the CDK2/Cyclin A protein kinase.  Inhibition profiling of D-luciferin over a 103-protein kinase panel showed significant inhibition of a small set of protein kinases, in particular the DYRK-family, but also other members of the CMGC-group, including ERK8 and CK2.  Inhibition profiling on a 16-member focused library derived from D-luciferin confirms that D-luciferin represents a DYRK-selective chemotype of fragment-like mol. wt.  Thus, observation of its inhibitory activity and the initial SAR information reported here promise to be useful for further design of protein kinase inhibitors with related scaffolds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqEtt2EfYajrVg90H21EOLACvtfcHk0liY_4w9ENlUKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjsFGjsL4%253D&md5=5d3fd3650bf11958c7e60a5656b28dfd</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.02.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.02.035%26sid%3Dliteratum%253Aachs%26aulast%3DRothweiler%26aufirst%3DU.%26aulast%3DEriksson%26aufirst%3DJ.%26aulast%3DStensen%26aufirst%3DW.%26aulast%3DLeeson%26aufirst%3DF.%26aulast%3DEngh%26aufirst%3DR.%2BA.%26aulast%3DSvendsen%26aufirst%3DJ.%2BS.%26atitle%3DLuciferin%2520and%2520derivatives%2520as%2520a%2520DYRK%2520selective%2520scaffold%2520for%2520the%2520design%2520of%2520protein%2520kinase%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D94%26spage%3D140%26epage%3D148%26doi%3D10.1016%2Fj.ejmech.2015.02.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kii, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumida, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonamoto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato-Sumida, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koike, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibuya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagiwara, M.</span></span> <span> </span><span class="NLM_article-title">Selective inhibition of the kinase DYRK1A by targeting its folding process</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">11391</span>, <span class="refDoi"> DOI: 10.1038/ncomms11391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1038%2Fncomms11391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=27102360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC28XmslShtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=11391&author=I.+Kiiauthor=Y.+Sumidaauthor=T.+Gotoauthor=R.+Sonamotoauthor=Y.+Okunoauthor=S.+Yoshidaauthor=T.+Kato-Sumidaauthor=Y.+Koikeauthor=M.+Abeauthor=Y.+Nonakaauthor=T.+Ikuraauthor=N.+Itoauthor=H.+Shibuyaauthor=T.+Hosoyaauthor=M.+Hagiwara&title=Selective+inhibition+of+the+kinase+DYRK1A+by+targeting+its+folding+process&doi=10.1038%2Fncomms11391"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of the kinase DYRK1A by targeting its folding process</span></div><div class="casAuthors">Kii, Isao; Sumida, Yuto; Goto, Toshiyasu; Sonamoto, Rie; Okuno, Yukiko; Yoshida, Suguru; Kato-Sumida, Tomoe; Koike, Yuka; Abe, Minako; Nonaka, Yosuke; Ikura, Teikichi; Ito, Nobutoshi; Shibuya, Hiroshi; Hosoya, Takamitsu; Hagiwara, Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11391</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autophosphorylation of amino-acid residues is part of the folding process of various protein kinases.  Conventional chem. screening of mature kinases has missed inhibitors that selectively interfere with the folding process.  Here we report a cell-based assay that evaluates inhibition of a kinase at a transitional state during the folding process and identify a folding intermediate-selective inhibitor of dual-specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A), which we refer to as FINDY.  FINDY suppresses intramol. autophosphorylation of Ser97 in DYRK1A in cultured cells, leading to its degrdn., but does not inhibit substrate phosphorylation catalyzed by the mature kinase.  FINDY also suppresses Ser97 autophosphorylation of recombinant DYRK1A, suggesting direct inhibition, and shows high selectivity for DYRK1A over other DYRK family members.  In addn., FINDY rescues DYRK1A-induced developmental malformations in Xenopus laevis embryos.  Our study demonstrates that transitional folding intermediates of protein kinases can be targeted by small mols., and paves the way for developing novel types of kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE2gsAsp-YjLVg90H21EOLACvtfcHk0lgLSyhIAX38GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmslShtr8%253D&md5=5d64de412dd168a415a3da052d3afedc</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fncomms11391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms11391%26sid%3Dliteratum%253Aachs%26aulast%3DKii%26aufirst%3DI.%26aulast%3DSumida%26aufirst%3DY.%26aulast%3DGoto%26aufirst%3DT.%26aulast%3DSonamoto%26aufirst%3DR.%26aulast%3DOkuno%26aufirst%3DY.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DKato-Sumida%26aufirst%3DT.%26aulast%3DKoike%26aufirst%3DY.%26aulast%3DAbe%26aufirst%3DM.%26aulast%3DNonaka%26aufirst%3DY.%26aulast%3DIkura%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DN.%26aulast%3DShibuya%26aufirst%3DH.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DSelective%2520inhibition%2520of%2520the%2520kinase%2520DYRK1A%2520by%2520targeting%2520its%2520folding%2520process%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D11391%26doi%3D10.1038%2Fncomms11391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of 3,5-disubstituted 7-azaindoles as Trk inhibitors with anticancer and antiangiogenic activities</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">5337</span>– <span class="NLM_lpage">5349</span>, <span class="refDoi"> DOI: 10.1021/jm3002982</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3002982" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5337-5349&author=S.+Hongauthor=J.+Kimauthor=J.+H.+Seoauthor=K.+H.+Jungauthor=S.+S.+Hongauthor=S.+Hong&title=Design%2C+synthesis%2C+and+evaluation+of+3%2C5-disubstituted+7-azaindoles+as+Trk+inhibitors+with+anticancer+and+antiangiogenic+activities&doi=10.1021%2Fjm3002982"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm3002982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3002982%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DSeo%26aufirst%3DJ.%2BH.%26aulast%3DJung%26aufirst%3DK.%2BH.%26aulast%3DHong%26aufirst%3DS.%2BS.%26aulast%3DHong%26aufirst%3DS.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%25203%252C5-disubstituted%25207-azaindoles%2520as%2520Trk%2520inhibitors%2520with%2520anticancer%2520and%2520antiangiogenic%2520activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5337%26epage%3D5349%26doi%3D10.1021%2Fjm3002982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. G.</span>; <span class="NLM_string-name">Sim, T.</span>; <span class="NLM_string-name">Gray, N.</span>; <span class="NLM_string-name">Zhou, W.</span>; <span class="NLM_string-name">Chang, J. W.</span>; <span class="NLM_string-name">Zhang, J.</span>; <span class="NLM_string-name">Weisberg, E.</span></span> <span> </span><span class="NLM_article-title">Fused Heterocyclic Compounds and Their Uses</span>. PCT Int. Appl. <span class="NLM_patent">WO 2010144909 A1</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=H.+G.+Choi&author=T.+Sim&author=N.+Gray&author=W.+Zhou&author=J.+W.+Chang&author=J.+Zhang&author=E.+Weisberg&title=Fused+Heterocyclic+Compounds+and+Their+Uses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DH.%2BG.%26atitle%3DFused%2520Heterocyclic%2520Compounds%2520and%2520Their%2520Uses%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miduturu, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwiatkowski, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brault, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippakopoulos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwaller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrgard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarrinkar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">High-throughput kinase profiling: a more efficient approach toward the discovery of new kinase inhibitors</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">868</span>– <span class="NLM_lpage">879</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2011.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1016%2Fj.chembiol.2011.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=21802008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsFarurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=868-879&author=C.+V.+Miduturuauthor=X.+Dengauthor=N.+Kwiatkowskiauthor=W.+Yangauthor=L.+Braultauthor=P.+Filippakopoulosauthor=E.+Chungauthor=Q.+Yangauthor=J.+Schwallerauthor=S.+Knappauthor=R.+W.+Kingauthor=J.+D.+Leeauthor=S.+Herrgardauthor=P.+Zarrinkarauthor=N.+S.+Gray&title=High-throughput+kinase+profiling%3A+a+more+efficient+approach+toward+the+discovery+of+new+kinase+inhibitors&doi=10.1016%2Fj.chembiol.2011.05.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">High-Throughput Kinase Profiling: A More Efficient Approach toward the Discovery of New Kinase Inhibitors</span></div><div class="casAuthors">Miduturu, Chandrasekhar V.; Deng, Xianming; Kwiatkowski, Nicholas; Yang, Wannian; Brault, Laurent; Filippakopoulos, Panagis; Chung, Eunah; Yang, Qingkai; Schwaller, Juerg; Knapp, Stefan; King, Randall W.; Lee, Jiing-Dwan; Herrgard, Sanna; Zarrinkar, Patrick; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">868-879</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Selective protein kinase inhibitors have only been developed against a small no. of kinase targets.  Here we demonstrate that "high-throughput kinase profiling" is an efficient method for the discovery of lead compds. for established as well as unexplored kinase targets.  We screened a library of 118 compds. constituting two distinct scaffolds (furan-thiazolidinediones and pyrimido-diazepines) against a panel of 353 kinases.  A distinct kinase selectivity profile was obsd. for each scaffold.  Selective inhibitors were identified with submicromolar cellular activity against PIM1, ERK5, ACK1, MPS1, PLK1-3, and Aurora A,B kinases.  In addn., we identified potent inhibitors for so far unexplored kinases such as DRAK1, HIPK2, and DCAMKL1 that await further evaluation.  This inhibitor-centric approach permits comprehensive assessment of a scaffold of interest and represents an efficient and general strategy for identifying new selective kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKLvN9eLNvybVg90H21EOLACvtfcHk0ljtJ5jDfK1dTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsFarurw%253D&md5=d62a4771b1215551f3913b93d6eca7ee</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DMiduturu%26aufirst%3DC.%2BV.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DKwiatkowski%26aufirst%3DN.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DBrault%26aufirst%3DL.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DChung%26aufirst%3DE.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DSchwaller%26aufirst%3DJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DKing%26aufirst%3DR.%2BW.%26aulast%3DLee%26aufirst%3DJ.%2BD.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DZarrinkar%26aufirst%3DP.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DHigh-throughput%2520kinase%2520profiling%253A%2520a%2520more%2520efficient%2520approach%2520toward%2520the%2520discovery%2520of%2520new%2520kinase%2520inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D868%26epage%3D879%26doi%3D10.1016%2Fj.chembiol.2011.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoreen, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hur, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabatini, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Discovery of 9-(6-aminopyridin-3-yl)-1-(3-(trifluoromethyl)phenyl)benzo[h][1,6]naphthyridin-2(1H)-one (Torin2) as a potent, selective, and orally available mammalian target of rapamycin (mTOR) inhibitor for treatment of cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1473</span>– <span class="NLM_lpage">1480</span>, <span class="refDoi"> DOI: 10.1021/jm101520v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101520v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvFeis7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1473-1480&author=Q.+Liuauthor=J.+Wangauthor=S.+A.+Kangauthor=C.+C.+Thoreenauthor=W.+Hurauthor=T.+Ahmedauthor=D.+M.+Sabatiniauthor=N.+S.+Gray&title=Discovery+of+9-%286-aminopyridin-3-yl%29-1-%283-%28trifluoromethyl%29phenyl%29benzo%5Bh%5D%5B1%2C6%5Dnaphthyridin-2%281H%29-one+%28Torin2%29+as+a+potent%2C+selective%2C+and+orally+available+mammalian+target+of+rapamycin+%28mTOR%29+inhibitor+for+treatment+of+cancer&doi=10.1021%2Fjm101520v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 9-(6-Aminopyridin-3-yl)-1-(3-(trifluoromethyl)phenyl)benzo[h][1,6]naphthyridin-2(1H)-one (Torin2) as a potent, selective, and orally available mammalian target of rapamycin (mTOR) inhibitor for treatment of cancer</span></div><div class="casAuthors">Liu, Qingsong; Wang, Jinhua; Kang, Seong A.; Thoreen, Carson C.; Hur, Wooyoung; Ahmed, Tausif; Sabatini, David M.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1473-1480</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The mTOR mediated PI3K/AKT/mTOR signal transduction pathway has been demonstrated to play a key role in a broad spectrum of cancers.  Starting from the mTOR selective inhibitor 1 (Torin1), a focused medicinal chem. effort led to the discovery of an improved mTOR inhibitor 3 (Torin2, I), which possesses an EC50 of 0.25 nM for inhibiting cellular mTOR activity.  Compd. 3 exhibited 800-fold selectivity over PI3K (EC50: 200 nM) and over 100-fold binding selectivity relative to 440 other protein kinases.  Compd. 3 has significantly improved bioavailability (54%), metabolic stability, and plasma exposure relative to compd. 1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpznkwEqQGOULVg90H21EOLACvtfcHk0ljtJ5jDfK1dTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvFeis7c%253D&md5=845ed4ca35e5544954db71cd6813528e</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm101520v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101520v%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DS.%2BA.%26aulast%3DThoreen%26aufirst%3DC.%2BC.%26aulast%3DHur%26aufirst%3DW.%26aulast%3DAhmed%26aufirst%3DT.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DDiscovery%2520of%25209-%25286-aminopyridin-3-yl%2529-1-%25283-%2528trifluoromethyl%2529phenyl%2529benzo%255Bh%255D%255B1%252C6%255Dnaphthyridin-2%25281H%2529-one%2520%2528Torin2%2529%2520as%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520available%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%2520inhibitor%2520for%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1473%26epage%3D1480%26doi%3D10.1021%2Fjm101520v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redmond, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urisman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burlingame, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pak, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jovicic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gitler, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seeley, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddique, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigio, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trojanowski, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, E. J.</span></span> <span> </span><span class="NLM_article-title">Activation of HIPK2 promotes ER stress-mediated neurodegeneration in amyotrophic lateral sclerosis</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">41</span>– <span class="NLM_lpage">55</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2016.05.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1016%2Fj.neuron.2016.05.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2016&pages=41-55&author=S.+Leeauthor=Y.+Shangauthor=S.+A.+Redmondauthor=A.+Urismanauthor=A.+A.+Tangauthor=K.+H.+Liauthor=A.+L.+Burlingameauthor=R.+A.+Pakauthor=A.+Jovicicauthor=A.+D.+Gitlerauthor=J.+Wangauthor=N.+S.+Grayauthor=W.+W.+Seeleyauthor=T.+Siddiqueauthor=E.+H.+Bigioauthor=V.+M.+Leeauthor=J.+Q.+Trojanowskiauthor=J.+R.+Chanauthor=E.+J.+Huang&title=Activation+of+HIPK2+promotes+ER+stress-mediated+neurodegeneration+in+amyotrophic+lateral+sclerosis&doi=10.1016%2Fj.neuron.2016.05.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2016.05.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2016.05.021%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%26aulast%3DShang%26aufirst%3DY.%26aulast%3DRedmond%26aufirst%3DS.%2BA.%26aulast%3DUrisman%26aufirst%3DA.%26aulast%3DTang%26aufirst%3DA.%2BA.%26aulast%3DLi%26aufirst%3DK.%2BH.%26aulast%3DBurlingame%26aufirst%3DA.%2BL.%26aulast%3DPak%26aufirst%3DR.%2BA.%26aulast%3DJovicic%26aufirst%3DA.%26aulast%3DGitler%26aufirst%3DA.%2BD.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DSeeley%26aufirst%3DW.%2BW.%26aulast%3DSiddique%26aufirst%3DT.%26aulast%3DBigio%26aufirst%3DE.%2BH.%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DChan%26aufirst%3DJ.%2BR.%26aulast%3DHuang%26aufirst%3DE.%2BJ.%26atitle%3DActivation%2520of%2520HIPK2%2520promotes%2520ER%2520stress-mediated%2520neurodegeneration%2520in%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DNeuron%26date%3D2016%26volume%3D91%26spage%3D41%26epage%3D55%26doi%3D10.1016%2Fj.neuron.2016.05.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruce, I.</span>; <span class="NLM_string-name">Budd, E.</span>; <span class="NLM_string-name">Edwards, L.</span>; <span class="NLM_string-name">Howsham, C.</span></span> <span> </span><span class="NLM_article-title">Pyridines and Pyrazines as Inhibitors of Pi3k</span>. PCT Int. Appl. <span class="NLM_patent">WO 2009115517 A2</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=I.+Bruce&author=E.+Budd&author=L.+Edwards&author=C.+Howsham&title=Pyridines+and+Pyrazines+as+Inhibitors+of+Pi3k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBruce%26aufirst%3DI.%26atitle%3DPyridines%2520and%2520Pyrazines%2520as%2520Inhibitors%2520of%2520Pi3k%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krug, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinemann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, U.</span></span> <span> </span><span class="NLM_article-title">XDSAPP: a graphical user interface for the convenient processing of diffraction data using XDS</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">568</span>– <span class="NLM_lpage">572</span>, <span class="refDoi"> DOI: 10.1107/S0021889812011715</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1107%2FS0021889812011715" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsFGmtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2012&pages=568-572&author=M.+Krugauthor=M.+S.+Weissauthor=U.+Heinemannauthor=U.+Mueller&title=XDSAPP%3A+a+graphical+user+interface+for+the+convenient+processing+of+diffraction+data+using+XDS&doi=10.1107%2FS0021889812011715"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">XDSAPP: a graphical user interface for the convenient processing of diffraction data using XDS</span></div><div class="casAuthors">Krug, Michael; Weiss, Manfred S.; Heinemann, Udo; Mueller, Uwe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">568-572</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">XDSAPP is a Tcl/Tk-based graphical user interface for the easy and convenient processing of diffraction data sets using XDS.  It provides easy access to all XDS functionalities, automates the data processing and generates graphical plots of various data set statistics provided by XDS.  By incorporating addnl. software, further information on certain features of the data set, such as radiation decay during data collection or the presence of pseudo-translational symmetry and/or twinning, can be obtained.  Intensity files suitable for CCP4, CNS and SHELX are generated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCqFLQ2J-k07Vg90H21EOLACvtfcHk0lggXqDmLUqQnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnsFGmtLo%253D&md5=8f0b78fdea7ed6cc580de9eb561e8b9e</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1107%2FS0021889812011715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889812011715%26sid%3Dliteratum%253Aachs%26aulast%3DKrug%26aufirst%3DM.%26aulast%3DWeiss%26aufirst%3DM.%2BS.%26aulast%3DHeinemann%26aufirst%3DU.%26aulast%3DMueller%26aufirst%3DU.%26atitle%3DXDSAPP%253A%2520a%2520graphical%2520user%2520interface%2520for%2520the%2520convenient%2520processing%2520of%2520diffraction%2520data%2520using%2520XDS%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2012%26volume%3D45%26spage%3D568%26epage%3D572%26doi%3D10.1107%2FS0021889812011715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afonine, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunkoczi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echols, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Headd, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapral, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oeffner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwart, P. H.</span></span> <span> </span><span class="NLM_article-title">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1107/S0907444909052925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunkocziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.+W.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grosse-Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=PHENIX%3A+a+comprehensive+Python-based+system+for+macromolecular+structure+solution&doi=10.1107%2FS0907444909052925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0lggXqDmLUqQnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunkoczi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.%2BW.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DPHENIX%253A%2520a%2520comprehensive%2520Python-based%2520system%2520for%2520macromolecular%2520structure%2520solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D213%26epage%3D221%26doi%3D10.1107%2FS0907444909052925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodson, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keegan, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krissinel, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNicholas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannu, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potterton, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, K. S.</span></span> <span> </span><span class="NLM_article-title">Overview of the CCP4 suite and current developments</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">242</span>, <span class="refDoi"> DOI: 10.1107/S0907444910045749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1107%2FS0907444910045749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=21460441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=235-242&author=M.+D.+Winnauthor=C.+C.+Ballardauthor=K.+D.+Cowtanauthor=E.+J.+Dodsonauthor=P.+Emsleyauthor=P.+R.+Evansauthor=R.+M.+Keeganauthor=E.+B.+Krissinelauthor=A.+G.+Leslieauthor=A.+McCoyauthor=S.+J.+McNicholasauthor=G.+N.+Murshudovauthor=N.+S.+Pannuauthor=E.+A.+Pottertonauthor=H.+R.+Powellauthor=R.+J.+Readauthor=A.+Vaginauthor=K.+S.+Wilson&title=Overview+of+the+CCP4+suite+and+current+developments&doi=10.1107%2FS0907444910045749"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the CCP4 suite and current developments</span></div><div class="casAuthors">Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.; Dodson, Eleanor J.; Emsley, Paul; Evans, Phil R.; Keegan, Ronan M.; Krissinel, Eugene B.; Leslie, Andrew G. W.; McCoy, Airlie; McNicholas, Stuart J.; Murshudov, Garib N.; Pannu, Navraj S.; Potterton, Elizabeth A.; Powell, Harold R.; Read, Randy J.; Vagin, Alexei; Wilson, Keith S.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  The CCP4 (Collaborative Computational Project, No. 4) software suite is a collection of programs and assocd. data and software libraries which can be used for macromol. structure detn. by X-ray crystallog.  The suite is designed to be flexible, allowing users a no. of methods of achieving their aims.  The programs are from a wide variety of sources but are connected by a common infrastructure provided by std. file formats, data objects and graphical interfaces.  Structure soln. by macromol. crystallog. is becoming increasingly automated and the CCP4 suite includes several automation pipelines.  After giving a brief description of the evolution of CCP4 over the last 30 years, an overview of the current suite is given.  While detailed descriptions are given in the accompanying articles, here it is shown how the individual programs contribute to a complete software package.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_wWMMIol6UrVg90H21EOLACvtfcHk0lh5P8RjBFpjMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D&md5=c407e4d47bef46864be336d60147c17d</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1107%2FS0907444910045749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910045749%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DBallard%26aufirst%3DC.%2BC.%26aulast%3DCowtan%26aufirst%3DK.%2BD.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DKeegan%26aufirst%3DR.%2BM.%26aulast%3DKrissinel%26aufirst%3DE.%2BB.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%26aulast%3DMcCoy%26aufirst%3DA.%26aulast%3DMcNicholas%26aufirst%3DS.%2BJ.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DPotterton%26aufirst%3DE.%2BA.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26atitle%3DOverview%2520of%2520the%2520CCP4%2520suite%2520and%2520current%2520developments%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D235%26epage%3D242%26doi%3D10.1107%2FS0907444910045749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skubak, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebedev, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannu, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholls, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A. A.</span></span> <span> </span><span class="NLM_article-title">REFMAC5 for the refinement of macromolecular crystal structures</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1107/S0907444911001314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1107%2FS0907444911001314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=21460454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=355-367&author=G.+N.+Murshudovauthor=P.+Skubakauthor=A.+A.+Lebedevauthor=N.+S.+Pannuauthor=R.+A.+Steinerauthor=R.+A.+Nichollsauthor=M.+D.+Winnauthor=F.+Longauthor=A.+A.+Vagin&title=REFMAC5+for+the+refinement+of+macromolecular+crystal+structures&doi=10.1107%2FS0907444911001314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">REFMAC5 for the refinement of macromolecular crystal structures</span></div><div class="casAuthors">Murshudov, Garib N.; Skubak, Pavol; Lebedev, Andrey A.; Pannu, Navraj S.; Steiner, Roberto A.; Nicholls, Robert A.; Winn, Martyn D.; Long, Fei; Vagin, Alexei A.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">355-367</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">This paper describes various components of the macromol. crystallog. refinement program REFMAC5, which is distributed as part of the CCP4 suite.  REFMAC5 utilizes different likelihood functions depending on the diffraction data employed (amplitudes or intensities), the presence of twinning and the availability of SAD/SIRAS exptl. diffraction data.  To ensure chem. and structural integrity of the refined model, REFMAC5 offers several classes of restraints and choices of model parameterization.  Reliable models at resolns. at least as low as 4 Å can be achieved thanks to low-resoln. refinement tools such as secondary-structure restraints, restraints to known homologous structures, automatic global and local NCS restraints, 'jelly-body' restraints and the use of novel long-range restraints on at. displacement parameters (ADPs) based on the Kullback-Leibler divergence.  REFMAC5 addnl. offers TLS parameterization and, when high-resoln. data are available, fast refinement of anisotropic ADPs.  Refinement in the presence of twinning is performed in a fully automated fashion.  REFMAC5 is a flexible and highly optimized refinement package that is ideally suited for refinement across the entire resoln. spectrum encountered in macromol. crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5Jq-i2qIq5rVg90H21EOLACvtfcHk0lh5P8RjBFpjMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D&md5=f8f3202d246908500057ad7c71015b7b</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1107%2FS0907444911001314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911001314%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DSkubak%26aufirst%3DP.%26aulast%3DLebedev%26aufirst%3DA.%2BA.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DSteiner%26aufirst%3DR.%2BA.%26aulast%3DNicholls%26aufirst%3DR.%2BA.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DLong%26aufirst%3DF.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26atitle%3DREFMAC5%2520for%2520the%2520refinement%2520of%2520macromolecular%2520crystal%2520structures%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D355%26epage%3D367%26doi%3D10.1107%2FS0907444911001314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and development of Coot</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0lh5P8RjBFpjMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yabut, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domogauer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcangelo, G.</span></span> <span> </span><span class="NLM_article-title">Dyrk1A overexpression inhibits proliferation and induces premature neuronal differentiation of neural progenitor cells</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">4004</span>– <span class="NLM_lpage">4014</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.4711-09.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1523%2FJNEUROSCI.4711-09.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=20237271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvVantLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=4004-4014&author=O.+Yabutauthor=J.+Domogauerauthor=G.+D%E2%80%99Arcangelo&title=Dyrk1A+overexpression+inhibits+proliferation+and+induces+premature+neuronal+differentiation+of+neural+progenitor+cells&doi=10.1523%2FJNEUROSCI.4711-09.2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Dyrk1A overexpression inhibits proliferation and induces premature neuronal differentiation of neural progenitor cells</span></div><div class="casAuthors">Yabut, Odessa; Domogauer, Jason; D'Arcangelo, Gabriella</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4004-4014</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Dyrk1A is a member of the mammalian Dyrk [dual-specificity tyrosine-(Y)-phosphorylation regulated kinase] family of protein kinases that is expressed at high levels in the brain, but its role in the development and function of this organ is not well understood.  The human DYRK1A gene is located on trisomic chromosome 21 in Down syndrome (DS) patients, leading to its overexpression.  Dyrk1A is also overexpressed in animal models of DS and in gene-specific transgenic mice that consistently exhibit cognitive impairment.  To elucidate the cellular and mol. mechanisms that are affected by increased levels of Dyrk1A in the developing brain, we overexpressed this kinase in the embryonic mouse neocortex using the in utero electroporation technique.  We found that Dyrk1A overexpression inhibits neural cell proliferation and promotes premature neuronal differentiation in the developing cerebral cortex without affecting cell fate and layer positioning.  These effects are dependent on the Dyrk1A kinase activity and are mediated by the nuclear export and degrdn. of cyclin D1.  This study identifies specific Dyrk1A-induced mechanisms that disrupt the normal process of corticogenesis and possibly contribute to cognitive impairment obsd. in DS patients and animal models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiDJCyOeZkjLVg90H21EOLACvtfcHk0liWVL0kngO7YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvVantLs%253D&md5=78bb38762bdf2aa1b98be076ce56c209</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4711-09.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4711-09.2010%26sid%3Dliteratum%253Aachs%26aulast%3DYabut%26aufirst%3DO.%26aulast%3DDomogauer%26aufirst%3DJ.%26aulast%3DD%25E2%2580%2599Arcangelo%26aufirst%3DG.%26atitle%3DDyrk1A%2520overexpression%2520inhibits%2520proliferation%2520and%2520induces%2520premature%2520neuronal%2520differentiation%2520of%2520neural%2520progenitor%2520cells%26jtitle%3DJ.%2520Neurosci.%26date%3D2010%26volume%3D30%26spage%3D4004%26epage%3D4014%26doi%3D10.1523%2FJNEUROSCI.4711-09.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paudel, H. K.</span></span> <span> </span><span class="NLM_article-title">Glycogen synthase kinase 3 beta phosphorylates Alzheimer’s disease-specific Ser(396) of microtubule-associated protein tau by a sequential mechanism</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">3125</span>– <span class="NLM_lpage">3133</span>, <span class="refDoi"> DOI: 10.1021/bi051634r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi051634r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=3125-3133&author=T.+Liauthor=H.+K.+Paudel&title=Glycogen+synthase+kinase+3+beta+phosphorylates+Alzheimer%E2%80%99s+disease-specific+Ser%28396%29+of+microtubule-associated+protein+tau+by+a+sequential+mechanism&doi=10.1021%2Fbi051634r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fbi051634r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi051634r%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DT.%26aulast%3DPaudel%26aufirst%3DH.%2BK.%26atitle%3DGlycogen%2520synthase%2520kinase%25203%2520beta%2520phosphorylates%2520Alzheimer%25E2%2580%2599s%2520disease-specific%2520Ser%2528396%2529%2520of%2520microtubule-associated%2520protein%2520tau%2520by%2520a%2520sequential%2520mechanism%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D3125%26epage%3D3133%26doi%3D10.1021%2Fbi051634r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skytte
Rasmussen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mouilleron, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar Shrestha, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowitz Larsen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abudu Princely, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Reilly, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sjottem, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tooze, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamark, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansen, T.</span></span> <span> </span><span class="NLM_article-title">ATG4B contains a C-terminal LIR motif important for binding and efficient cleavage of mammalian orthologs of yeast Atg8</span>. <i>Autophagy</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">834</span>– <span class="NLM_lpage">853</span>, <span class="refDoi"> DOI: 10.1080/15548627.2017.1287651</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;key=10.1080%2F15548627.2017.1287651" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=834-853&author=M.+Skytte%0ARasmussenauthor=S.+Mouilleronauthor=B.+Kumar+Shresthaauthor=M.+Wirthauthor=R.+Leeauthor=K.+Bowitz+Larsenauthor=Y.+Abudu+Princelyauthor=N.+O%E2%80%99Reillyauthor=E.+Sjottemauthor=S.+A.+Toozeauthor=T.+Lamarkauthor=T.+Johansen&title=ATG4B+contains+a+C-terminal+LIR+motif+important+for+binding+and+efficient+cleavage+of+mammalian+orthologs+of+yeast+Atg8&doi=10.1080%2F15548627.2017.1287651"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1080%2F15548627.2017.1287651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15548627.2017.1287651%26sid%3Dliteratum%253Aachs%26aulast%3DSkytte%2BRasmussen%26aufirst%3DM.%26aulast%3DMouilleron%26aufirst%3DS.%26aulast%3DKumar%2BShrestha%26aufirst%3DB.%26aulast%3DWirth%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DR.%26aulast%3DBowitz%2BLarsen%26aufirst%3DK.%26aulast%3DAbudu%2BPrincely%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DN.%26aulast%3DSjottem%26aufirst%3DE.%26aulast%3DTooze%26aufirst%3DS.%2BA.%26aulast%3DLamark%26aufirst%3DT.%26aulast%3DJohansen%26aufirst%3DT.%26atitle%3DATG4B%2520contains%2520a%2520C-terminal%2520LIR%2520motif%2520important%2520for%2520binding%2520and%2520efficient%2520cleavage%2520of%2520mammalian%2520orthologs%2520of%2520yeast%2520Atg8%26jtitle%3DAutophagy%26date%3D2017%26volume%3D13%26spage%3D834%26epage%3D853%26doi%3D10.1080%2F15548627.2017.1287651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIL" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIL','PDB','6EIL'); return false;">PDB: 6EIL</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIP','PDB','6EIP'); return false;">PDB: 6EIP</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIJ','PDB','6EIJ'); return false;">PDB: 6EIJ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIR','PDB','6EIR'); return false;">PDB: 6EIR</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIQ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIQ','PDB','6EIQ'); return false;">PDB: 6EIQ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIS','PDB','6EIS'); return false;">PDB: 6EIS</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EJ4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EJ4','PDB','6EJ4'); return false;">PDB: 6EJ4</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIF" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIF','PDB','6EIF'); return false;">PDB: 6EIF</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIV" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIV','PDB','6EIV'); return false;">PDB: 6EIV</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5A3X" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5A3X','PDB','5A3X'); return false;">PDB: 5A3X</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5A4T" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5A4T','PDB','5A4T'); return false;">PDB: 5A4T</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LXD" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LXD','PDB','5LXD'); return false;">PDB: 5LXD</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LXC" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LXC','PDB','5LXC'); return false;">PDB: 5LXC</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i32"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01847">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_40502"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01847">10.1021/acs.jmedchem.7b01847</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Complete table with all 23 inhibitors, molecular formula strings of the inhibitors, scaffolds of all 23 inhibitors; crystallographic table of the nine crystal structures, omit maps, surface plots and a superimposition of all the nine inhibitors bound to the ATP pocket of DYRK1A, table of the kinome scan, additional tau phosphorylation assays, overview of the cell based NFAT mediated luciferase reporter gene activity assay including the positive controls, and NMR spectra and HPLC of the new compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01847/suppl_file/jm7b01847_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Detailed kinome scan results (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01847/suppl_file/jm7b01847_si_002.csv">CSV</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01847/suppl_file/jm7b01847_si_003.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01847/suppl_file/jm7b01847_si_001.pdf">jm7b01847_si_001.pdf (2.48 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01847/suppl_file/jm7b01847_si_002.csv">jm7b01847_si_002.csv (17.14 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01847/suppl_file/jm7b01847_si_003.csv">jm7b01847_si_003.csv (1.81 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB codes for DYRK1A complexes are the following: compound <b>AC12</b>, 6EIF; compound <b>AC15</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EJ4">6EJ4</a>; compound <b>AC20</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIJ">6EIJ</a>; compound <b>AC22</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIL">6EIL</a>; compound <b>AC23</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIP">6EIP</a>; compound <b>AC24</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIQ">6EIQ</a>; compound <b>AC25</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIR">6EIR</a>; compound <b>AC27</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIS">6EIS</a>; compound <b>AC28</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EIV">6EIV</a>. Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01847&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-17%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01847%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01847" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                11MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67996adb991e3c64","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
